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In the mammalian nervous system, synaptic transmission is largely mediated by 
ligand-gated ion channels which are aggregated in high density in the membrane of the 
post-synaptic target cell in direct apposition to nerve terminals. In the central nervous 
system (CNS), the majority of excitatory input is mediated by glutamatergic α-amino-3-
hydroxy-5-methylisoxazole-4-propionic acid (AMPA) and N-methyl D-aspartate 
(NMDA) receptors, while inhibitory transmission is governed almost entirely by glycine 
and γ-aminobutyric acid (GABAA) receptors. In the peripheral nervous system (PNS), 
cholinergic transmission is mediated at the neuromuscular junction (NMJ) by 
acetylcholine receptors (AChRs) clustered on the muscle cell surface. In all synapses, the 
efficiency of synaptic transmission is largely controlled by the density of 
neurotransmitter receptors, and changes in receptor density have been shown to be crucial 
for synaptic development and synaptic plasticity. 
Although neuromuscular synapses and synapses within the CNS differ markedly 
in a number of respects, the list of striking similarities between peripheral cholinergic 
synapses and central glycinergic, GABAergic and glutamatergic synapses is growing: the 
role of receptor recycling in maintaining receptor density, the activity-dependence of 
receptor dynamics, the rapid dynamics of receptor-associated proteins and the differential 
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regulation of receptor and receptor-associated proteins are all ways in which the 
machinery of the NMJ has recently been shown to behave similarly to synapses in the 
CNS. It therefore seems likely that similar cellular and molecular mechanisms may be 
regulating the clustering, maintenance and stability of post-synaptic receptor densities. 
These similarities are intriguing enough to justify the use of the NMJ as a model synapse 
that may inform processes occurring at synapses in the central nervous system.  
The simple question still remains, however: why use the NMJ as a model 
synapse? First, the neuromuscular synapse is large and easily accessible, allowing 
repetitive imaging in the living animal. Second, the extremely high-affinity AChR ligand, 
bungarotoxin, can be used to selectively label AChRs at the post-synaptic membrane. 
Finally, the large number of receptors and associated proteins at the post-synaptic 
membrane allows protein number and density to be accurately quantified. Together, these 
characteristics enable the investigation of receptor dynamics at individual synapses in 
vivo over long periods of time. It is our hope, therefore, that the robust findings in the 
NMJ can provide insights and potential new avenues of research, either methodologically 
or conceptually, for studies of protein dynamics in the central nervous system. Indeed, in 
this thesis I show a number of ways in which the post-synaptic protein dynamics of the 
NMJ are similar, in ways not previously thought, to the dynamics of PSD proteins at 
inhibitory and/or excitatory synapses in the CNS. Before engaging these studies, 
however, it is necessary to first put them in context.  
The body of work contained in this thesis focuses on two critical protein 
components of the post-synaptic scaffolding complex at the NMJ which allow synaptic 
transmission to occur: the acetylcholine receptors and the receptor-associated protein of 
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the synapse (rapsyn), which underlies the receptor and anchors it in place at the muscle 
surface. Accordingly, the introduction will be broken into two parts that each serve as a 
separate reviews: the first (“Running to stand still: ionotropic receptor dynamics at 
central and peripheral synapses”) will focus on the current state of our understanding of 
ionotropic receptor dynamics in synapses both in the central and peripheral nervous 
systems, and the second (“The role of dynamic receptor-associated proteins in the 
development and plasticity of the synapse”) will outline the emerging research focus on 
the role of receptor-associated proteins in the regulation of receptor dynamics in these 
synapses. 
 
A note on the use of the term “turnover”. “Turnover” has been used to describe 
protein dynamics for decades. The definition now has come to refer to a number of 
different protein properties. One definition of turnover is the time that it takes for a 
protein to be synthesized, inserted into the membrane, removed and degraded. This is 
normally referred to as “metabolic turnover”. Experiments using radioactive ligands such 
as bungarotoxin-35I, on the other hand, label acetylcholine receptors already on the 
membrane surface at the time of incubation, and so “turnover” in these experiments 
(found by measuring the radioactivity remaining in the membrane at later time points) is 
a determination of the time it takes for surface receptors to be internalized, degraded and 
ejected from the cell. This might be called “surface dwell-time”. The types of 
experiments performed in our lab deal almost exclusively with synaptic receptors. 
Therefore, when we measure changes in receptor number using fluorescent ligands, we 
are determining the dwell-time of receptors in the synapse. In this dissertation this last 
 4
definition of turnover is used and is referred to as “synaptic dwell-time”, “synaptic 
turnover” or simply “receptor turnover”.  
Running to Stand Still: Ionotropic Receptor Dynamics at Central and 
Peripheral Synapses 
Previously published in Molecular Neurobiology (Mol Neurobiol. 2006 Oct;34(2):137-51) 
Emile G. Bruneau and Mohammed Akaaboune 
Abstract 
In order for synapses to form and function, neurotransmitter receptors must be 
recruited to a location on the post-synaptic cell in direct apposition to pre-synaptic 
neurotransmitter release. Once inserted into the post-synaptic membrane, receptors are 
not fixed in place, however, but are permanently exchanged between synaptic and extra-
synaptic regions, and cycle between the surface and intracellular compartments. In this 
review, we will highlight and compare the current knowledge about the dynamics of 
acetylcholine receptors at the vertebrate peripheral neuromuscular junction and AMPA, 
NMDA, and GABA receptors in central synapses.  
Introduction 
Much of our understanding about rapid changes in receptor trafficking in response 
to activity has come from studies on the AMPA receptor (Bredt and Nicoll, 2003; 
Malenka, 2003; Collingridge et al., 2004). Using primary neuronal cultures and 
organotypic hippocampal slice preparations a large body of work has found that 
AMPARs are inserted and removed rapidly from the synapse in response to different 
stimulation protocols. These changes in receptor density are involved in the processes of 
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long-term potentiation and long-term depression, which have long been thought to be 
cellular mechanisms of learning and memory (Bliss and Lomo, 1973; Bear and Malenka, 
1994). Interestingly, many of the characteristic behaviors of AMPA receptors have been 
found to apply to NMDA and GABA receptors in the central nervous system (CNS) and 
acetylcholine receptors (AChRs) in peripheral neuromuscular junctions (NMJs).  
Just as findings in the CNS have directed investigation in peripheral synapses, 
work in the NMJ has given great insights into the processes of pre-synaptic vesicular 
release, synaptic pruning, receptor clustering and surface mobility that have proved to be 
applicable to synapses in the central nervous system. This is due largely to the 
accessibility of the neuromuscular junction and the availability of the highly specific 
acetylcholine receptor ligand bungarotoxin, which has allowed the analysis of in vivo 
synapse formation and maintenance in living animals. More recently, much work has 
been done to understand the trafficking of acetylcholine receptors at the neuromuscular 
junction. The NMJ is dramatically larger than a central synapse and has the extremely 
high synaptic receptor density of >10,000 receptors/μm2. Building on research begun 
over 3 decades ago into the dynamics of AChRs, more recent studies using conjugated 
bungarotoxin, fluorescent labeling and time-lapse imaging in the living mouse have given 
us great insights into synaptic receptor dynamics in vivo.  
While each receptor has its own complement of accessory proteins and regulatory 
elements to enable receptor trafficking and activity-dependent changes in trafficking to 
occur, some interesting commonalities between excitatory and inhibitory synapses of the 
central nervous system, and cholinergic synapses in the peripheral nervous system have 
emerged that will also be explored in this review. 
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Regulation of AMPAR dynamics at excitatory central synapses: 
The AMPA receptor is a tetrameric ionotropic glutamate receptor composed of 
Glu1-4 subunits (Hollmann and Heinemann, 1994), which are expressed as GluR1/2 and 
GluR2/3 heteromers in most brain regions (Zhu et al., 2000). A number of studies in 
recent years have used both direct and indirect methods to measure basal dynamics 
(removal, insertion, recycling and lateral mobility) of AMPARs (Figure 1A). These 
studies have shown that the half-life of AMPARs varies widely depending on cell type 
and technique used (optical, biochemical or electrophysiological), ranging from minutes 
to days. For example, [S]35 uptake experiments have estimated the turnover of AMPARs 
in cerebellar granule cells to be 18-23 hours for GluR2/3 and GluR4 subunits (Huh and 
Wenthold, 1999), and 48 hours for the GluR1 subunit (Archibald et al., 1998), while 
biotinylation assays have estimated surface GluR1 expression to have a t1/2 of 30 hours 
on cultured cerebellar granule cells (Archibald et al., 1998), 11-43 hours on spinal cord 
cultures (depending upon culture age) (Mammen et al., 1997; O'Brien et al., 1998) and 
~1-2 hours on cultured hippocampal neurons (Ehlers, 2000; Passafaro et al., 2001; Park et 
al., 2004). Using fluorescent bungarotoxin to bind to recombinant AMPARs and 
fluorescent AMPAR antibodies, however, the insertion and removal of AMPARs under 
basal conditions has been shown to occur very rapidly, on the order of minutes (Lin et al., 
2000; Sekine-Aizawa and Huganir, 2004). Similar results were obtained when 
electrophysiological recording were used: the run down or run up of synaptic AMPAR 
EPSCs in response to pharmacological blockade of either exocytosis or endocytosis was 
found to occur rapidly over a time course of minutes (Nishimune et al., 1998; Luscher et 
al., 1999; Luthi et al., 1999; Lee et al., 2004).  
 7
One limitation of most of these studies is that they are not able to resolve synaptic 
and extra-synaptic receptor pools. Most recently, an elegant study using photoinactivation 
of AMPARs with the compound ANQX allowed a more complete analysis of AMPA 
receptors dynamics (Adesnik et al., 2005). This technique has the power to specifically 
determine AMPAR turnover at distinct neuronal regions (synaptic, extrasynaptic and 
soma). Interestingly, this study found that AMPAR insertion at the soma was rapid (t1/2 
<15 minutes), while AMPAR recovery at extra-synaptic and synaptic sites on the 
dendrites was much slower, on the order of hours. Although the average half-life on the 
neuronal surface is reasonably consistent with the average surface half-life estimated in 
previous work, this study is still at odds with a number of previous studies showing fast 
synaptic insertion and removal of AMPARs.  
Although the above-mentioned estimates of AMPAR half-life under basal 
conditions vary widely from minutes to days, it is almost universally accepted that rapid 
and significant changes in AMPAR number can occur within seconds at synaptic sites in 
response to activity. For example, during long-term depression (LTD) or long-term 
potentiation (LTP), the endocytosis, exocytosis or recycling of receptors can be altered by 
the regulated association of AMPARs with a number of intracellular proteins which 
increase or decrease synaptic AMPAR expression (Bredt and Nicoll, 2003; Gomes et al., 
2003; Malenka, 2003; Collingridge et al., 2004; Palmer et al., 2005). LTP and LTD, 
which have been most extensively studied in the hippocampus, have been shown to 
involve changes in the GluR1/2 receptors which are expressed at a low basal level 
synaptically and are then inserted into the synapse rapidly in response to LTP induction 
protocols (Shi et al., 1999; Ehlers, 2000; Hayashi et al., 2000; Lu et al., 2001; Passafaro 
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et al., 2001; Shi et al., 2001; Lee et al., 2004). Conversely, GluR1/2 receptors are 
removed rapidly in response to LTD or de-potentiation (Ehlers, 2000; Lin et al., 2000; 
Lee et al., 2002; Brown et al., 2005). Consistent with this, GluR2 and GluR2/3 knockout 
mice show no deficits in LTP or LTP-dependent learning (Jia et al., 1996; Meng et al., 
2003) while the targeted deletion of GluR1 significantly impairs LTP (Zamanillo et al., 
1999) and hippocampus-dependent learning (Reisel et al., 2002; Schmitt et al., 2003), 
which can be rescued by the delivery of GluR1 into the hippocampus (Schmitt et al., 
2005). Further, rapid experience-dependent insertion of GluR1/2 receptors has been 
shown to occur in vivo after fear conditioning in the amygdala (Rumpel et al., 2005), and 
the rapid removal of GluR1/2 receptors has been observed in vivo after monocular 
deprivation in the visual cortex (Heynen et al., 2003) or activity deprivation in the barrel 
cortex (Takahashi et al., 2003). 
AMPAR dynamics are regulated by a host of accessory proteins that facilitate or 
inhibit the insertion and removal of AMPARs. For example, the TARP family of proteins 
(γ-3, γ-4, γ-8 and Stargazin (γ-2)) bind AMPARs to the post-synaptic density protein, 
PSD-95 to mediate AMPAR synaptic clustering (Hashimoto et al., 1999; Chen et al., 
2000; Schnell et al., 2002; Rouach et al., 2005; Tomita et al., 2005a; Nicoll et al., 2006). 
TARP-AMPAR association is activity-dependent, as glutamate binding has been shown 
to dissociate TARPs from AMPARs (Tomita et al., 2004), and Stargazin phosphorylation 
has been shown to mediate the expression of both LTP and LTD (Tomita et al., 2005b). It 
has been suggested that TARP-AMPAR dissociation might facilitate lateral diffusion of 
AMPARs out of synapses and into the extra-synaptic space, where they could be 
internalized by clathrin-coated pits (Triller and Choquet, 2003; Tomita et al., 2005a). In 
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fact, a mechanism of receptor delivery and removal from synapses by extra-synaptic 
endo- and exocytosis and lateral diffusion was first described for acetylcholine receptors 
in the neuromuscular junction (Axelrod et al., 1976) and has since been found to occur 
similarly for AMPARs. In glutamatergic synapses, endocytic zones have been identified 
in the extra-synaptic area close to the PSD (Blanpied et al., 2002), and pH-sensitive GFP-
conjugates have shown that internalization occurs in this area in response to NMDAR 
activation (Ashby et al., 2004). The lateral movement of AMPARs between synaptic and 
extra-synaptic spaces is regulated by calcium (Borgdorff and Choquet, 2002), and single 
particle imaging shows that receptor mobility within the PSD and extra-synaptic area is 
increased with treatments that stimulate neuronal activity (Tardin et al., 2003; Groc et al., 
2004). Finally, transient internalization of extracellular receptors appears to precede 
synaptic loss of receptors (Ashby et al., 2004) and diffuse extra-synaptic staining of 
inserted AMPARs has also been observed to precede AMPAR aggregation at the PSD 
(Passafaro et al., 2001), indicating that the extra-synaptic area may be involved both in 




Figure 1.1. A model of post-synaptic receptor dynamics at glutamatergic and cholinergic 
synapses. (A) Receptor dynamics at excitatory glutamatergic synapses in the central nervous system. At 
glutamatergic synapses the density of AMPARs at synaptic sites is controlled by the insertion, lateral 
migration, degradation and recycling of receptors. These dynamics can be altered by a number of 
different events, including activity and phosphorylation, and are regulated by intracellular scaffolding 
proteins. (B) Receptor dynamics at excitatory cholinergic synapses in the peripheral neuromuscular 
junction. Similar to receptors in the central nervous system, the density of AChRs at synaptic sites in 
the NMJ is controlled by the insertion, lateral migration, degradation and recycling of receptors. AChR 
dynamics are also controlled by activity and phosphorylation, as well as by proteins in the intracellular 
scaffold. 
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A number of proteins have also been shown to be involved in subunit-specific 
regulation of AMPAR dynamics. The “short-tailed” AMPAR subunits, including GluR2 
and GluR3, are stabilized at synapses by the binding of GRIP or its homologue ABP, and 
GluR2 subunits are additionally stabilized by NSF (Dong et al., 1997; Osten et al., 2000; 
Braithwaite et al., 2002; Hanley et al., 2002; Lee et al., 2002). Disruption of GRIP/ABP 
binding by PICK1 and the replacement of NSF with the clathrin adaptor protein AP-2 
induce the endocytosis of GluR2/3 AMPARs (Chung et al., 2000; Perez et al., 2001; 
Hanley et al., 2002; Chung et al., 2003; Seidenman et al., 2003; Hayashi and Huganir, 
2004; Hanley and Henley, 2005; Lu and Ziff, 2005). The “long-tailed” AMPAR subunits, 
including GluR1 and GluR4, have quite different intracellular binding domains, which 
allow another complement of proteins to regulate their dynamics. SAP-97, for example, 
links GluR1 to PSD-95, a protein that localizes specifically to synapses (Leonard et al., 
1998; Valtschanoff et al., 2000; Gardoni et al., 2003; Rumbaugh et al., 2003; Cai et al., 
2006; Jin et al., 2006). The AMPAR-SAP-97 interaction has been shown previously to be 
essential for activity-dependent delivery of GluR1 into spines (Mauceri et al., 2004; 
Nakagawa et al., 2004) (however, see (Kim et al., 2005)), and PSD-95 has been shown to 
modulate AMPAR incorporation during LTP in vivo (Ehrlich and Malinow, 2004).  
Regulation of NMDAR dynamics at excitatory central synapses: 
The NMDAR is a heterotetramer composed of NR1, NR2(A-D) and NR3(A-B) 
subunits, all of which have endo- and exocytosis motifs that allow binding of regulatory 
proteins. In the mammalian forebrain NMDARs are predominantly expressed as NR1/2A 
and NR1/2B diheteromers (Kew et al., 1998; Vicini et al., 1998; Rumbaugh and Vicini, 
1999; Tovar and Westbrook, 1999). Although the discovery that AMPA receptors 
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undergo rapid changes in response to activity has driven much of the research on receptor 
dynamics at the glutamatergic synapse towards the AMPA receptor, focus has more 
recently turned towards the trafficking of the NMDAR (Carroll and Zukin, 2002; 
Wenthold et al., 2003; Nong et al., 2004; Perez-Otano and Ehlers, 2005). Similar to the 
AMPAR, NMDAR half-life estimates vary depending upon experimental method, 
ranging from hours to days, and NMDAR half-life also changes significantly through 
development. For example, in cultures from early stage neurons, a surface biotinilation 
assay found that over 20% of NMDARs are internalized after 30 minutes (t1/2 < 2 hours) 
(Roche et al., 2001), which is comparable to 15% internalization of surface AMPARs 
after 30 minutes (Ehlers, 2000). In more mature neurons the turnover of NMDARs slows 
dramatically (Roche et al., 2001) to a rate that is 2-3 fold slower than AMPARs  (Huh 
and Wenthold, 1999; Ehlers, 2000; Lin et al., 2000; Nong et al., 2003; Sharma et al., 
2006b).  
As with AMPARs, the synaptic delivery and removal of NMDARs in response to 
activity can be much more rapid than indicated above, with significant changes in 
NMDAR number occurring within minutes. For example, glycine/glutamate treatment 
causes an ~25% decrease in surface NMDAR expression after 15 minutes in cultured 
hippocampal cells (Nong et al., 2003), and LTP-induction in adult hippocampal cells 
results in an ~20% increase in NMDARs in the same time period (Grosshans et al., 
2002). Similarly, dark-reared neo-natal rats show rapid and persistent increases in NR2A 
subunit expression in the visual cortex in vivo within an hour of light exposure (Quinlan 
et al., 1999). As with the AMPAR, the dynamics and resulting changes in surface 
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expression of the NMDAR can be controlled at the level of insertion, removal or 
recycling. 
Several studies have shown that the insertion of the NMDAR is strongly regulated 
by the NR1 subunit. NMDA export is first regulated at the level of translation, as the 
NR1 subunit can be spliced to produce alternate C-terminal tails, with activity blockade 
resulting in a C’-cassette that allows rapid export and chronic stimulation resulting in 
down-regulation of this isoform (Standley et al., 2000; Scott et al., 2001; Xia et al., 2001; 
Mu et al., 2003). An ER retention signal on the NR1 C-terminal region also serves as a 
control point for exocytosis and surface expression and has been shown to be regulated 
by PKC (Scott et al., 2003). PKC, a kinase that is also implicated in the dynamics of 
AMPARs (Chung et al., 2000; Kim et al., 2001; Seidenman et al., 2003) and GABARs 
(Connolly et al., 1999b), has been shown to increase NMDAR surface expression (Lan et 
al., 2001), and is essential for LTP expression in hippocampal slices from older mice 
(Grosshans et al., 2002). Since the NR1 subunit is obligatory for the surface expression of 
NMDARs, the activity-dependent alternate splicing and PKC masking of a retention 
signal allow NMDAR exocytosis to be altered by activity to control surface expression. 
While the NR1 subunit also contains signals that are potentially involved in 
internalization (Scott et al., 2004), NMDAR endocytosis appears to be controlled largely 
by signals on the intracellular tails of NR2A and NR2B. The NR2 subunits bind to the 
homologous PDZ-containing proteins PSD-95 and SAP102 (Lau et al., 1996; Muller et 
al., 1996; Barria and Malinow, 2002; Sans et al., 2003; Chung et al., 2004; Sans et al., 
2005), which play a role in anchoring or stabilizing NMDARs rather than facilitating 
their delivery to synapses. For example, the delivery of NR2B to neonatal synapses 
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precedes PSD-95 (Washbourne et al., 2004) and PSD-95 knockouts still express surface 
NMDARs (Migaud et al., 1998). Instead, the association of PSD-95 with the NR2 subunit 
of the NMDAR appears to regulate internalization, as activity-dependent de-
phosphorylation of NR2 results in the replacement of PSD-95 with the clathrin adaptor 
protein, AP-2, which initiates endocytosis (Roche et al., 2001; Lavezzari et al., 2003; 
Chung et al., 2004; Prybylowski et al., 2005). This interaction is mediated by a number of 
different factors. For example, the NMDAR co-agonist glycine is able to recruit AP-2 to 
synapses, and subsequent binding of both glycine and NMDA/glutamate initiates rapid 
internalization of NMDARs, which results in LTD at synapses (Nong et al., 2003).  
After endocytosis, NR2A and NR2B receptors are trafficked along different 
pathways: the NR2A-containing receptors appear mostly in late endosomes on the way to 
lysosomal degradation while the NR2B-containing receptors are found in recycling 
vesicles, which are able to deliver ~15% of internalized receptors back to the surface after 
1 hour (Lavezzari et al., 2004; Scott et al., 2004). While changes in NMDAR expression 
have traditionally been thought to mediate homeostatic plasticity changes through slow 
cycling mechanisms (Perez-Otano and Ehlers, 2005), the rapid cycling of NMDARs 
observed more recently suggests a method by which very rapid changes in NMDAR 
surface expression could be modulated. Indeed, while AMPAR dynamics have been 
shown to control much of the activity-dependent changes observed in early post-natal 
neurons, changes in NMDAR number have been associated with LTP in older cells 
(Grosshans et al., 2002). Also in support of this idea is the finding that in older cultures of 
rat hippocampal neurons, the internalization of NMDAR subunits occurs just as rapidly 
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as AMPAR subunits after the stimulation of mGluRs and the initiation of LTD (Snyder et 
al., 2001). 
Between exocytosis and endocytosis lies a robust mechanism allowing for the 
surface exchange of receptors between the synaptic and extrasynaptic spaces (Triller and 
Choquet, 2003). Elegant single-particle tracking experiments have shown that the 
NMDAR mobility is high outside of synapses and decreases markedly once it enters the 
synapse (Tovar and Westbrook, 2002; Groc et al., 2004). This mobility has also been 
shown to be altered by activity, which could potentially be due to the activity-dependent 
up-regulation of synaptic PSD-95 (Ehrlich and Malinow, 2004). 
Regulation of GABA receptor dynamics at inhibitory central synapses: 
The GABAA receptor is a pentameric ionotropic receptor that is constructed from 
seven subunit classes. However, it seems likely that the majority of GABARs in vivo are 
composed of two α, two β and one γ subunit (Rabow et al., 1995; Sieghart and Sperk, 
2002), and are anchored to the intracellular cytoskeleton by the GABA receptor 
associated protein (GABARAP) and gephyrin (Wang et al., 1999a; Hanus et al., 2004; 
Luscher and Keller, 2004). The GABAA receptor is responsible for the majority of 
inhibitory transmission in the adult brain, and GABAR surface expression is regulated in 
vivo by a number of endogenous and exogenous factors including ethanol, insulin and 
agonist binding (Wan et al., 1997; Kneussel, 2002; Kumar et al., 2003). The lifetime of 
GABAR has been shown to have two phases: one rapid with a t1/2 of ~ 4 hours, and one 
more slow with a t1/2 of ~ 32 hours (Borden et al., 1984). More recently GABAR lifetime 
was estimated to be ~ 12 hours (Kittler et al., 2005). The surface dwell time has been 
measured with biotinylation assays, which show 25% internalization after 30 minutes (t1/2 
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~ 1 hour) (Kittler et al., 2005). However, this assay is not able to resolve recycled 
receptors or distinguish between synaptic and extrasynaptic zones and therefore may 
underestimate the lifetime of GABA receptors. 
Although comparatively little is known about GABAR dynamics, much work 
shows that GABARs share characteristics with both AMPA/NMDARs and AChRs. For 
example, as with the ionotropic glutamate receptors, constitutive endocytosis of surface 
GABARs is initiated by clathrin-mediated endocytosis and is regulated by the 
phosphorylation state of the adaptor protein AP-2 (Kittler et al., 2001; Herring et al., 
2003; Kittler et al., 2005). After internalization, GABARs are either targeted to 
lysosomes for degradation, or are recycled back into the plasma membrane (Connolly et 
al., 1999b; Connolly et al., 1999a; Barnes, 2000). This recycling mechanism is able to 
insert 50% of internalized receptors back to the surface after internalization (Kittler et al., 
2005). Also potentially involved in the cycling of internalized GABARs is the ubiquitin-
like molecule, Plic-1, which prevents proteosomal degradation and potentially increases 
the size of the available intracellular pool of GABARs (Bedford et al., 2001). Recently, 
the proteins NSF and GRIP-1 have also been found at GABAergic post-synaptic sites 
(Kittler et al., 2001; Kittler et al., 2004; Goto et al., 2005), raising the possibility that 
these two proteins, which regulate ionotropic receptor trafficking in glutamatergic 
synapses, may play a key role in GABAR dynamics. Finally, while GABARs share a 
number of trafficking proteins with glutamatergic receptors, they also have a cytoskeletal 
anchoring framework in common with AChRs. Namely, the intracellular cytoskeleton 
complex to which both of these receptors bind is the dystrophin-glycoprotein complex 
(DGC). The role of the DGC in regulated trafficking of GABARs is poorly understood, 
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though disruption of a number of DGC proteins results in a reduction both in the size of 
GABAR clusters and the overall number of surface GABARs (Knuesel et al., 1999).  
Regulation of AChR dynamics at excitatory peripheral neuromuscular synapses: 
At the adult NMJ, the acetylcholine receptor is composed of two α, one β, one δ 
and one ε subunit (Mishina et al., 1986; Gu and Hall, 1988; Missias et al., 1996). Early in 
development the γ subunit is highly expressed and is capable of forming functional 
channels, but is replaced completely by ε subunit-containing receptors in the adult (Gu 
and Hall, 1988). Because of the availability of a snake toxin alpha-bungarotoxin (BTX) 
that selectively and irreversibly labels AChRs, the turnover of AChRs at developing, 
mature and denervated NMJs has been studied extensively using radioactively-labeled 
BTX. These studies primarily used I125-BTX to determine the loss of receptors from 
muscle cells. Using this approach, the time course of AChR loss was estimated by 
comparing radioactivity between muscles from different animals that were examined at 
varying times after applying the radioactive toxin. These studies found that the half-life 
of receptors on mature, innervated muscle cells ranges from ~ 7-13 days (Bevan and 
Steinbach, 1983; Stanley and Drachman, 1983; Salpeter and Loring, 1985). Although the 
I125-BTX approach forged the first inroads into estimating ionotropic receptor turnover in 
vivo, it had some drawbacks. First, by summing radio-labeled ligands from the entire 
muscle it could not reveal the receptor dynamics at individual neuromuscular junctions. 
For example, muscles with different populations of muscle fiber types may have different 
turnover rates. Second, the inactivation of AChRs with BTX could greatly affect the way 
that AChRs are removed from synapses. Lastly, the density of postsynaptic molecules 
can change enormously when the junction expands or shrinks during growth or 
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denervation, which could give erroneous estimates when counting radio-labeling on 
muscle cross-sections. 
The subsequent development of fluorescently-conjugated bungarotoxin and 
quantitative fluorescence microscopy largely circumvented these limitations. Studies 
utilizing this tool have been able to more directly study the turnover of AChRs by 
assaying the intensity of fluorescently tagged BTX that is irreversibly bound to AChRs at 
individual identified junctions viewed more than one time in living mice (Green et al., 
1975; Fambrough, 1979). This approach has led to a substantially different view of 
AChR dynamics than was provided by previous studies (Figure 1B). For example, they 
showed that when neuromuscular transmission was functional, receptor lifetime in the 
junctional membrane was quite long (~ 2 weeks). However when all AChRs were 
inactivated by BTX or another AChR inhibitor, curare, receptor lifetime decreased 
substantially to a t1/2 of several hours (Akaaboune et al., 1999). 
Recently, we have devised a novel labeling method that has revealed that AChRs 
at the NMJ are not simply degraded upon internalization, as previously thought (Gardner 
and Fambrough, 1979). Instead, a significant number of receptors, rather than being 
metabolized upon internalization, recycle back into the postsynaptic membrane (Bruneau 
et al., 2005a). The unexpectedly high contribution of recycled AChRs at synapses implies 
that the classical concept of “metabolic stability” of junctional AChRs as previously 
defined (Salpeter and Loring, 1985) must be revised. Specifically, earlier work did not 
consider the possibility that receptors continuously recycle back to the postsynaptic 
membrane with their bungarotoxin tag to contribute to the junctional receptor population. 
This work has led to the idea that previous experiments using fluorescently labeled BTX 
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must be re-interpreted (Salpeter and Loring, 1985; Andreose et al., 1993; Caroni et al., 
1993; Akaaboune et al., 1999; Akaaboune et al., 2002). This also argues that junctional 
AChRs are being internalized from the surface at a significantly faster rate (t1/2 ~ 4 days 
after a one-time blockade) than previously thought. Since recycled and pre-existing 
AChRs can be labeled with different fluorophores, we have also monitored the lifetime of 
recycled and pre-existing AChRs from the same postsynaptic membrane and found that 
recycled AChRs turn over ~4 times more rapidly than pre-existing AChRs (Bruneau and 
Akaaboune, unpublished data).  
In sharp contrast to innervated synapses, AChRs on mouse-derived C2C12 
myotubes do not recycle (Bruneau et al., 2005a), despite the short half-life of AChRs in 
the postsynaptic membrane (Bruneau et al., 2005b). This suggests that a nerve factor(s) is 
required for triggering the recycling of AChRs and indicates that the insertion of newly 
synthesized AChR is the main source for maintaining normal receptor density at any 
given time in aneural muscle cells. We are now in the process of exploring the nature of 
the nerve factors that may be involved in the initiation of receptor recycling.  
As with other ionotropic receptors in central synapses, the turnover rate of AChRs 
at the NMJ is also subject to synaptic activity. For example following muscle 
denervation, AChR lifetime decreases substantially to a t1/2 of ~1-3 days (Gu and Hall, 
1988; Shyng and Salpeter, 1989; Rotzler et al., 1991). Interestingly, the blockade of 
synaptic transmission not only increases the turnover rate of AChRs, but also depresses 
the insertion of recycled AChRs into the postsynaptic membrane (Bruneau et al., 2005a). 
However, blocking synaptic potentials with TTX does not affect AChR dynamics, 
suggesting that spontaneous release of neurotransmitter is sufficient to maintain normal 
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AChR turnover (Akaaboune et al., 1999). In support of this idea, the loss of AChRs can 
be prevented in denervated muscle by the restoration of synaptic activity or direct muscle 
stimulation (Rotzler and Brenner, 1990; Rotzler et al., 1991; Andreose et al., 1993; 
Akaaboune et al., 1999). 
Previous studies have shown that the nerve clustering factor agrin not only causes 
aggregation of AChRs but also may increase the stability of AChRs at denervated 
neuromuscular junctions (Bezakova et al., 2001). Work with mouse-derived C2C12 
aneural myotubes, however, shows that agrin does not alter receptor turnover (Bruneau et 
al., 2005b), which suggests that other factors present at the mature NMJ in conjunction 
with agrin may be implicated in AChR stability. The lifetime of AChRs can also be 
controlled by postsynaptic scaffolding proteins. For example in mice lacking alpha 
dystrobrevin, a protein of the dystrophin glycoprotein complex (DGC), dramatic changes 
occur in the NMJ, including a severe reduction in the number and the density of 
postsynaptic receptors as well as a rapid rate of removal (t1/2 ~2.7 days vs. ~2 weeks in 
control) (Akaaboune et al., 2002). Similar reductions in AChR number and density are 
observed in mice lacking alpha syntrophin (Adams et al., 2000), although the lifetime of 
AChRs was not assessed in this study. Recent work from the Phillips lab has further 
implicated the receptor-associated protein rapsyn in controlling the lifetime of AChRs: 
electroporation of rapsyn into mouse muscle in vivo decreased the loss of AChRs 
(Gervasio and Phillips, 2005). From our unpublished results, it appears that rapsyn does 
not play an important role in AChR dynamics at clusters on the surface of aneural 
myotubes, however (Bruneau and Akaaboune, unpublished results). The investigation of 




Although a large body of work now exists on ionotropic receptor dynamics in the 
central nervous system, this work is limited by the inaccessibility of these synapses and 
has therefore been done almost exclusively in culture or organotypic slice preparations 
outside of the intact system. The peripheral neuromuscular junction, on the other hand, is 
highly accessible in the living animal. The fundamental question, therefore, is whether 
the NMJ is similar enough to provide insights into synapses in the CNS. In the past 30 
years the NMJ has proved its utility on this score by driving the understanding of synapse 
elimination, pre-synaptic quantal release, extra-synaptic endo- and exocytosis and lateral 
migration of receptors. In the field of receptor dynamics, however, the applicability of 
information gained about AChRs from in vivo studies seemed to be of limited 
applicability to ionotropic receptors in the CNS because of a few key apparent 
differences: namely a synaptic AChR turnover at least 2 orders of magnitude slower than 
AMPARs, and a lack of AChR recycling. Over the last few years these apparent 
differences have been slowly dismantled as estimates of AMPAR lifetime have decreased 
with new methods while the estimates of AChR dynamics have increased. The discovery 
that receptor recycling, which is a hallmark of receptor dynamics in central synapses, also 
takes place at the NMJ has further brought central and peripheral receptor dynamics into 
closer relation (Figure 1). Finally, as the components of the intracellular scaffolds of each 
of the ionotropic receptors have become resolved, structural homologies between 
AMPA/NMDAR and GABARs, as well as GABARs and AChRs have begun to appear. 
It will be most interesting to see if understanding the functional role of these proteins at 
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the accessible NMJ can help to continue the trend of in vivo investigation at peripheral 
synapses informing our understanding and directing research into processes that occur at 
central synapses in vivo. It is a productive tradition that will hopefully continue to carry 
forward our understanding of ionotropic receptor dynamics in the intact, living animal. 
The Role of Dynamic Receptor-Associated Proteins in the Development 
and Plasticity of the Synapse 
Introduction 
The recruitment and maintenance of a high density of ionotropic receptors at post-
synaptic sites is necessary for proper synaptic function. Changes in receptor density 
which are crucial both for synaptic development and synaptic plasticity are controlled by 
several factors ranging from electrical activity to postsynaptic scaffolding proteins. For 
example, genetic knock-outs of one of a number of intracellular scaffolding proteins 
result in the prevention or disruption of post-synaptic receptor aggregation. Necessary for 
the clustering of ionotropic receptors are a class of receptor-associated proteins that link 
receptors to the intracellular scaffold and stabilize them at post-synaptic sites.  
At the cholinergic neuromuscular junction (NMJ), the acetylcholine receptor 
(AChR)-associated protein rapsyn is responsible for receptor anchoring and is crucial for 
the initiation of AChR clustering (Maimone and Enigk, 1999; Bartoli et al., 2001). 
Analogously, at inhibitory synapses in the central nervous system, the receptor-associated 
protein gephyrin is necessary for the aggregation of glycine (Kirsch et al., 1993; Feng et 
al., 1998b) and many subtypes of γ-aminobutyric acid (GABAA) receptors (Essrich et al., 
1998; Kneussel et al., 1999). In excitatory central synapses, the glutamatergic AMPA and 
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NMDA receptors are similarly anchored in place. Anchoring at glutamatergic synapses, 
however, is not mediated by a single receptor-associated protein, but instead by a family 
of proteins including the most prevalent member, PSD-95, which binds directly to 
NMDA receptors and indirectly to AMPA receptors (Kim and Sheng, 2004). 
In addition to their role in receptor anchoring, each of these receptor-associated 
proteins is involved in the regulation of intracellular signaling and the maintenance of the 
scaffolding complex. Through their many protein-interacting domains, they are able to 
bind proteins that regulate scaffold dynamics and protein transcription, implicating 
receptor-associated proteins as central organizers of the post-synaptic apparatus.  
Finally, mounting evidence points to the potential role of transient inter-molecular 
interactions in mediating receptor stability at individual synapses. Recent work has 
therefore focused on characterizing the collective dynamics of receptors and their 
associated scaffolding proteins. Interestingly, the picture emerging from this work is a 
post-synaptic structure in which receptor-associated proteins are highly dynamic and 
involved in regulating changes in receptor density both during development and at the 
mature, dynamic post-synaptic structure.  
In this review, we will review emerging literature on the dynamics of receptor-
associated proteins and their role in maintaining the post-synaptic apparatus at both 
peripheral and central synapses. Although we will largely focus our analysis on the 
functionally homologous rapsyn and gephyrin receptor-associated proteins, we will visit 




At the neuromuscular junction (NMJ), pentameric acetylcholine receptors 
(AChRs) mediate the activation of muscle action potentials. AChRs bind directly to the 
receptor associated protein of the synapse (rapsyn), which is thought to anchor receptors 
to the intracellular protein scaffold. The importance of a number of these scaffolding 
proteins has been elucidated using genetic tools. For example, it has been found that mice 
deficient in the muscle specific kinase (MuSK) or Dok-7 fail to form AChR clusters both 
in vitro and in vivo (DeChiara et al., 1996; Beeson et al., 2006; Okada et al., 2006), while 
dystrobrevin, dystroglycan and utrophin knock-out mice show decreases in the number of 
junctional receptors (Deconinck et al., 1997; Grady et al., 1997; Sanes, 1997; Cote et al., 
1999; Grady et al., 2000; Jacobson et al., 2001; Grady et al., 2003). These genetic studies, 
along with biochemical experiments, have led to a model for AChR anchoring at the 
post-synaptic density in which AChRs link directly to rapsyn, rapsyn binds to β-
dystroglycan, β-dystroglycan binds to utrophin and utrophin forms a connection to the 
intracellular actin cytoskeleton (James et al., 1996; Sanes and Lichtman, 2001; Galkin et 
al., 2002; Huebsch and Maimone, 2003; Dobbins et al., 2006).  
The essential role of rapsyn in the anchoring of AChRs to the scaffold and the 
clustering of receptors at post-synaptic sites in vivo is illustrated by the complete lack of 
clustered receptors at nerve endplates in rapsyn-/- mice and the lack of receptor clusters 
on myotubes generated from these mice (Gautam et al., 1995; Gautam et al., 1999). 
Depletion of rapsyn expression with RNAi in adult rat muscle fibers in vivo also results 
in the rapid disappearance of AChR clusters, showing that rapsyn is necessary for both 
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the formation and the maintenance of AChR clustering (Kong et al., 2004). Together this 
genetic data points to rapsyn as an indispensable receptor anchoring protein. 
Although the tertiary structure of rapsyn has not been solved, it contains multiple 
binding domains (Figures 1.2 and 1.3). The activation of MuSK/Dok7 by neural agrin 
results in the increased association of rapsyn to AChR and concomitant receptor 
clustering (Reist et al., 1992; Sanes and Lichtman, 2001; Moransard et al., 2003; Okada 
et al., 2006). Recently it has been shown that the stabilization of receptor clustering at 
post-synaptic sites is at least partly mediated by the increased association of rapsyn 
(which is almost exclusively synthesized at the synapse) to calpain, a protease that 
initiates AChR dispersal when unbound (Chen et al., 2007). Additionally, post-synaptic 
sites on muscles from rapsyn-/- mice show disruptions of the dystrophin-glycoprotein 
complex, with near complete lack of utrophin and syntrophin, while the synaptically-
localized laminin β2 extracellular matrix protein is present (Gautam et al., 1995). This 
indicates that rapsyn is involved, at least indirectly, in the formation of the intracellular 
scaffolding complex rather than simply serving to tether receptors to a pre-formed 
scaffold. This implicates rapsyn not only as an anchor to AChRs, but also as a modulator 
of signaling cascades which are, themselves, capable of modulating AChR clustering. 
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Since many proteins of the dystrophin-glycoprotein complex are present in the 
central nervous system, the potential role of rapsyn in clustering of CNS pentameric 
Figure 1.2. Primary structures and known interacting domains of rapsyn and gephyrin receptor-
associated proteins. Both rapsyn and gephyrin have distinct domains involved in self-association and 
protein binding. (A) The N-terminal region of rapsyn is sufficient to traffic rapsyn to the cell surface, 
and N-terminal myristoylation is responsible for anchoring rapsyn to the membrane (Ramarao and 
Cohen, 1998). Seven putative tetratricopeptide repeat (TPR) regions mediate rapsyn self-association 
and the association of rapsyn with the protease calpain (Ramarao and Cohen, 1998; Ramarao et al., 
2001; Chen et al., 2007). A coiled-coil domain (codons 297-330) binds directly to the intracellular loops 
of all of the AChR subunits, and a RING-H2 domain associates with β-dystroglycan (Cartaud et al., 
1998; Maimone and Enigk, 1999; Bartoli et al., 2001). β-dystroglycan in turn binds to the intracellular 
cytoskeleton through its interaction with utrophin and to the extracullar matrix protein laminin via α-
dystroglycan (Henry and Campbell, 1996; Montanaro et al., 1998; Henry and Campbell, 1999). Rapsyn 
is therefore thought to mechanically stabilize receptors at the synapse by serving as the protein linker 
between the AChR and beta-dystroglycan (Sanes and Lichtman, 2001). (B) Analysis of crystallized 
gephyrin has found that glycine receptor binding occurs after folding of the protein and 
multimerization. Gephyrin contains a G-domain and an E-domain that mediate the formation of a 
hexagonal gephyrin lattice in sub-synaptic aggregates (Sola et al., 2001; Saiyed et al., 2007). The G- 
and E-domains are connected by a linker region, which is thought to contain the binding sites for 
tubulin and the tubulin-interacting motor protein, dynein (Fuhrmann et al., 2002). Gephyrin also 
associates with the actin-interacting proteins mena/VASP and profilin (Giesemann et al., 2003; Neuhoff 
et al., 2005), as well as the signaling factor collybistin (Kins et al., 2000; Harvey et al., 2004) and 
transcriptional regulator RAFT1 (Sabatini et al., 1999). 
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receptors has also been investigated. When co-expressed with neuronal AChRs in 
heterologous cells, rapsyn has been shown to cluster and increase the metabolic stability 
of neuronal nicotinic receptors (Kassner et al., 1998). Similarly, rapsyn has been shown 
to bind to and cluster GABAARs when co-expressed in heterologous cells (Yang et al., 
1997; Ebert et al., 1999). Despite rapsyn’s ability to bind to these pentameric receptor 
types, however, rapsyn does not appear to play a functional role in the formation of CNS 
synapses as rapsyn expression is inessential for the clustering of neuronal nicotinic 
AChRs in neurons (Feng et al., 1998a).  
 
The regulation of receptor density at synaptic sites has been extensively studied at 
the NMJ, and the insertion, removal, recycling and lateral migration of receptors into and 
out of the post-synaptic membrane have all been shown to be involved in maintaining a 
dynamic equilibrium of synaptic AChRs (Akaaboune et al., 1999; Akaaboune et al., 
2002; Bruneau et al., 2005b; Bruneau and Akaaboune, 2006a). Given that the AChR 
associates intimately with rapsyn, an increasing focus has turned towards the role of 
rapsyn in regulating AChR density at the synapse. However, little is known about the 
behavior of the rapsyn molecule over time. Recently our lab has begun to examine the 
dynamics of rapsyn itself, yielding interesting observations about the stability and 
regulation of this protein. 
Although rapsyn is clearly necessary for the induction of receptor clustering, its 
involvement in regulating AChR density at the developing or mature synapse is not well 
understood. While the availability of high-affinity fluorescent bungarotoxin conjugates 
have allowed AChR dynamics to be extensively studied, the inaccessibility of 
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intracellular rapsyn to extracellular ligands has prevented the study of rapsyn dynamics in 
living cells. Recently, we have used a rapsyn-GFP construct to circumvent this limitation. 
By transfecting muscle cells with the rapsyn-GFP fusion construct we have shown that 
rapsyn-GFP is able to take the place of endogenous rapsyn at cluster sites to keep overall 
rapsyn density constant, and that the presence of rapsyn-GFP at cluster sites has no effect 
on AChR density or turnover (Bruneau and Akaabourne, 2007), a result which has been 
seen with our recent work in vivo, as well (Bruneau and Akaaboune, unpublished data). 
This is in contrast to previous studies which have found that over-expressing rapsyn 
through electroporation or injection in adult mouse muscles slightly but significantly 
increases receptor density and stability at post-synaptic sites (Phillips et al., 1997; Wang 
et al., 1999b; Gervasio and Phillips, 2005; Gervasio et al., 2007). This discrepancy may 
be explained by the observation that in our in vitro system the total concentration of 
rapsyn was the same at clusters containing or devoid of rapsyn-GFP, likely because 
rapsyn-GFP is able to replace endogenous rapsyn to keep overall rapsyn density constant 
(Bruneau and Akaabourne, 2007). 
Using fluorescent recovery after photobleaching (FRAP) to investigate rapsyn-
GFP dynamics, we found that rapsyn turns over more rapidly than AChRs in vitro and 
that rapsyn is unaffected by protein phosphatase inhibition that causes significant changes 
in receptor removal and insertion (Bruneau and Akaabourne, 2007). Ongoing work in our 
lab has taken this investigation into the living mouse muscle in vivo. Using 
electroporation we have been able to successfully introduce the rapsyn-GFP construct 
into individual NMJs without damaging the muscle fibers. Consistent with our in vitro 
results we have found that rapsyn also turns over more rapidly than receptors in vivo 
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(Bruneau and Akaaboune, unpublished data). While AChR turnover and trafficking are 
dramatically altered by activity (Akaaboune et al., 1999; Bruneau et al., 2005a; Bruneau 
and Akaaboune, 2006a), rapsyn turnover appears to be unaffected by pharmacological 
post-synaptic activity blockade or by surgical muscle denervation (Bruneau and 
Akaaboune, unpublished data), indicating that both in vitro and in vivo the turnover of 
rapsyn and AChRs are regulated by different mechanisms. It is possible that changing the 
turnover of receptor-associated proteins at cluster sites may be a factor regulating 
receptor density, and this intriguing possibility is currently under investigation in our lab. 
At the very least, the fast turnover of receptor-associated proteins could allow for rapid 
changes in rapsyn density within the synapse, which could drive alterations in the 
intracellular scaffold morphology during development and aging. 
In humans, rapsyn has been implicated in muscular dystrophies including 
myasthenic syndrome. One hallmark of this illness is a dramatic decrease in post-synaptic 
AChR density, and mutations in the rapsyn gene or promoter region have been shown to 
be the primary cause of synaptic pathogenesis in a number of reported cases (Ohno et al., 
2002; Maselli et al., 2003; Ohno et al., 2003; Banwell et al., 2004). In addition to the 
disruption of junctional folding caused by rapsyn mutations or deficiencies, mutations in 
the rapsyn protein cause a decrease in the number of post-synaptic rapsyn and receptor 
proteins. The use of mutant rapsyn-GFP fusion proteins should enable a very complete 
investigation of the molecular-level pathophysiology of these muscular dystrophies.  
Finally, a number of studies have shown that rapsyn, and not dystrophin or 
dystrobrevin, accompanies AChRs in the same intracellular vesicles during exocytosis 
both in heterologous cells and in the modified neuromuscular junction that is the torpedo 
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electric organ (Marchand et al., 2000; Marchand et al., 2001; Marchand et al., 2002). 
While this indicates that rapsyn and AChRs can potentially be delivered in the same 
intracellular compartments, the possibility that rapsyn accompanies receptors during 
endocytosis or recycling (as a regulatory chaperone or a non-regulatory binding partner) 
is currently being investigated. At the least, the fact that the surface expression of AChRs 
is decreased but not abolished in rapsyn knock-out mice indicates that even though 
rapsyn may accompany receptors to the cell surface it is not essential for receptor 
exocytosis (Gautam et al., 1995).  
 
Gephyrin 
In inhibitory synapses of the brain and spinal cord, the synaptic clustering and 
localization of glycine and GABAA receptors is mediated by the scaffolding protein 
gephyrin (Kirsch et al., 1993; Essrich et al., 1998; Feng et al., 1998b; Kneussel et al., 
1999). Gephyrin is a 93-kD tubulin binding protein that associates directly with the 
intracellular loop of the glycine receptor β-subunit, and indirectly through a putative 
linker protein to the intracellular portion of gamma-subunit containing GABAA receptors 
(Meyer et al., 1995). Similar to rapsyn knockouts, glycine receptor clustering is absent in 
mice that are lacking gephyrin either because of genetic deletion or RNAi (Kirsch et al., 
1993; Feng et al., 1998b; Levi et al., 2004); at the same time α2- and γ2-containing 
GABAA receptor clustering is dramatically decreased in gephyrin knockout mice 
(Kneussel et al., 1999; Jacob et al., 2005; Yu et al., 2007), even though overall GABAAR 
surface expression remains unaffected (Kneussel et al., 1999; Kneussel et al., 2001). 
Further, it has been shown that GABAergic inhibitory post-synaptic currents, synaptic 
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plasticity and performance on learning tasks are all significantly compromised when 
gephyrin expression or clustering is disrupted (Papadopoulos et al., 2007; Yu et al., 
2007), while whole cell GABA-mediated currents are unaffected (Yu et al., 2007). This 
indicates that gephyrin may be necessary for both the initiation and maintenance of 
inhibitory receptor clustering which is required for proper synaptic function. 
Figure 1.3. A model illustrating the central role of receptor-associated proteins in the clustering 
complex. (A) At acetylcholine receptor clusters rapsyn binds the intracellular portion of the receptor 
subunits. The activation of rapsyn and the clustering of receptors is initiated by agrin or laminin, and 
rapsyn stabilizes receptors through a direct association with beta-dystroglycan. Cytoskeletal re-
organization is controlled by the association of rapsyn to calpain. (B) At inhibitory synapses glycine 
and/or GABA receptors mediate neurotransmission. The activation of gephyrin clustering requires 
glycine receptor activity, and gephyrin binds directly to the intracellular loop of the glycine receptor 
beta-subunit. Direct binding of gephyrin to the GABA receptor has not been observed, but gephyrin is 
required for γ2-GABA receptor subunit clustering. Like rapsyn, gephyrin links receptors to the 
intracellular cytoskeleton (through mena/VASP) and regulates signaling through interactions with 
collybistin. 
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In addition to a number of functional binding domains on gephyrin which allow 
self-association and the association of gephyrin with scaffolding proteins (Figures 1.2 and 
1.3), gephyrin binds to a number of signaling molecules which may help regulate 
synaptic structure. Collybistin is a guanine nucleotide exchange factor that binds to 
gephyrin and, similar to calpain in AChR clusters at the NMJ, has been proposed to 
modulate cytoskeletal remodeling and be involved in gephyrin and GABAAR clustering 
(Kins et al., 2000; Erickson and Cerione, 2001; Papadopoulos et al., 2007). Collybistin 
knockout mice display dramatic decreases in GABAAR clustering in amygdala and 
hippocampus and show deficits in synaptic plasticity and learning (Papadopoulos et al., 
2007). Also on the list of regulatory proteins which bind to and are potentially modulated 
by gephyrin is RAFT1 (mTOR), which is a regulator of mRNA translation that has been 
shown to be active only if bound to gephyrin (Sabatini et al., 1999). Finally, gephyrin 
binds to the actin-associating mena/VASP (vasodilator stimulated protein) and profilin 
proteins (Giesemann et al., 2003), which are involved in actin regulation, implying that 
gephyrin not only relies on the cytoskeleton for anchoring but may be directly involved in 
regulating cytoskeletal dynamics and thereby altering synaptic structure.  
 
The dynamics of the glycine receptor have recently been investigated in a series 
of elegant single-particle tracking experiments. Twenty-five years ago, investigation of 
AChR lateral diffusion led to the ‘diffusion-trap’ model of synaptic receptor 
accumulation (Young and Poo, 1983). Single particle imaging studies have allowed a 
more direct investigation of this hypothesis at glycinergic synapses. Using coated beads, 
rapidly bleaching protein fluorophores and non-bleaching quantum dots it has been 
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shown that individual glycine receptors move with near-Brownian motion outside of 
synaptic sites but slow considerably once they are within the synaptic region (Meier et 
al., 2001; Dahan et al., 2003; Charrier et al., 2006). Gephyrin appears to be critical for the 
trapping and stabilization of glycine receptors, as co-transfection of glycine receptors and 
gephyrin in heterologous cells or the over-expression of gephyrin in neuronal cells 
dramatically decreases receptor lateral mobility (Meier et al., 2001). Similarly, when 
gephyrin surface expression is decreased with shRNA or with a dominant negative 
gephyrin, glycine receptor mobility increases (Charrier et al., 2006).  
Although the dynamics of GABAA receptors have not been examined as 
extensively as ACh or glycine receptors, studies using recombinant GABAARs 
containing either the bungarotoxin binding site (Bogdanov et al., 2006) or a tag allowing 
electrophysiological identification (Thomas et al., 2005) have found that GABAARs are 
rapidly inserted and removed at the neuronal membrane, and that they transfer rapidly 
between synaptic and extra-synaptic regions by lateral diffusion. As with glycine 
receptors, gephyrin appears to play a critical role in the regulation of GABAAR dynamics 
as disruption of gephyrin with RNAi decreases the number and density of GABAAR 
clusters while increasing GABAAR cluster mobility on the surface of cultured 
hippocampal neurons (Jacob et al., 2005). 
The dynamics of gephyrin itself have also just recently begun to be investigated. 
These studies have used a recombinant gephyrin fused to a fluorescent marker and 
introduced it into cultured spinal cord neurons (Hanus et al., 2006). Using time-lapse 
imaging this group investigated the overall movement of individual gephyrin clusters 
following pharmacological manipulation. By examining intra-cluster fluctuations over 
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short time periods and the movement of the entire cluster over longer time periods they 
found that gephyrin dynamics within clusters were decreased when F-actin was disrupted, 
while movements of the entire clusters were tubulin dependent. Interestingly, synaptic 
activity specifically stabilized the intra-cluster movement of gephyrin. Although these 
studies did not examine the insertion, removal or lateral mobility of gephyrin into or out 
of individual synaptic sites as has been done with rapsyn, it nevertheless supports a 
similar model of receptor-associated protein dynamics potentially playing a role in 
regulating changes in receptor density at post-synaptic sites. 
PSD-95 
Most excitatory transmission in the mammalian brain is mediated by glutamate. 
At glutamatergic synapses, anchoring of the main receptor types is mediated by a family 
of PDZ binding proteins. Most ubiquitous and best characterized of these glutamatergic 
PSD proteins is PSD-95, which binds directly to NMDARs through the C-terminus of the 
NR2 subunit, and indirectly to AMPARs through interactions with SAP-97 and Stargazin 
(Rutter and Stephenson, 2000; Chetkovich et al., 2002; Choi et al., 2002; Schnell et al., 
2002; Cai et al., 2006). Unlike rapsyn or gephyrin, PSD-95 does not appear to be 
necessary for NMDA receptor clustering: genetic knock-outs do not prevent post-
synaptic receptor accumulation, and time-lapse imaging indicates that NMDA receptors 
actually begin to cluster at post-synaptic site prior to the arrival of PSD-95 (Washbourne 
et al., 2002). This protein is involved, however, in regulating AMPA receptor density 
changes and, like rapsyn and gephyrin, is highly dynamic. 
Similar to rapsyn and gephyrin, PSD-95 has multiple interaction domains capable 
of mediating self-association and also of binding structural proteins (Kim et al., 1997; 
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Colledge et al., 2000) and signaling molecules (Kim et al., 1998; Tezuka et al., 1999; 
Penzes et al., 2001; Kalia and Salter, 2003) in the intracellular scaffold. Although PSD-
95 clusters NMDARs when the two proteins are co-expressed in heterologous cells (Kim 
et al., 1995), it is not necessary for NMDAR clustering, and gain- and loss-of function 
constructs have no effect on NMDAR-mediated excitatory post-synaptic currents 
(EPSCs) (Barria and Malinow, 2002; Prybylowski et al., 2005).  
 
As with rapsyn and gephyrin, recent work has also focused on the turnover of 
PSD-95 as a means of controlling the synaptic localization and density of receptors. 
Using a PSD-95 fusion construct and FRAP experiments similar to the ones used to 
examine rapsyn turnover, it has been shown that PSD-95 turns over rapidly at 
glutamatergic synapses in hippocampal cultures in vitro (Kuriu et al., 2006; Sharma et al., 
2006a). This fast constitutive turnover could allow for very rapid changes in PSD-95 
expression at synapses, which would in turn dramatically alter AMPA receptor levels. 
Indeed, the over-expression or knockdown of PSD-95 has been shown to dramatically 
alter AMPAR-mediated currents by altering synaptic expression of AMPA receptors 
(Hayashi et al., 2000; Ehrlich and Malinow, 2004; Nakagawa et al., 2004). These 
synaptic changes driven by the alteration of PSD-95 density have further been shown to 
mediate LTP in slice cultures in vitro (Stein et al., 2003; Bingol and Schuman, 2004; Lin 
et al., 2004), and the expression of PSD-95 has also been linked to enhanced learning in 
vivo (Ehrlich and Malinow, 2004; Yao et al., 2004) [however, see (Migaud et al., 1998)]. 
Finally, the active clustering function of PSD-95 requires palmitoylation (Topinka and 
Bredt, 1998), and the cycling of palmitate on synaptic PSD-95 is also able to alter 
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synaptic PSD-95 levels, potentially adding another layer of control to synaptic PSD-95 
expression (El-Husseini Ael et al., 2002). 
The rapid cycling of post-synaptic density proteins illustrated by rapsyn, gephyrin 
and PSD-95 appears to be the rule rather the exception. Along with PSD-95, other PDZ 
proteins studied as GFP fusion proteins with FRAP have proven to be very dynamic both 
at the drosophila NMJ and in hippocampal neuronal cell cultures, turning over even more 
rapidly than PSD-95 (Rasse et al., 2005; Kuriu et al., 2006; Sharma et al., 2006a). 
Together these emerging data challenge a view of the post-synaptic scaffold as a static 
structure. Given the important role that many of these scaffolding proteins play in the 
density, turnover and localization of post-synaptic receptors, this also indicates that 
changes in scaffolding protein turnover may have dramatic effects on synaptic structure, 
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 Using optical imaging assays, we investigated the dynamics of acetylcholine 
receptors (AChRs) at laminin-associated clusters on cultured myotubes in the absence or 
presence of the nerve-derived clustering factor, agrin. Using fluorescence recovery after 
photobleaching (FRAP) on fluorescent bungarotoxin-labeled receptors, we found that ~ 
9% of original fluorescence was recovered after 8 hours as surface AChRs were recruited 
into clusters.  By quantifying the loss of labeled receptors and the recovery of 
fluorescence after photobleaching, we estimated that the half-life of clustered receptors 
was ~ 4.5 hours. Despite the rapid removal of receptors, the accumulation of new 
receptors at clusters was robust enough to maintain receptor density over time. We also 
found that the AChR half-life was not affected by agrin despite its role in inducing the 
aggregation of AChRs. Interestingly, when agrin was added to myotubes grown on 
laminin-coated substrates, most new receptors were not directed into preexisting laminin-
induced clusters but instead formed numerous small aggregates on the entire muscle 
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surface. Time-lapse imaging revealed that the agrin-induced clusters could be seen as 
early as 1 hour, and agrin treatment resulted in the complete dissipation of laminin-
associated clusters by 24 hours. These results reveal that while laminin and agrin are 
involved in the clustering of receptors they are not critical to the regulation of receptor 
metabolic stability at these clusters, and further argue that agrin is able to rapidly and 
fully negate the laminin-substrate clustering effect while inducing the rapid formation of 
new clusters. 
Introduction 
Through the course of neuromuscular development the most prominent emerging 
feature of the postsynaptic membrane surface is the high density of acetylcholine 
receptors (AChRs) at the nerve endplate.  In rodents, early in embryonic development 
AChRs are distributed evenly over the muscle surface (Bevan and Steinbach, 1977).  By 
around E13, nerve-independent clustering of receptors occurs in the general region of 
eventual innervation (Lin et al., 2001).  Upon innervation a few days later, the receptor 
clusters that lie outside of muscle innervation sites disappear and new clustering of 
receptors is rapidly induced in direct and tight apposition to each nerve endplate (Lin et 
al., 2001).  The receptor clusters continue to morphologically differentiate post-natally, 
resulting in a dramatic increase in AChR density to > 10,000/µm2 at the mature 
neuromuscular junction (NMJ) that drops to < 10/µm2 within a few microns of the NMJ 
boundary (Fertuck and Salpeter, 1974; Fambrough, 1979). 
The metabolic stability of AChRs has been extensively studied both in vivo and in 
vitro. Using conjugates of bungarotoxin (a snake venom that binds specifically and quasi-
irreversibly to AChRs), it has been shown that AChR turnover in cultured aneural 
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myotubes is rapid, with a half-life of 7-24 hours depending on experimental conditions 
(Devreotes and Fambrough, 1975; Wang et al., 1999b; Trinidad and Cohen, 2004). At 
innervated and functional adult neuromuscular junctions, however, receptor stability 
dramatically increases (t1/2 ~10-14 days) (Salpeter and Loring, 1985; Akaaboune et al., 
1999).  What remains unclear is the dynamics of receptors during the early stages of 
embryonic development and whether these dynamics are modulated by neuronal factors. 
A crucial factor that affects AChR clustering during development in vivo is agrin, 
a nerve-derived heparin sulphate proteoglycan that activates both a muscle specific 
kinase (MuSK), and rapsyn, an intracellular protein that is found in 1:1 stoichiometry 
with AChRs (Burden et al., 1983; Sealock et al., 1984; Valenzuela et al., 1995; Sanes and 
Lichtman, 2001). Indeed, mice deficient in either MuSK or rapsyn fail to form any AChR 
clusters either during development or on dissociated myotubes (Gautam et al., 1995; 
DeChiara et al., 1996). Agrin knockout mice, however, do form receptor clusters in the 
endplate zone by E14.5, but these clusters disappear after failing to stabilize or reform 
under nerve endplates after innervation (Lin et al., 2001). Based on these observations it 
was suggested that agrin may act to stabilize AChR clusters rather than initiate their 
formation.  
Since it would be difficult to study receptor dynamics in utero directly, we have 
used a culture system that produces post-synaptic receptor clusters that are remarkably 
similar in morphology and maturation to those seen during post-synaptic apparatus 
development in vivo (Kummer et al., 2004). This culture system was developed by 
growing myotubes on another factor known to influence receptor clustering in vitro: the 
nerve-independent extracellular matrix protein laminin (Vogel et al., 1983).  In this work 
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we sought to study the effect of agrin on AChR dynamics directly using fluorescence 
imaging assays, and used the same assay to analyze the effect of laminin per se on the 
metabolic stability of clustered AChRs.  This approach has led to the observation that 
agrin and laminin do not alter AChR metabolic stability, and it unexpectedly revealed 
that agrin is able to induce the accumulation of new receptors into new cluster sites while 
preventing the maintenance of receptor density at preexisting laminin-associated clusters.   
Materials and Methods 
Cell culture. C2C12 myotubes obtained from American Type Cell Culture were grown 
in DMEM supplemented with 20% fetal bovine serum at 37˚ C, split into 35-mm culture 
dishes and differentiated 2 days later at cell confluence by replacing the media with 
DMEM supplemented with 5% horse serum.  Media was then changed every two days 
and cells were imaged 4-6 days after differentiation.  For laminin-coated cultures, culture 
dishes were coated with 5 µg/ml polyornathine (Sigma-Aldrich) in distilled water, air 
dried and then incubated overnight at 37˚C with EHS laminin (10 µg/ml) (Invitrogen) in 
L-15 media supplemented with 0.5% sodium bicarbonate.  Dishes were then aspirated of 
excess laminin media immediately before plating cells.  Laminin coated plates caused 
rapid differentiation and growth of muscle cells. Consequently, imaging of AChRs on 
myotubes grown on laminin substrate was done at time points slightly earlier than those 
for non-laminin substrate myotubes (3-5 days). 
Fluorescence Microscopy. Images were taken with a digital CCD camera (Retiga EXi, 
Burnaby, BS, Canada) using a water immersion objective (20X UAPO 0.7 NA Olympus 
BW51, Optical Analysis Corporation, NH).  Images were captured at 25% light intensity 
through a neutral density filter (to limit photobleaching effects) on an Olympus51 
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microscope using IPLab, and images were then quantified using Matlab and converted 
into figures in Photoshop.  
 To study the rate of AChR removal from receptor clusters, cells were incubated 
with α-bungarotoxin conjugated to an Alexa fluorophore (BTX-Alexa 594) (5 µg/ml, 1 
h) and washed gently 3 times in differentiation media; a second dose of BTX-Alexa 488 
was added to ensure that all receptors were saturated and then cultures were washed 
gently 3 times and imaged at time 0. Residual BTX left in the culture media for the 
duration of the experiment after time 0 was therefore primarily BTX-Alexa 488 and not 
BTX-Alexa 594.  This ensured that any new receptors that were inserted into the 
membrane would bind residual BTX-488 and therefore would not contribute to BTX-
Alexa 594 fluorescence detected at later time points. From 2-8 hours later the same 
clusters were re-imaged and their fluorescence intensity was assayed using a quantitative 
fluorescence imaging technique, as described by Turney and colleagues (Turney et al., 
1996), with minor modifications.  Control myotubes were saturated with BTX-594, 
imaged, and then immediately incubated in BTX-488 until imaging at 8 hours.  Loss of 
fluorescence at the clusters on these myotubes was indistinguishable from the loss of 
fluorescence at tubes subjected to the BTX-488 labeling only immediately before 
imaging at 8 hours.  This implies both that the unbinding and re-binding of BTX 
conjugates does not occur at a measurable rate over 8 hours, and that blocking new 
functional receptors does not affect receptor removal.  This last point was supported by 
the fact that the addition of the sodium channel blocker tetrodotoxin also did not alter the 
removal of receptors from clusters over the same time period. 
 42
 To study the rate of AChR insertion into receptor clusters, cells were saturated 
with BTX-Alexa 594 as described above, washed gently 3 times and then immediately 
imaged. Four and/or 8 h later the same clusters were re-imaged and their fluorescence 
intensity was assayed, and then a second dose of the same BTX-Alexa 594 was added to 
saturate the new AChRs inserted at each time point, and fluorescence intensity was again 
determined. Clusters that had “rolled” over to the edge of the tube as it grew and 
therefore existed in multiple focal planes, or clusters on myotubes that were dying or 
shrinking at the later time point were discarded.  This did not present a problem on 
laminin-coated dishes as the clusters in these preparations were large and easy to 
differentiate from each other, and they always formed at the laminin-muscle cell 
boundary and therefore were consistently in a single focal plane.   
 To study the lateral migration of AChRs, cells were saturated with BTX-Alexa 
488 and washed gently 3 times. Immediately after imaging, the fluorescence of single 
clusters was carefully removed with a 10mW argon laser emitting at 488 nm and passed 
through neutral density filters that blocked 87.5% of the laser emission. Photobleaching 
typically took less than 5 seconds/cluster. At later time points the bleached and non-
bleached neighboring “sister” clusters were found and re-imaged.  The FRAP 
experiments were done in the presence of either unlabeled BTX or BTX-Alexa 594 to 
prevent rebinding of photo-unbound BTX-Alexa 488 (Akaaboune et al., 2002). 
Agrin treatment. Either 100 ng/ml or 500 ng/ml of C-terminal agrin (R&D Systems, 
Minneapolis, MN) was added to culture dishes either 16 hours prior to initial imaging or 
immediately before the initial images were taken.  After all washing steps, additional 
agrin was added to maintain the concentration throughout the imaging session. 
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Laminin treatment. Cell cultures were treated with a soluble laminin (10µg/ml) 
immediately before initial imaging and through the imaging period. After all washing 
steps, additional laminin was added to maintain the concentration throughout the imaging 
session.  Cells were labeled and imaged as describe above.  
Results 
Substrate laminin does not affect the rate of receptor removal. 
To estimate the receptor removal rate at individual spontaneous AChR clusters 
over time, C2C12 myotube cultures were labeled with BTX-Alexa 594 (5 µg/ml, 1 h), 
and then incubated in BTX-Alexa 488 (5 µg/ml, 10 min) to ensure that saturation was 
achieved.  The fluorescence intensities of clusters were then assayed immediately after 
saturation and then 4 and/or 8 hours later.  4 hours after initial labeling, fluorescent 
intensity had decreased to 56% ±19 SD (n=94 cluster/5 cultures) of original fluorescence, 
and had decreased further to 38% ±20 SD (n=39 clusters/4 cultures) of original 
fluorescence at 8 hours (Figure 2.1 A,C). We next wanted to determine if receptor 
removal is altered in clusters found on the surface of myotubes that are grown on a 
laminin substrate. These clusters show some striking similarities to mature 
neuromuscular junctions in terms of size, topology and the general morphological 
development from “plaque” to “open” to “pretzel-like” shapes, as described by Kummer 
et al., 2004. Further, these clusters form between muscle and dish and so lie in a single 
focal plane and do not tend to change location as muscles grow or even contract, making 
these clusters relatively easy to image when labeled with fluorescent molecules. When 
the fluorescence intensity of labeled receptor clusters was assayed at 4h, we found that 
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61% ±12 SD (n=92 clusters/4 cultures) of original fluorescence remained, and at 8h 44% 
±14 SD (n=71 clusters/4 cultures) of original fluorescence remained (Figure 2.1 B,C).  
This loss was not due to the photobleaching of fluorescent bungarotoxin bound to 
receptors, as the same control cluster imaged several times experienced little if any loss 
of fluorescence (<1% fluorescence loss at each sequential image). The loss of 
fluorescence was also not dependent upon spontaneous unbinding of BTX from AChRs, 
since BTX-labeled receptor complexes that remained bound to the laminin as “ghost” 
clusters (after the muscle they were originally clustered on had died) did not bind to new 
BTX-Alexa of a different color added days later.  This is in agreement with studies that 
have shown that the BTX-AChR bond is essentially irreversible (Devreotes and 
Fambrough, 1975, Sanes and Lichtman, 2001).  Therefore these results suggest that while 
substrate laminin dramatically alters receptor cluster size and morphology, it does not 
increase AChR half-life at these clusters. 
Since the effect of c-terminal agrin on increasing the number of spontaneous 
clusters is well documented (Ferns et al., 1993), we wanted to investigate whether the 
clustering activity of agrin is also involved in altering the rate of receptor removal. To 
examine this possibility, cultured myotubes were grown either on a laminin substrate or 
non-coated culture dishes and incubated with c-terminal agrin (100 ng/ml) either the 
night before imaging (t = –16 h) or immediately prior to initial imaging (t = 0 h).  In both 
cases, agrin concentration was maintained in the culture through the duration of the 
experiment and BTX-Alexa labeling was done as detailed above.  When we measured 
receptor loss from spontaneous clusters at 4 hours in the presence of agrin, we found that 
48% ±20 SD (n=39 clusters/4 cultures) of the original fluorescence was retained, and that 
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the fluorescence dropped to 38% ±20 SD (n=12 clusters/3 cultures) at 8h, which was 
nearly identical to the rate of fluorescence lost from clusters on myotubes in the absence 
of agrin (Figure 2.1 C).  In many cases it was difficult to accurately identify or quantify 
the original clusters at later time points either because clusters often “rolled” over the side 
of the muscle out of a single focal plane as the myotube grew, or because they 
fragmented over time.  We therefore only used clusters in this study that could be clearly 
distinguished from neighboring clusters and accurately quantified at 4 h and 8 h.  
When myotube cultures expressing laminin-induced clusters were treated with c-
terminal agrin (hereafter referred to as “agrin”, unless otherwise noted) and fluorescence 
loss was examined at both 4 h and 8 h, we found that the agrin had no effect on the rate of 
receptor removal: at 4 h the fluorescent intensity was 63% ±13 SD (n=74 clusters/4 
cultures) of original fluorescence, and at 8 h fluorescent intensity was 37% ±14 SD (n=74 
clusters/4 cultures) of original fluorescence (Figure 2.1 C). While agrin did cause clear 
and dramatic increases in receptor cluster number (consistent with previous studies), 
these results indicate that agrin does not affect AChR stability at spontaneous clusters or 
laminin-induced clusters on C2C12 myotubes. 
Lateral Migration of AChRs. 
Given that the rate of receptor removal from receptor clusters was nearly identical 
for myotubes grown in the presence or absence of laminin substrate, and since laminin-
induced clusters are larger, easier to identify and lie in the same focal plane, we carried 
out most of the following experiments only on myotubes grown on laminin substrate. 
First we were interested to know whether the diffusible AChRs contribute to cluster 
density. If lateral migration of receptors accounts for an appreciable amount of 
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fluorescence over time then measurements of fluorescence at later time points would not 
allow an accurate computation of receptor half-life. To determine the contribution of 
laterally migrating AChRs to cluster density, we saturated all preexisting AChRs on the 
myotube surface with BTX-Alexa 488 and then used an argon laser to selectively remove 
the fluorescence from all the receptors at single laminin-induced clusters. In this way, 
only the pre-existing diffusible AChRs on the membrane remained fluorescently labeled. 
All photobleaching experiments were performed in the presence of unlabeled 
bungarotoxin or BTX-Alexa 594 to prevent the rebinding of any BTX-Alexa 488 that 
may have been induced to unbind by the laser (Akaaboune et al., 2002).  
Since photobleaching was done on living myotubes we performed a number of 
controls to confirm that the argon laser did not have deleterious effects in our 
experimental design in vitro. We found that myotube growth was normal, and nuclei 
under photobleached regions appeared healthy, even on myotubes that were completely 
photobleached over their entire surface.  Bleached clusters themselves also appeared to 
be unaffected by the bleaching process, as the accumulation of new receptors measured 
with a distinctly colored BTX-Alexa at later time points revealed that the addition of new 
receptors at bleached clusters was equal to that at non-bleached neighboring “sister” 
clusters on the surface of the same myotube.  Photobleaching therefore had no observable 
deleterious effect on the muscle cell or bleached cluster.  Bleaching of sister clusters by 
residual laser light was also minimal. 
From 2 hours to 8 hours after photobleaching the recovery of fluorescence was 
monitored. We found that the fluorescence recovery was circumferential around the 
original cluster area, consistent with a diffusion-trap process, and that bleached clusters  
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Figure 2.1. Receptor removal at single acetylcholine receptor clusters in vitro is unaffected by 
laminin or agrin. (A) Example of a number of myotubes displaying small, spontaneous AChR clusters.  
Receptors were labeled once with BTX-Alexa 594 and the loss in fluorescence was assayed at 4 and 8 
hours.  (B) Example of a single fused myotube grown on a laminin substrate displaying multiple 
laminin-induced AChR clusters and assayed for fluorescent loss as in (A).  Note that these clusters are 
larger and more topologically complex than the non-laminin clusters in (A). Scale bar = 20 µm. (C) A 
Histogram summarizing the fluorescence at 4 and 8 hours of clusters on myotubes grown in the 
presence or absence of laminin substrate and in the presence or absence of agrin.  Receptors at clusters 
on the surface of myotubes grown on a laminin substrate show approximately the same stability as 
receptors at clusters on myotubes lacking substrate. Agrin treatment 16 hours prior to or immediately 
after initial imaging had little effect on the removal rate of clustered receptors on myotubes grown in 
the presence or absence of a laminin substrate.  All plots represent mean ±S.E.M. 
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gradually gained back ~ 9% (9.4% ±4 SD, n = 49) of their original fluorescence intensity 
after 8 hours (Figure 2.2 A). Since previous work indicates that recycling does not occur 
in cultured myotubes (Gardner and Fambrough, 1979), we assume that these laterally 
migrating receptors diffuse solely through the membrane surface. After 2, 4 and 6 hours, 
fluorescence recovery was 5.6% (±2 SD, n = 39), 9.4% (±4 SD, n = 23) and 9.7% (±5 
SD, n = 21), respectively. These data were fit well by a single exponential curve (Figure 
2.2 B) with R2 = 0.98. When sister clusters were not laser illuminated, 44% of 
fluorescence remained after 8 hours, consistent with our calculations of fluorescence loss 
at clusters on myotubes not exposed to the laser (Figure 2.2 A).  Since the remaining 
fluorescence at a non-bleached sister cluster is a combination of both the preexisting 
labeled receptors and the recovery from laterally migrating receptors, we subtracted out 
the amount of fluorescence signal due to lateral migration to determine the amount of 
fluorescence due only to originally clustered receptors (44% - 9% = 35% of receptors 
remaining after 8 hours). After collecting data for the loss of fluorescence at unbleached 
clusters at the 2, 4, 6 and 8 hour time points (78% ±13 SD, n = 42; 61% ±11 SD, n = 92; 
48% ±8 SD, n = 20; 44% ±14 SD, n = 71, respectively), this correction for lateral 
migration was done at each data point to give a new curve that allowed us to estimate 
receptor half-life (Figure 2.2 B).  This curve was fit well by a single exponential with R2 
= 0.99. Interestingly, the only point that was slightly elevated compared to the 
exponential fit was the 8-hour time point, which was also the time at which aggregations 
of intracellular fluorescent puncta became prevalent.  Although every effort was made to 
only image clusters that did not have these puncta near them, it seems likely that this 
intracellular fluorescence might have contributed to the total cluster fluorescence, thus 
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causing this slight elevation above the actual fluorescence from clustered receptors at this 
time point.  The receptor half-life of 4.5 hours derived from this corrected decay is far 
more rapid than the uncorrected half-life calculated from our experiments that measured 
fluorescence loss only (t1/2 ~ 7 hours), and approximately two times shorter than previous 
estimates that have ignored lateral migration and trapping of diffusible surface AChRs. 
Figure 2.2. Contribution of diffusible acetylcholine receptors to laminin-induced clusters.  (A) 
Example of a single myotube grown on laminin substrate that was imaged prior to, immediately after 
and 8 hours after photobleaching.  At 8 hours the fluorescence recovery at bleached clusters was ~ 9%, 
indicating that a significant number of diffusible preexisting labeled receptors had moved into the 
bleached cluster.  “Sister” clusters on the myotube that were not exposed to the laser lost more than half 
of their fluorescence after 8 hours, as expected (see Figure 1). Scale bar = 20 µm. (B) Data from a 
number of experiments performed at 2, 4, 6 and 8 hour time points.  At each time point the average 
fluorescence due to lateral migration was subtracted from the total average fluorescence remaining to 
obtain the number of preexisting receptors remaining at a cluster.  All data were fit by single 
exponential curves. All points represent mean ±S.E.M. 
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Accumulation of new receptors compensates for removal of old receptors to 
maintain receptor density at AChR clusters. 
While the rapid loss of receptors from laminin-induced AChR clusters is partially 
offset by the trapping of laterally migrating receptors, we wanted to determine whether 
the accumulation of new receptors at myotube clusters is able to provide enough 
additional receptors to match receptor removal and maintain receptor density over time. 
To determine the amount of new receptor accumulation at clusters, myotubes were 
labeled with BTX-Alexa 594 (5 µg/ml, 1 h), and clusters were imaged immediately. Four 
hours later, the same clusters were imaged to determine the amount of fluorescence lost, 
and new BTX-Alexa 594 was then added to the myotube culture to saturate all new 
receptors that had accumulated at clusters since the initial BTX-Alexa 594 saturation. We 
found that on myotubes grown on laminin substrate and on myotubes grown without 
substrate, accumulation of new receptors at existing clusters allowed receptor density to 
be maintained: laminin-associated clusters were at 101% of original fluorescence at 5 h 
±21% SD (n = 72 clusters/5 cultures) (Figure 2.3 A, B), and non-laminin clusters were at 
95% of original fluorescence at 5 h (±20 SD, n=22 clusters/3 cultures) (Figure 2.3 B). 
These results suggest that the accumulation of new receptors at clusters on myotubes 
grown on both laminin- and non-laminin substrates is rapid and robust enough to 
maintain receptor density at individual clusters even as muscle and cluster morphology 
often change over time.  Similar results were obtained at 8 hours, see figure 2.6. 
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Agrin causes new cluster formation and disrupts laminin substrate-associated 
clusters. 
Although the experiments above showed that laminin substrate and soluble agrin alone do 
not alter receptor half-life at individual AChR clusters, laminin and agrin are known to 
interact directly and indirectly to induce receptor clustering (Denzer et al., 1997; 
Sugiyama et al., 1997; Montanaro et al., 1998). We therefore wanted to determine if the 
Figure 2.3. Accumulation of new receptors at single acetylcholine receptor clusters in vitro.  (A) 
Myotubes grown on a laminin substrate that were saturated with BTX-Alexa 594 immediately before 
the first image.  A sample cluster is shown in the inset that was quantitatively imaged at time 0 and 4 
hours later.  The loss of fluorescence was assayed, and then the cluster was imaged a third time after 
new BTX-Alexa 594 was added to label new AChRs. Note that even though the overall morphology of 
laminin-associated clusters can change markedly over 4 hours, the receptor density is maintained by the 
accumulation of new receptors. Scale bar = 20 µm. (B) Summary of data from multiple experiments 
with both laminin and non-laminin substrates. Note that insertion allows both laminin-associated and 
non-laminin clusters to maintain receptor density over a 5 hour time period. All points represent mean 
±S.E.M. 
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clustering effect of laminin is affected by the addition of agrin.  To do this, myotubes 
grown on a laminin substrate were saturated with BTX-Alexa 594 (5µg/ml, 1.5) and 
exposed to a high dose of agrin (100 – 500 ng/ml).  Either 16 hours after or immediately 
following agrin treatment, initial images for each condition were taken to identify clusters 
saturated with BTX-Alexa 594 (Figure 4, “preexisting”, pseudo-color).  For each 
condition, 8 hours after initial imaging the same myotubes were re-imaged and then 
incubated with BTX-Alexa 488 to label all new receptors.  On control myotubes grown 
on laminin substrate and not treated with agrin, no new clusters formed over the 8-hour 
time period (Figure 2.4 A) while old receptors were selectively removed from the inside 
of developing cluster (Figure 2.4 A), as previously described by Kummer et al, 2004. 
Interestingly, on the myotubes incubated with agrin, immediately after initial imaging we 
found that while the fluorescence from preexisting laminin-induced clusters labeled with 
BTX-Alexa 594 (red) disappeared over time at a normal rate (37% ±14 SD, n=74 
clusters/4 cultures fluorescence remaining at 8 hours), numerous small clusters formed 
from pre-labeled AChRs on the surface of the myotubes (Figure 2.4 B, arrowheads). This 
is consistent with previous studies that have found that agrin-induced receptor 
aggregation is independent of new protein synthesis (Wallace, 1988). However, new 
AChRs that were identified with BTX-Alexa 488 (green) were also found to be 
concentrated at these clusters (Figure 2.4 B, arrowheads). Cells pre-incubated in agrin the 
night before initial imaging displayed many of these small clusters, but lacked discernible 
laminin-induced clusters when imaged the next day (Figure 4C, time 0 “preexisting”). 
The agrin-induced clusters, however, were stable over 8 hours and no new clusters 
appeared at 8 hours that had not existed at time 0 (Figure 2.4 C).  This implies that the c-
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terminus of agrin induces either a preferential targeting of new AChRs to agrin-induced 
clusters over laminin-induced clusters, or that receptors, once inserted randomly into the 
membrane, are trapped by agrin-induced clusters more effectively than laminin-induced 
clusters as they diffuse laterally in the membrane. 
 
Figure 2.4. Agrin decreases the accumulation of new receptors at laminin-associated clusters and 
induces clustering of preexisting and new receptors at novel cluster sites.  (A-C) Labeling schemes 
and sample images for control myotubes and myotubes incubated with a high dose of agrin either at the 
time of initial imaging or 16 hours prior to initial imaging, and then re-imaged 8 hours later. (A) In non-
agrin treated cells, laminin-associated myotubes display large clusters (left panel), typical removal of 
preexisting receptors (second panel) and a normal pattern of receptor insertion (third panel).  Overlay 
(right panel) reveals that preexisting receptors are preferentially removed from the center of the 
developing cluster and new receptors accumulate around the entire cluster.  (B) When agrin is added to 
the culture immediately before the first image is taken, preexisting receptors can be seen to aggregate 
into new clusters after 8 hours that did not exist at the time of initial imaging (second panel, 
arrowheads). New receptors are also preferentially added to these new agrin-induced clusters (third 
panel, arrowheads).  (C) When incubated in agrin for 16 hours prior to initial imaging (and then for the 
duration of the experiment), myotubes are devoid of laminin-induced clusters at time  0 (left panel), the 
small agrin clusters are maintained over the next 8 hours (second panel) and new receptors accumulate 
only at these preexisting clusters (third panel). Scale bar = 20 µm.
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In order to gain a better temporal resolution of the agrin effect on the redirection 
of new receptors, we examined the agrin effect over a 3-hour time period using time-
lapse imaging. Myotubes were grown on a laminin substrate and incubated with agrin at 
the time of initial imaging, and then re-imaged 1 and 3 hours later (Figure 2.5 A). After 
only one hour, small clusters of preexisting receptors labeled with BTX-Alexa 488 could 
be detected, and these clusters became more defined by 3 hours (Figure 2.5 B, first 
panels). While some of the clustering of preexisting receptors clearly occurred at places 
where AChR cluster “seeds” existed at 0 h (arrowheads), others appeared at regions that 
were not obviously seeded by receptors (arrows). When BTX-Alexa 594 was added to 
label new receptors, labeling was clearly visible at laminin-induced clusters but was not 
able to be resolved at the agrin-induced clusters at 1 hour. However, when the same 
myotube was re-imaged again at 3 hours after new BTX-Alexa 594 incubation, new 
receptors were clearly visible at the agrin-induced clusters (Figure 2.5 B, second panels). 
These results indicate that the effect of agrin is rapid, occurring within one hour of 
incubation.  This effect was also specific to agrin, as soluble laminin (10 µg/ml) added in 
the same manner as agrin failed to induce new cluster formation over the same time 




Figure 2.5. Time-lapse imaging of agrin-induced cluster formation on the surface of myotubes 
grown on laminin substrate.  (A) Scheme for the BTX-Alexa labeling and agrin treatment of 
myotubes.  (B) Example of a single myotube treated with 100 ng of agrin and imaged 3 times.  First 
panels (left) represent preexisting receptors labeled at time 0 and imaged at 0, 1 and 3 hours later. 
Second panels (from the left) show the same myotube labeled with BTX-Alexa 594 to stain new 
receptors that have accumulated at the clusters between time 0 and each of the later time points.  Third 
panels are overlays of the first two panels at each time point.  Note that by 1 hour small receptor 
aggregates can be detected on the muscle surface and that at 3 hours these preexisting receptors have 
clustered and new receptors are clearly visible and co-localized at these agrin-induced clusters. 
Arrowheads indicate clusters that formed where cluster “seeds” existed at time 0; arrows indicate 
clusters that formed at regions on the surface where no receptor cluster seeds could be seen at time 0. 
(C) When soluble laminin was added instead of agrin to myotubes grown on laminin substrate no new 
clusters could be detected, indicating that the formation of new clusters is specific to agrin-treatment. 
Scale bar = 20 µm. 
 56
Effect of agrin on the accumulation of new receptors at agrin-induced and laminin 
substrate-induced clusters. 
Having found that agrin does not alter the rate of receptor removal rate from 
membrane clusters (see Figure 2.1), we wanted to determine whether agrin modulates the 
accumulation of new AChRs into clusters. To do this we continually labeled all receptors 
with the same fluorescent BTX conjugate and quantified the amount of fluorescence at 
new agrin-induced clusters and large distinct laminin substrate clusters over time. 
Myotubes were saturated with BTX-Alexa 594 and then imaged in the presence of agrin 
(100 ng/ml). The same clusters were re-imaged 4 and 8 hours later after being re-
saturated with new BTX-Alexa 594  (5µg/ml, 1h) to label any new receptors that had 
accumulated at clusters over each time period (Figure 2.6 A).  In this way the full 
complement of clustered receptors (both preexisting and new) was imaged at each time 
point. While total fluorescence at 4 and 8 hours remained near 100% at laminin-
associated myotube clusters in the absence of agrin, we found that the total receptor 
number at laminin-induced clusters treated with agrin decreased to 89% ±17 SD (n=71 
clusters/3 cultures) of original fluorescence at 4 hours and 61% ±23 SD (n=78 clusters/3 
cultures) of original fluorescence at 8 hours (Figure 2.6 B). In addition we found that less 
than 5% of original fluorescence was recovered after photobleaching at laminin-induced 
clusters in the presence of agrin compared to approximately 10% in the absence of agrin, 
indicating that the lateral migration of diffuse preexisting AChRs into preexisting clusters 
was altered by agrin treatment.  
We next wanted to estimate the number of new receptors that were integrated into 
clusters by lateral migration versus targeted insertion. To do this we first calculated the 
contribution in original fluorescence of new receptors by subtracting the preexisting 
 57
receptors remaining at clusters after 8 hours from the full complement of receptors 
(preexisting + new) found at clusters at this time. For example, at 8 hours preexisting + 
new receptors at laminin-associated clusters account for 97% of original fluorescence, 
and preexisting receptors alone account for 44% of original fluorescence. Therefore 53% 
of the original fluorescence is due to new receptors at 8 hours. Assuming that < 10% of 
original fluorescence is due to the lateral diffusion of new receptors > 43% must be due 
to direct insertion of new receptors. However, in agrin-challenged cultures, only 24% of 
original fluorescence is contributed by new receptors (61% - 37%) at 8 hours. Assuming 
that < 5% of original fluorescence is due to the lateral diffusion of new receptors, direct 
insertion of new receptors must account for at least 15% of original fluorescence at 8 
hours. Therefore, while laminin-associated clusters disappear over time and are absent 24 
hours after agrin treatment, this appears not to be the result of increased receptor removal 
or cluster fragmentation, but rather because the accumulation of new receptors through 
both diffusion/trap and targeted insertion is decreased markedly within 8 hours of agrin 
treatment, presumably dropping to undetectable levels within 24 hours.  
Finally, we observed that this agrin effect occurred even if the agrin was removed 
after imaging at 8 hours. Indeed a single 30 minute incubation with agrin was sufficient 
to produce an effect similar to that seen when agrin was used for the duration of the 
experiment, albeit at a reduced effect, suggesting that a single agrin treatment is sufficient 
to activate downstream machinery necessary for the redirection of new AChRs and the 




Figure 2.6. Agrin treatment decreases the accumulation of new receptors at preexisting laminin-
induced clusters and increases insertion of new receptors into agrin-induced clusters, as revealed 
by quantitative fluorescence imaging. (A) A sample image shows the decrease in total receptor 
number at laminin-associated clusters and the subsequent appearance and increase in total receptor 
number at agrin-clusters beginning at 4 hours. Scale bar = 20 µm. (B) AChR clusters on myotubes 
grown on a laminin substrate were saturated with the same fluorescent bungarotoxin three times (before 
each of the three imaging time points at 0 h, 4 h and 8 h) to ensure that all receptors (both preexisting 
and new) were quantitatively imaged.  This showed that receptor density is maintained at control 
clusters formed on myotubes grown on laminin substrate over 8 hours (red trace).  Agrin treatment 
immediately before initial imaging resulted in a marked decrease in total receptor number at laminin-
induced clusters over 8 hours (blue trace); since agrin does not increase receptor removal (see figure 1), 
this must be due to a decrease in receptor insertion.  At the same time, agrin resulted in a marked 
increase in new receptor aggregation at agrin-induced clusters that had appeared by 4 hours. All points 
represent mean ±S.E.M. 
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Discussion 
In this work, we used quantitative fluorescence imaging and FRAP techniques to 
study AChR dynamics at single spontaneous and laminin-induced clusters over time. 
While receptors on myotubes grown on a laminin substrate aggregate into large, 
differentiated clusters, we demonstrated that receptor half-life at these clusters was hardly 
affected, having a t1/2 of about 4.5 hours. In addition we found that the total number of 
receptors at individual laminin-induced and non-laminin clusters remained nearly 
constant over time. Furthermore, we found that c-terminal agrin is not involved in 
regulating the metabolic stability of receptors, although its critical role in clustering 
receptors is undisputed. Finally, agrin treatment of laminin-induced clusters resulted in 
the formation of numerous small agrin clusters on the myotube surface while the 
accumulation of new receptors at preexisting laminin clusters was significantly 
decreased.  
The metabolic stability of surface AChRs on developing cultured myotubes has 
been studied previously and these receptors were found to have a t1/2 of 7-24 hours, 
depending on cell type and experimental design. Most of these previous studies used 
radio-labeled bungarotoxin (I125-BTX), estimating the time course of AChR removal by 
comparing the amount of radioactivity released into the media to the total amount of the 
radioactivity at the time of initial labeling. However this method does not distinguish 
between diffuse and clustered receptors and the estimate of receptor half-life is derived 
by pooling together all receptors from the entire population of cells in a culture 
(Devreotes and Fambrough, 1975; Miller, 1984; O'Malley et al., 1993). In addition this 
technique does not distinguish between the surface AChRs and the receptors that are 
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removed from the membrane but not yet degraded (Devreotes and Fambrough, 1975), 
potentially inflating the calculations of surface receptor half-life. More recently a few 
attempts have been made to study the removal of receptors from individual clusters in 
cultured myotubes using fluorescence assays. These studies have found that the t1/2 of 
removal of clustered receptors ranges from 7-20 hours (Kim and Nelson, 2000; Trinidad 
and Cohen, 2004). These studies did not, however, take into account the pool of diffuse 
receptors that are able to laterally migrate into the receptor clusters over time.  In our 
work we also used fluorescent bungarotoxin to assay receptor removal, but we used 
FRAP to determine the amount of lateral migration into individual clusters over time. 
Before taking into account the contribution of laterally diffusing AChRs to cluster density 
we found that receptor half-life was ~ 7 hours, and after correcting for lateral migration 
we estimated the half-life of AChRs at clusters to be ~ 4.5 hours. This rate is more rapid 
than previous estimates that have ignored the migration of diffuse AChRs.  
Our work also demonstrated that the accumulation of new receptors at preexisting 
clusters was quite rapid, matching receptor removal to maintain receptor density over 
time. It further implied that a significant number of these new receptors are targeted 
directly to the clusters: since results from our FRAP experiments clearly show that the 
diffusion of preexisting receptors accounts for < 10% of original fluorescence 
accumulated at clusters over 8 hours, one would assume that new receptors would 
laterally migrate at a similar rate, also contributing < 10% of original fluorescence after 8 
hours. If this assumption is correct, then a significant number of new AChRs, which 
account for > 50% of original fluorescence after 8 hours, must be inserted directly into 
the preexisting clusters. This result is consistent with previous studies that showed that a 
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significant number of new inserted receptors are targeted directly to clusters (Bursztajn et 
al., 1985). 
One interesting finding demonstrated by this work is that c-terminal agrin is not 
involved in the maintenance of receptors at either spontaneous or elaborated laminin-
induced clusters on myotubes, even when a large dose of agrin (100 – 500ng/ml) was 
added to the cultures.  Previously it has been shown that the initiation of receptor 
clustering occurs in agrin deficient mice, but that these clusters disappear later on which 
suggests that agrin might have a role in maintaining receptor clusters rather than initiating 
them (Lin et al., 2001). In transfected denervated muscle, too, agrin has been shown to 
stabilize receptors at ectopic clusters (Bezakova et al., 2001).  This could be due to the 
fact that this study used full-length agrin rather than the c-terminal agrin that was used in 
the present study.  While the c-terminal region of agrin is known to be responsible for the 
receptor aggregation affect seen in vitro, it is possible that other regions on agrin might 
alter receptor stability at those clusters.   
While some studies hint at the action of agrin on receptor stability in vivo, most of 
the studies that have investigated the effect of c-terminal agrin on clustering in vitro have 
quantified clustering by the number of clusters per myotube (Nitkin et al., 1987; 
Gesemann et al., 1995; Cornish et al., 1999), using an increase in the number of clusters 
as an indirect indicator of increased AChR “stability” rather than examining agrin’s effect 
on receptor turnover at the clusters themselves. Here, by showing explicitly that c-
terminal agrin has no effect on AChR metabolic stability at individual clusters, we 
provide direct evidence that the clustering region of agrin is not involved in regulating 
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AChR half-life in myotube clusters, suggesting that c-terminal agrin does not act as a 
stabilizer of metabolic stability in this culture system, but only as a cluster inducer.  
Since agrin and laminin are clustering factors known to effect the aggregation of 
AChRs during development in living animals, an obvious question arises from the current 
work: does the laminin/agrin interaction observed here potentially shed light on any 
developmental phenomenon in vivo? While speculative, there are some interesting 
parallels between our observations and the development of the nerve-endplate region 
during embryonic development. The initial clustering of AChRs on muscle fibers at the 
future endplate region is induced by nerve-independent factors.  One such factor that is 
able to induce cluster formation is laminin, which when added in solution to muscle cell 
cultures does not induce large, complex clusters, but when allowed to form as a substrate 
on laminin-coated dishes does result in such formation (Sugiyama et al., 1997; Kummer 
et al., 2004).  As laminin exists as a part of the extracellular matrix that forms a layer in 
between muscle fibers in vivo, it seems plausible that the substrate laminin represents a 
more likely mimic of endogenous laminin deposition than soluble laminin applied to 
dissociated muscle cells.  As such, laminin becomes a candidate for the factor responsible 
for the early, nerve-independent clustering observed at ~E14 in mice, as has been 
suggested (Sugiyama et al., 1997).  By E18.5, nerve endplates have contacted the muscle 
cells and released high local concentrations of agrin.  Subsequent to this innervation are 
the disappearance of extra-synaptic clusters and then the formation of clusters directly 
under the nerve endplate. While our observations of decreased AChR accumulation in 
laminin-induced clusters after agrin treatment is consistent with this developmental 
progression, it must be stressed that the agrin used in our study is c-terminal agrin, which 
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contains the receptor aggregation activity of agrin but lacks the laminin-binding site, so 
the applicability of the laminin and agrin clustering interactions to in vivo remains highly 
speculative.  Still, it will be interesting to see if these factors do indeed interact during 
this intriguing developmental transition. 
In sum, while agrin appears to induce the formation of multiple new clusters, even 
while it causes the degradation of existing laminin clusters, it does not contribute to 
receptor stability at these clusters. Agrin does have a rapid and dramatic effect on clusters 
that form on myotubes grown on laminin-substrate, however, significantly decreasing 
accumulation into these clusters and eventuating in their dissolution after 24 hours, while 
resulting in the simultaneous induction of numerous small clusters at novel clustering 
sites. These results therefore support the “induction” but not the “stabilizing” hypothesis 
of c-terminal agrin action on clustered acetylcholine receptors. 
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Abstract 
In the central nervous system, receptor recycling is critical for synaptic plasticity; 
however, the recycling of receptors has never been observed at peripheral synapses. 
Using a novel imaging technique, we show here that nicotinic acetylcholine receptors 
(AChRs) recycle into the postsynaptic membrane of the neuromuscular junction (NMJ). 
By sequentially labeling AChRs with biotin-bungarotoxin and streptavidin-fluorophore 
conjugates, we were able to distinguish recycled, pre-existing and new receptor pools at 
synapses in living mice. Time-lapse imaging revealed that recycled AChRs were 
incorporated into the synapse within hours of initial labeling, and that their numbers 
increased with time. At fully functional synapses AChR recycling was robust and 
comparable to the insertion of newly synthesized receptors, while chronic synaptic 
activity blockade nearly abolished receptor recycling. Finally, using the same sequential 
labeling method we found that acetylcholinesterase, another synaptic component, does 
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not recycle. These results identify an activity-dependent AChR recycling mechanism that 
enables the regulation of receptor density, which could lead to rapid alterations in 
synaptic efficacy. 
Introduction 
The density of neurotransmitter receptors is an important parameter in regulating 
the efficacy of synaptic transmission. In both the central (O'Brien et al., 1998; Carroll et 
al., 1999a) and peripheral (Fambrough and Hartzell, 1972; Akaaboune et al., 1999; Sanes 
and Lichtman, 2001) nervous systems, alterations in synaptic transmission cause changes 
in postsynaptic receptor density. Such changes are important in many forms of synaptic 
plasticity, which lead to the strengthening or weakening of synaptic connections (Carroll 
et al., 1999b; Luscher et al., 1999).  Several mechanisms at central nervous synapses, 
including receptor recycling, are known to be involved in regulating synaptic plasticity 
(Nishimune et al., 1998; Noel et al., 1999; Ehlers, 2000; Kim and Lisman, 2001; 
Malinow and Malenka, 2002; Bredt and Nicoll, 2003; Park et al., 2004).  In peripheral 
cholinergic neuromuscular junctions, however, it is not known whether acetylcholine 
receptors are stable until they are removed and degraded in a one-way trip to the 
lysosomes, or if they are in constant movement between internal compartments and the 
plasma membrane. To address this issue, we have developed a novel imaging technique 
that enables us to study new aspects of AChR dynamics at neuromuscular junctions in 
vivo. By selectively labeling different AChR pools (pre-existing, recycled and new) 
within a single synapse in the living mouse we were able to provide an estimate of the 
contribution of each pool to the NMJ over time. We found that a significant number of 
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these receptors undergo recycling back to the NMJ, and that this recycling is dramatically 
affected by alterations in synaptic activity. 
Material and Methods 
In vivo imaging. All animal usage followed methods approved by the University of 
Michigan Committee on the Use and Care of Animals. Adult female mice (20-27 grams, 
NSA, Harlan Sprague Dawley, Indianapolis, IN) were anesthetized with an intra-
peritoneal injection of ketamine and xylazine (17.38 mg/ml). Sternomastoid muscle 
exposure and neuromuscular junction imaging was done as previously described in detail 
(Lichtman et al., 1987; van Mier and Lichtman, 1994; Akaaboune et al., 1999). Briefly, 
the anesthetized mouse was placed on its back on the stage of a customized 
epifluorescence microscope, and neuromuscular junctions were viewed under a coverslip 
with a water immersion objective (20X UAPO 0.7 NA, Olympus BW51, Optical 
Analysis Corporation, NH) and a digital CCD camera (Retiga EXi, Burnaby, BC, 
Canada). Mice were intubated and ventilated for the duration of the imaging sessions.  
For imaging at multiple time points, the mouse was sutured after each session and 
allowed to fully recover before the next imaging session. 
Labeling of distinct AChR pools. After exposure of the sternomastoid muscle, AChRs 
were saturated first with fully substituted BTX-biotin (5 µg/ml, 1.5 h, Molecular Probes, 
Eugene, OR) and then with streptavidin conjugated to Alexa 660 (10 µg/ml, 2.5 h, 
Molecular Probes, Eugene, OR) to saturate all biotin sites. To ensure that all receptors 
and all biotin sites were saturated, distinct colors of tetramethyl-rhodaminated BTX  
conjugate (TMR-BTX) and streptavidin-Alexa (streptavidin-Alexa 488) were added to 
the sternomastoid muscle. Superficial synapses were then immediately imaged (IPLAB 
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software, Scanalytics, VA). Hours or days later the mouse was re-anesthetized, and the 
sternomastoid muscle was re-exposed and bathed with streptavidin-Alexa 488 to label the 
recycled AChRs and TMR-BTX to label the new AChRs. The muscle was washed, and 
the same synapses were relocated and imaged. In this way, we were able to distinguish 
the preexisting, new and recycled receptor pools. To rule out the possibility that 
streptavidin-Alexa binds directly to receptors, sternomastoid muscles were lightly labeled 
with TMR-BTX (5 μg/ml, 2 min application) to identify synapses. Streptavidin-Alexa 
488 (green) (10 μg/ml) was then applied to the sternomastoid muscle for 2.5 h. In these 
junctions no green labeling was observed, indicating that streptavidin does not bind 
directly to receptors.  
Denervation. The sternomastoid muscle was denervated by excising a 5 mm piece of 
nerve to prevent its regeneration. 10 days later the mouse was anesthetized and labeled as 
described above.  
Muscle stimulation. Denervated muscle was stimulated by placing stimulating 
electrodes at either end of the muscle (3-ms bipolar pulses of 10-13 V at 10 Hz for 1-s 
duration every 2 s for the entire 8 hour period).   
Continuous blockade of activity. To study the effect of muscle postsynaptic activity 
blockade on the insertion of recycled and new receptors, curare (2.5 mg/ml), a poison that 
binds reversibly to AChRs, was applied to the sternomastoid muscle to block 
neuromuscular transmission. For the duration of the experiment a coverslip was placed 
over the exposed muscle to prevent it from drying. Every two hours, additional curare 
solution was applied to the muscle. Animals were intubated with a ventilator for the 
duration of the experiment to prevent asphyxiation.   
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Cell culture. C2C12 cells (obtained from American Type Culture Collection, VA) were 
cultured on laminin coated dishes in medium containing 20% FBS and then switched 
after 2 days to 5% HS to induce differentiation into myotubes. 3-5 days after 
differentiation cultures were labeled and imaged as with muscles in vivo. We used the 
appearance of the cells under phase contrast illumination to distinguish receptor clusters 
on living muscle cells from ghost receptor clusters.  
Immunocytochemistry. Longitudinal sections (20 µm) of fixed (2% PFA) sternomastoid 
muscle that was labeled 4 days earlier with BTX-biotin (5 µg/ml, 1.5 h) followed by a 
saturating dose of fluorescent or unlabeled streptavidin (10 µg/ml, 2.5 h) were blocked 
with 10% BSA and goat serum, permeabilized with 1% triton X-100 and incubated with 
primary antibodies for 1-2 h at room temperature in blocking solution. The primary 
antibodies used were as follows: antibody to biotin (1:200, monoclonal 2F5, anti-biotin-
Alexa 488/594, Molecular Probes, OR); rat anti-acetylcholine receptor (1:500, mAb35 or 
mAb210, Sigma, St. Louis); rabbit anti-early endosomal antigen (1:300, EEA1, Abcam, 
Cambridge, MA). The sections were then washed extensively in PBS and incubated for 1 
hour with  secondary goat anti-rat antibody conjugated to either Alexa 594 or Alexa 488 
(Molecular Probes, OR),  and/or with secondary sheep anti-rabbit antibody conjugated to 
Texas Red (Abcam, Cambridge, MA). 
Confocal microscopy.  The analysis of intracellular and extracellular colocalization was 
carried out using a 60X oil immersion lens and laser illumination on a confocal Zeiss 
LSM 510 microscope. A series of optical planes were collected in the z dimension (z-
stack), and collapsed into a single image. Images presented in the Results section were 
produced and adjusted for brightness and contrast using Adobe Photoshop CS. 
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Quantitative fluorescence imaging. In experiments involving multiple color fluorescent 
ligands (such as the one illustrated in Figure 1), the camera gain was adjusted to give a 
nicely exposed image on each color channel, but because of differences in the extent of 
labeling of the different ligands and the quantum efficiency of different fluorophores, it 
was not possible to compare the relative number of molecules labeled with each ligand. 
When such comparisons were essential (Figures 4.7 and 4.8) the fluorescence intensity of 
labeled receptors at neuromuscular junctions was assayed using a quantitative 
fluorescence imaging technique, as described by Turney and colleagues (Turney et al., 
1996), with minor modifications. This technique incorporates compensation for image 
variation that may be caused by spatial and temporal changes in the light source and 
camera between imaging sessions by calibrating all images with a non-fading reference 
standard.   A key feature of the quantitative imaging approach used in the current study is 
that it involves three sequential labeling steps with the same ligands (BTX-biotin and 
streptavidin-Alexa 594). Thus, as long as we verified that labeling had reached saturation 
and that the image pixel intensity was not saturated, it was simple to get an accurate 
quantitative measurement corresponding to the number of AChRs in each pool.  
Results 
Recycling of AChRs at the neuromuscular junctions of live animals 
Experiments such as the one illustrated in Figure 3.1 suggested that AChRs are 
recycled at the postsynaptic membrane of the neuromuscular junction. The sternomastoid 
muscle of this mouse was labeled with a saturating dose of biotin-labeled -bungarotoxin 
(BTX-biotin) (5 µg/ml, 1.5 h), which binds with extremely high affinity to AChRs 
(Green et al., 1975; Fambrough, 1979).  BTX-biotin bound receptors were then saturated 
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with streptavidin conjugated to a fluorescent Alexa dye (10 µg/ml, 2.5 h), which in turn 
forms a noncovalent, very high affinity bond with biotin (Weber et al., 1989; Green, 
1990).  To test whether all receptors were saturated with BTX-biotin and all biotins 
saturated with streptavidin-Alexa, immediately after the unbound BTX-biotin and 
streptavidin-Alexa 660  were washed away (pseudo color, blue) the muscle was exposed 
to alternately colored streptavidin-Alexa (streptavidin-Alexa 488 (green), 10 µg/ml) and 
fluorescent -BTX (tetramethyl-rhodamine tagged (BTX-TMR) (red), 5µg/ml). The 
superficial synapses were then imaged (Figure 3.1 A). The absence of red and green 
fluorescence indicates that saturation was achieved (Figure 3.1 B,C). When the same 
synapse was exposed 24 hours later to streptavidin-Alexa 488 and BTX-TMR, much of 
the original fluorescence from the streptavidin-Alexa 660 remained (Figure 3.1 D) but 
there was also significant fluorescence on the green (streptavidin-Alexa 488) and red ( -
BTX-TMR) channels (Figure 3.1 E,F). The blue label at 24 hours indicates that the 
majority of receptors were still bound to both of the original ligands.  The red label at 24 
hours indicates those receptors that appeared on the surface after the initial labeling 
period (whether newly synthesized or from an internal storage pool) as well as any 
surface receptors that had lost their BTX-biotin label. For the rest of this paper, all 
receptors that stain with fluorescent BTX after an initial saturating dose of BTX will be 
referred to as part of the pool of “new” receptors.  The green fluorescence present at 24 
hours indicates receptors that remained bound to BTX-biotin, but that had lost their 
streptavidin-Alexa 660 label. Given the expected high affinity of the streptavidin-biotin 
bond, we were surprised by the extent of loss of streptavidin. This matter is further 
considered below and in the discussion.  
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Figure 3.1. Multiple AChR pools are present at synapses on sternomastoid muscles of living mice. 
(A) In a living adult mouse, a neuromuscular junction of the sternomastoid muscle was labeled with a 
saturating dose of BTX-biotin followed by a saturating dose of streptavidin-Alexa 660 (blue, pseudo-
color). (B-C) The junction was then immediately bathed with a saturating dose of streptavidin-Alexa 
488 (green) and TMR-BTX (red). The absence of any labeling (even when camera exposure was 
increased significantly) indicates that all receptors and biotin sites were saturated by the initial 
applications. (D-G) The same neuromuscular junction imaged 24 hours later, after application of new 
streptavidin-Alexa 488 (green) and TMR-BTX (red) to the sternomastoid muscle.  The remaining pre-
existing receptors were still labeled with BTX-biotin/streptavidin-Alexa 660 (blue, pseudo-color). The 
streptavidin-Alexa 488 labeling indicates the presence of receptors that retained BTX-biotin sites but 
lost their streptavidin-Alexa 660. These free sites are unlikely due to the loss of streptavidin on the 
surface (see Figures 2-5) and therefore referred to as “recycled” receptors. The TMR-BTX labeling 
indicates receptors that were not bound to either BTX-biotin or streptavidin and are referred to as “new” 
receptors. Scale bar, 20 μm. 
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Dissociation of streptavidin from the AChR-bungarotoxin-biotin complex does not 
occur on the muscle surface 
We carried out a series of experiments to test whether the dissociation of 
streptavidin from biotin-BTX-AChR could occur on the cell surface. First, to estimate the 
intrinsic rate of dissociation of streptavidin from the biotin-BTX-AChR complex at the 
neuromuscular junction, mice were perfused with 2-4% paraformaldehyde in PBS and the 
sternomastoid muscle was removed and placed in a dish. We then labeled these muscles 
with saturating doses of BTX-biotin and then streptavidin-Alexa, as described above. 
Three to five days later, the muscle was bathed with a second color of fluorescent 
streptavidin. In contrast to the result obtained for receptors at synapses in living animals 
at this time (where a significant amount of the signal intensity was attributable to 
receptors that had lost their original streptavidin-Alexa tag and were then able to be 
relabeled with a new streptavidin-Alexa at a later time point, see Figure 3.1), no 
fluorescence from the second streptavidin fluorophore was observed (data not shown).  
Thus under these conditions the rate of biotin-streptavidin dissociation is negligible. As 
both the BTX-biotin and the streptavidin-Alexa were applied after fixation and extensive 
washing, this protocol likely accurately reflects the extremely slow intrinsic rate of 
biotin-streptavidin dissociation in the absence of processes associated with living cells.  
Another possibility is that factors released from living muscle may increase the 
dissociation of streptavidin on the muscle cell surface. To test this possibility, we took 
advantage of “ghost” clusters observed in aneural myotube cultures grown on laminin.  
C2C12 myotubes grown on laminin display large, complex AChR clusters that often 
remain bound to the laminin, even after the muscle cell that used to hold them on its 
surface has died (Kummer et al., 2004).  Sequentially saturating these ghost clusters with 
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BTX-biotin and streptavidin-Alexa 594 therefore enabled the analysis of AChR-BTX-
biotin-streptavidin complexes isolated from muscle membranes but still surrounded by 
living muscle cells in a normal extracellular milieu. When these ghost clusters were 
labeled with either streptavidin-Alexa 488 or anti-biotin 488 5 days later no green 
fluorescence was observed (Figure 3.2 A-C).  Thus there was no detectable dissociation 
of streptavidin over a five-day period when receptors are surrounded by medium, but not 
on living cells. We also tested for the dissociation of streptavidin from BTX-biotin on the 
surface of living myotubes. When receptor clusters on the myotube surface were labeled 
with BTX-biotin and saturated with streptavidin-Alexa 660, and then relabeled 12 hours 
later with (green) streptavidin-Alexa 488 and BTX-Alexa 594 (Figure 3.2 D-G), 
considerable red staining, but no green staining was observed. This indicated that despite 
a significant loss of fluorescence (due to the turnover rate of AChR) over this time period 
and significant insertion of new receptors, biotin-streptavidin dissociation did not occur 
under these conditions.  We also found that there is no significant difference in the rate of 
internalization of receptors on cultured C2C12 myotubes that were labeled with either 
fluorescent bungarotoxin (38% ±12.0 SD, of fluorescence remaining after 8 hours, n= 2 
cultures) or BTX-biotin-streptavidin-Alexa (33% ±10.0 SD, of fluorescence remaining, 
n= 2 cultures, p>0.1) (see supplemental figure S3.2). Together these results indicate that 
biotin-streptavidin dissociation does not occur even in a normal extracellular 
environment, and implies that recycling does not occur in aneural myotubes and that 





 While the previous experiments show that the dissociation of streptavidin from 
biotin does not occur from the surface of fixed muscle or AChR clusters on living or dead 
cultured myotubes, it is still possible that biological processes could occur at the surface 
of the NMJ of an intact muscle in vivo that might cause streptavidin-biotin dissociation 
from the surface of synapses (such as the secretion of proteases by infiltrating immune 
cells). To examine this possibility, we transplanted a portion of a sternomastoid muscle 
that was first fixed with 2% PFA and then labeled with BTX-biotin/streptavidin-Alexa 
Figure 3.2. Streptavidin does not dissociate from AChR-BTX-biotin clusters on muscle cells in 
culture. (A)  In C2C12 myotube cultures, “ghost” clusters (as described by Kummer et al., 2004) that 
were no longer associated with myotubes were labeled with BTX-biotin followed by streptavidin-Alexa 
594. (B) 5 days later, the same clusters were treated with streptavidin-Alexa 488 (to identify receptors 
that retained BTX-biotin and lost streptavidin). (C) Overlay of images in (A) and (B). The absence of 
green labeling in (B) indicates that there was no dissociation of streptavidin from receptor-
bungarotoxin-biotin complexes on ghost clusters after 5 days. (D) AChRs on a living C2C12 myotube 
that were labeled with a saturating dose of BTX-biotin followed immediately by a saturating dose of 
streptavidin-Alexa 660 (pseudo-color blue) and then imaged 12 hours later. (E and F) The same cells 
were then incubated with streptavidin-Alexa 488 (green) to label receptors that retain BTX-biotin and 
lose streptavidin, and BTX-Alexa 594 (red) to label new AChRs. The absence of green labeling in (E) 
indicates that no detectable streptavidin-biotin dissociation occurred over this time period, while the red 
labeling indicates the addition of new receptors. (G) Overlay of (D-F). Scale bar, 20 μm.  
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594 into the neck of a host mouse directly next to the living sternomastoid muscle. In this 
way the BTX-biotin/streptavidin bound to immobilized receptors after fixation was 
exposed to a fully active and living sternomastoid muscle environment.  As in the 
previous in vivo labeling studies described above, the mouse was then allowed to recover. 
Seven days later we quantified the amount of biotin-streptavidin dissociation at the NMJs 
of the fixed and transplanted muscle. We found that the original fluorescence of the 
transplanted muscles decreased by less than 3%, and we found no evidence of new 
streptavidin-Alexa binding, compared to normal levels of new streptavidin-Alexa binding 
observed at NMJs in the live host muscle.  These experiments indicate that extracellular 
proteases do not cause biotin-streptavidin dissociation on the surface of the muscle.  
To further rule out the possibility of extracellular dissociation of streptavidin from 
biotin, we used the same sequential labeling protocol on another synaptic component in 
vivo. Due to the availability of the snake toxin Fasciculin2, which selectively and 
specifically labels acetycholinesterase (AChE), we monitored the dissociation of 
streptavidin from Fasciculin2-biotin over 4 days. AChEs were labeled with biotinylated 
Fasciculin2 (7 µg/ml, 1 h), and then saturated with streptavidin-Alexa 594 (10 µg/ml, 2.5 
h). The mouse was allowed to recover and after 4 days the sternomastoid muscle was 
exposed to a new saturating dose of streptavidin-Alexa 488 (green). In sharp contrast to 
AChR recycling (Figure 3.3 A,B), we found that AChEs originally labeled with 
Fasciculin2-biotin/streptavidin-Alexa 594 showed barely detectable green labeling and 
therefore negligible biotin-streptavidin dissociation after 4 days (Figure 3.3 C,D). These 
results show that the dissociation of streptavidin from biotin does not occur on the surface 
of the synapses and rules out the possibility that extracellular proteases or other unknown 
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cellular processes at the cell surface are responsible for such dissociation, suggesting that 
this dissociation likely occurs in intracellular compartments after being internalized.   
 
 
Figure 3.3. Lack of streptavidin dissociation from AChE-Fasciculin2-biotin in vivo. (A) Example 
of a living adult mouse neuromuscular junction previously labeled with BTX-biotin (to label AChRs) 
followed by a saturating dose of streptavidin-Alexa 594 (red) at time 0 and imaged at 4 days. Red signal 
indicates the pre-existing receptors still remaining on day 4. (B) The same neuromuscular junction 
imaged after application of streptavidin-Alexa 488 (green). Green signal indicates the AChRs that were 
recycled over 4 days. (C) Example of a NMJ labeled with Fasciculin2-biotin (to label AChEs) followed 
by a saturating dose of streptavidin-Alexa 594 (red) at time 0 and imaged at 4 days. Red signal indicates 
the pre-existing acetycholinestrase remaining on day 4. (D) The same neuromuscular junction imaged 
after application of new streptavidin-Alexa 488 (green) and viewed with much higher camera gain than 
used in B. The weak green signal indicates that there is very little streptavidin dissociation after 4 days. 
If the same gain was used as in B, the fluorescence was almost undetectable. Scale bar, 20 μm. 
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In denervated muscle, receptors are known to turn over at an accelerated rate and 
muscle stimulation has been shown to prevent this increase in receptor loss (Salpeter and 
Loring, 1985; Andreose et al., 1993; Caroni et al., 1993; Akaaboune et al., 1999). If 
dissociation does not occur on the surface but only after the AChR-BTX-biotin- 
streptavidin complex is internalized, one would predict that decreasing the rate of 
internalization of receptors would also decrease the streptavidin-biotin dissociation. To 
test this possibility, we labeled synaptic AChRs on denervated muscle with BTX-biotin 
followed by streptavidin and then directly stimulated the sternomastoid muscle by 
placing stimulating electrodes at either end of the muscle for the entire 8 hour 
experiment. As predicted, 8 hours after stimulation we found no evidence of receptor loss 
(see supplemental figure S3.2). When we added a second dose of streptavidin-Alexa and 
then quantified the recovery of fluorescence, we did not see any evidence for new 
streptavidin-Alexa binding (see supplemental data). In contrast, binding of new 
streptavidin-Alexa was easily measurable in control, unstimulated muscle during the 
same time window. This result argues strongly that the dissociation of streptavidin from 
AChR-BTX-biotin does not occur spontaneously on the muscle surface, but rather only 
after internalization.  
Evidence for the intracellular dissociation of streptavidin from the AChR-
bungarotoxin-biotin complex  
If streptavidin dissociates from the AChR-BTX-biotin-Streptavidin-Alexa 
complex at an intracellular site, it should be possible to observe Alexa fluorescence in 
intracellular vesicles. It should also be possible to observe intracellular vesicles with 
biotin freed from streptavidin. To test the first possibility, muscles were initially labeled 
with a saturating dose of BTX-biotin (5 µg/ml, 1.5 h) followed by a saturating dose of 
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fluorescent streptavidin-Alexa 488. After an appropriate waiting time (4 days), the mouse 
was perfused with 2% paraformaldehyde. The sternomastoid muscle was then dissected 
and cut in longitudinal sections parallel to the axis of the muscle fibers to allow 
visualization of both the cell surface and the region below it, using confocal microscopy.  
In control muscles that were labeled with BTX-biotin/streptavidin-Alexa 488 and 
then immediately fixed and sectioned (rather than waiting 4 days), the antibody mediated 
AChR-labeling was intense at the surface receptors of the synapse, plus a number of 
small spots (puncta), while the streptavidin-Alexa labeling was also intense on the cell 
surface, but not visible in puncta. This is the expected result, because the AChR 
immunocytochemistry detects all receptors, including those present internally, while the 
streptavidin-Alexa staining procedure initially detects only surface receptors, and some 
time must elapse before they become internalized. However, when four days were 
allowed between labeling and fixation, we found that most of the initial streptavidin label 
colocalized with receptors on the surface and in intracellular puncta (Figure 3.4 A-F). Z-
stack analysis of the images confirmed that these colocalized fluorescent spots were 
beneath the muscle surface indicating that AChR-BTX-biotin-streptavidin was 
internalized as a complex. A significant number of the intracellular AChR-containing 
puncta were also labeled only by the anti-receptor antibody. These could be receptors that 
have lost their streptavidin label and are either in the process of recycling or degradation, 
or unlabeled newly synthesized receptors yet to be inserted. A small number of green 
fluorescent spots were also observed which did not colocalize with receptors, perhaps 
corresponding to accumulation of fluorescence in degradative vesicles.   
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It seemed likely that many of the puncta were intracellular vesicles. To test this 
possibility, muscle fibers were fixed and then processed so that AChR and the early 
endosome marker EEA1 could be detected immunocytochemically (Figure 3.4 G-O).  
The EEA1 labeling was present in a profusion of small spots located below the cell 
surface, while the AChR labeling consisted of intense labeling of the surface receptors of 
the synapse, plus a modest number of small spots. Although many EEA1 spots were 
negative for AChR, the vast majority of AChR positive spots were also positive for 
EEA1.  Thus puncta of AChR staining represent a reliable marker of internalized AChR. 
Given the high correlation between AChR labeling of puncta and EEA1 labeling of 
puncta, the presence of puncta that were labeled both for AChR and for streptavidin in 
the experiments shown in Figure 3.4 A-F demonstrates that fluorescent Alexa from 
surface AChRs labeled with BTX-biotin-streptavidin-Alexa is internalized. The puncta 
that stained only with the anti-receptor antibody but were negative for Alexa most likely 
represent newly synthesized receptors yet to be inserted, while the puncta that stained for 
Alexa, but not for AChR seem likely to correspond to degradative vesicles that have 
completely consumed their AChR.  
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Figure 3.4. Confocal imaging of AChR-bungarotoxin-biotin-streptavidin complexes in 
intracellular compartments. Sternomastoid muscles were labeled in living mice with BTX-biotin and 
saturated with streptavidin-Alexa 488. After 4 days the muscles were fixed, sectioned longitudinally 
and then processed for immunocytochemical detection of AChRs with an Alexa 594 conjugated 
secondary antibody. (A) Example of a stack of 20 confocal images (0.5 µm intervals) of a NMJ that was
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Having shown that the Alexa from AChR-BTX-biotin-streptavidin-Alexa 
complexes can be internalized, we next tested whether biotin that had lost streptavidin 
could also be observed inside of muscle fibers. We first showed that the anti-biotin 
antibody we were using can effectively stain AChR-BTX-biotin complexes (Figure 3.5 
A), but not AChR-BTX-biotin-streptavidin-Alexa 488 complexes (Figure 3.5 B-D). Thus 
if muscles are pretreated with BTX-biotin and streptavidin-Alexa, this antibody will label 
only receptor complexes that have been stripped of streptavidin. Confocal images of 
muscle sections saturated with BTX-biotin-streptavidin and fixed and processed 4 days 
later showed that staining with both the anti-AChR antibody and the anti-biotin antibody 
labeled the entire synaptic region, and both fluorescent labels were also found co-
localized in small spots in the vicinity of the junction (Figure 3.5 E-J). Approximately 
40% of the intracellular spots were labeled by both antibodies, and the rest were labeled 
only by the anti-receptor antibody. An alternate approach was also used to confirm the 
presence of free biotin within puncta. Longitudinal sections of mouse sternomastoid 
initially labeled with BTX-biotin/streptavidin-Alexa 488 and collapsed onto a single plane. The small 
green fluorescence puncta could represent either the accumulation of fluorescent streptavidin still 
attached to AChR-BTX-biotin complexes, or the accumulation of fluorescent streptavidin in 
intracellular compartments.  (B) Immunostaining with anti-AChR and secondary antibody conjugated to 
Alexa 594. These puncta could represent the presence of receptors that are newly synthesized, 
internalized and recycling, or internalized and in the process of degradation. (C) Overlay of the Alexa 
488 fluorescence colored green, and the anti-AChR fluorescence colored red. (D-F) Detail from the 
boxed regions in (A-C). Arrows indicate colocalization of original streptavidin-Alexa 488 (green) and 
AChR (red) in intracellular puncta, showing that the AChR-BTX-biotin-streptavidin complexes are 
internalized. Red arrowheads indicate intracellular puncta that contained only receptors (likely 
unlabeled receptors that are in the process of insertion or BTX-biotin labeled receptors in the process of 
recycling). Green arrowheads indicate intracellular puncta that contained only streptavidin-Alexa 488. 
(G-O) Example of a neuromuscular junction on a muscle section (labeled as described above) 
immunostained for AChRs and EEA1. (G-I) Eight confocal slices at 2 µm intervals were collapsed onto 
a single image plane. In the overlay image, green indicates anti-AChR immunostaining and red 
indicates anti-EEA1 immunostaining. (J-L) The boxed regions of panels G-I are shown at higher power. 
(M-O) Z-stack of fluorescence intensity taken at various depths along the white line indicated in panels 
J-L. The top of the section is to the right, and the width of these panels corresponds to a total depth of 
20 µm.  
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muscle saturated 4 days previously with BTX-biotin followed with streptavidin-Alexa 
594 or unlabeled streptavidin were fixed and permeabilized as described above, and 
labeled with anti-receptor antibody and streptavidin-Alexa 488. The number of green 




Figure 3.5. Confocal images of AChR-BTX-biotin complexes in intracellular compartments. (A) 
Example of a neuromuscular junction labeled with BTX-biotin followed by anti-biotin-Alexa 488 or 
594. This staining was a positive control to demonstrate that this antibody is able to effectively label 
biotin in complex with AChR. (B) Example of a neuromuscular junction that was labeled with biotin-
bungarotoxin followed by a saturating dose of streptavidin-Alexa 488 and then immediately fixed. (C) 
When the same synapse was immunostained with anti-biotin-Alexa 594, no red fluorescence was 
observed. The absence of staining with anti-biotin indicates that this antibody can only interact with 
BTX-biotin when it has been stripped of streptavidin. (D) Overlay of images in (B) and (C). (E) 
Example of a synapse on a muscle initially incubated with BTX-biotin/ streptavidin and then fixed and 
sectioned 4 days later and immunostained with anti-AChR and an Alexa 594 conjugated secondary 
antibody. (F) The same synapse as in (E) labeled with anti-biotin-Alexa 488. (G) Overlay of images in 
(E) and (F). (H-J) The boxed areas from panels (E-G) at higher magnification and viewed at a camera 
gain sufficient to saturate the signal from synaptic AChRs in order to accentuate the signal coming from 
the internal spots. Arrowheads indicate spots of fluorescence that stained positive for AChR but not for 
biotin, while arrows indicate spots where both labels were colocalized. Scale bar, 20 μm. 
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In summary, we see AChR-BTX-biotin complexes that have been stripped of their 
streptavidin labels both in intracellular vesicles and on the cell surface in vivo. Because 
we have seen no indication that dissociation occurs on the cell surface, the likely 
sequence is that the AChR-BTX-biotin-streptavidin complex is endocytosed into vesicles, 
the streptavidin is stripped off of the complex and degraded and then the AChR-BTX-
biotin complex is returned to the surface. For these and other reasons considered in the 
Discussion, we will refer to the pool of receptors that can be relabeled with a second 
color of streptavidin-Alexa as “recycled receptors”.  
Time-lapse imaging of synaptic AChR recycling 
Having found that receptors are able to recycle, we next wanted to determine how 
quickly recycled receptors were incorporated into the postsynaptic membrane. To do this, 
sternomastoid muscles of 3 mice were labeled with a low dose of BTX-biotin (5 µg/ml, 2 
min) (to ensure that synaptic activity remained fully functional (Lingle and Steinbach, 
1988)) followed by a saturating dose of streptavidin-Alexa 488. A dose of streptavidin-
Alexa 594 (30 min) was then added to ensure the saturation of all biotin sites (Figure 3.6 
A,B). Every 2 hours a fresh dose of streptavidin-Alex 594 was added to the muscle to 
label recycled receptors. Using high detector gain with a CCD camera, we were able to 
see a clear red fluorescence signal at 2 hours. In all 10 synapses imaged the fluorescence 
signal increased in intensity after each new strep-Alexa 594 application (Figure 3.6 C-F). 
This result suggests that recycled receptors are rapidly inserted into the membrane.  
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Effect of synaptic activity on the recycled and new AChR pools 
To quantitate the number of recycled and new receptors inserted into the same 
synapse over time, we used the same fluorophore in three distinct labeling steps, which 
allowed us to distinguish each receptor pool, and then we assayed fluorescence intensity 
using an established in vivo quantitative fluorescence method (Turney et al., 1996; 
Akaaboune et al., 1999). The sternomastoid muscle of 6 mice was saturated with an 
Figure 3.6. Time-lapse imaging of the appearance of recycled receptors. (A) In a living adult 
mouse, a neuromuscular junction of the sternomastoid muscle was labeled with a low dose of BTX-
biotin followed by a saturating dose of streptavidin-Alexa 488 (green). (B) The junction was then 
immediately bathed with a saturating dose of streptavidin-Alexa 594 (red) and viewed at substantially 
higher gain. The absence of any red labeling indicates that all biotins were initially saturated with 
streptavidin-Alexa 488.  (C-F) The same neuromuscular junction imaged every 2 hours for 8 hours, 
after application of new streptavidin-Alexa 594 (red) to the sternomastoid muscle before each time 
point.  Scale bar, 20 μm. 
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initial dose of BTX-biotin (5 µg/ml, 1.5 h) followed by streptavidin-Alexa 594 (red) (10 
µg/ml, 2.5 h) to saturate biotin sites. The fluorescence intensity of superficial 
neuromuscular junctions was then assayed at time 0, and then at a second time point 8 
hours, 1 day, 3 days or 4 days later (Figure 3.7 A,B). At 4 days we found that junctions 
labeled at t0 with a saturating dose of BTX-biotin/ streptavidin-Alexa 594 had lost 53% 
±3 SD (n=30) of their original fluorescence. To quantitate the amount of receptors that 
were recycled over time, we applied a second saturating dose of streptavidin-Alexa 594, 
and measured the resulting increase in fluorescence intensity. We found that at 4 days the 
fluorescence from the recycled receptors equaled 26% ±5 SD (n=29) of the original 
fluorescence (Figure 3.7 A,B).  
To quantitate the contribution of the new receptors added to these same synapses 
during the 4 days the sternomastoid muscle was then labeled with a fresh saturating dose 
of BTX-biotin followed with a fresh saturating dose of streptavidin-Alexa 594. We found 
that an additional 24% ±5 SD (n=29) of the original fluorescence was recovered (Figure 
3.7 A,B). In summary, four days after a single transient application of BTX-biotin the 
sum of remaining original (pre-existing), new and recycled receptors was very close to 
100% of the original signal, and the contribution of newly inserted receptors and recycled 
receptors were nearly equal at about 25% of original fluorescence each.   
When the contributions of original, recycled and new receptors were examined at 
earlier time points after the initial labeling (Figure 3.7 B), several interesting 
characteristics became apparent. At one day after a one-time bungarotoxin AChR 
blockade, the contribution of recycled receptors was less (18% ±5 SD of original 
fluorescence recovered, n=25) than that of new receptors (22% ±5 SD of original 
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fluorescence recovered, n=20, p< 0.005). This effect was even more pronounced at 8 
hours with recycled receptors contributing 9% ±3 SD of original fluorescence (n=30) and 
new receptors accounting for 17% ±7 SD (n=20, P<0.0001) (Figure 3.7 B).  
Figure 3.7. Quantification of original, recycled and new receptors at the neuromuscular junction 
following transient activity blockade. These pseudo-color images provide a linear representation of 
the density of AChRs (white-yellow, high density; red-black, low density). (A) Example of a mouse 
neuromuscular junction labeled with a saturating dose of BTX-biotin followed immediately by a 
saturating dose of streptavidin-Alexa 594, imaged, and then re-imaged 4 days later. The total 
fluorescence intensity (a measure of the total number of AChRs) was expressed as 100% at the initial 
labeling (first panel from the left, day 0) and normalized to this on each successive view. Second panel 
from the left represents the pre-existing receptors remaining after 4 days when more than 50% of the 
initial fluorescence is lost.  To quantitate the recycled receptors, streptavidin-Alexa 594 (red) 
fluorophore was then added to the muscle. The third panel from the left thus represents the sum of pre-
existing and recycled receptors after 4 days. New receptors were identified by next adding a saturating 
concentration of BTX-biotin followed by a saturating dose of streptavidin-Alexa 594 (red) as shown in 
the fourth panel. The fluorescence from these new receptors is added to the pre-existing and recycled 
receptors to determine the total receptor density after 4 days.  (B) Graph summarizing the amount of 
original receptors remaining after various times, and the proportion of new and recycled receptors that 
were inserted into the synapse; obtained from many junctions with the approach shown in (A). Each 
data point represents the mean percentage of original fluorescence intensity (±SEM).  
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Receptors in the pools defined as pre-existing and recycled both have BTX bound 
and so do not function, but the receptors in the new pool are unlabeled and therefore 
unblocked and functional. In the NMJ it is known that a large safety factor exists that 
enables synapses to be fully functional with only 10-20% of receptors being unblocked 
(Lingle and Steinbach, 1988).  Therefore, it would be expected that by 8 hours, the 17% 
of the total receptors that are new and unblocked would be sufficient to restore super-
threshold endplate potentials and muscle spiking activity. It thus seemed likely that the 
changes in the rate of receptor recycling in transiently blocked NMJs (1.5 h one-time 
bungarotoxin treatment) are the consequence of the initial activity blockade by BTX and 
subsequent restoration of neuromuscular transmission by new unlabeled and unblocked 
AChRs.  
To  further examine the role of synaptic activity on the insertion of recycled and 
new receptors, we monitored the appearance of receptors in continuously  blocked 
synapses, in which AChRs are reported to be lost at an accelerated rate (Salpeter and 
Loring, 1985; Martyn et al., 1992; Akaaboune et al., 1999). To test the effect of activity 
cessation on receptor trafficking, we chronically blocked synaptic transmission with 
curare (a poison that reversibly blocks AChRs), and so indirectly blocked muscle spiking. 
The longest this treatment could be carried out without mortality was 8 hours, plus a two 
hour treatment to label either recycled receptors, or new receptors but not both. However, 
this was sufficiently long to resolve several interesting differences from the one-time 
labeling of AChRs with saturating bungarotoxin, in which blockade is transient and 
muscle activity recovers over time (Figure 3.8). First, as expected from previous studies, 
the removal of original receptors was more pronounced (on average falling to 65% of the 
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initial fluorescence at 8 hours as compared to 74% in animals receiving a one time block 
with BTX). Second, the rate of appearance of new AChRs decreased to about 1/3 that 
observed when synaptic transmission was restored after a few hours, but remained at 
observable levels (4.5% ±2 SD, n=20). Most dramatically, the contribution of the 
recycled receptors decreased to nearly undetectable levels (0.4% ±1 SD of original 




Figure 3.8. Quantification of original, recycled and new receptors at the neuromuscular junction 
following a transient and maintained activity blockade. (A) Assessment of the extent of recycling 
after 8 hours following an initial transient blockade of activity with BTX-biotin. (B) Assessment of the 
extent of recycling after 8 hours following a maintained blockade of activity with curare. (C) Graph 
summarizing results obtained from many synapses studied as in (A and B). The data show the mean ± 
SEM. For all four conditions, the difference between the two experimental groups was significant (p< 
0.001). These experiments were not carried beyond 8 hours, because of mouse mortality from the long 
term curare treatment. It thus was not possible to measure recycling and new receptors at the same 




These results are based on the surprising finding that at sternomastoid muscle 
synapses in living mice, streptavidin dissociates unexpectedly rapidly from AChR-BTX-
biotin complexes. The dissociation of purified streptavidin from biotin in test tube assays 
is extremely slow, because of their extraordinarily high affinity (Chilkoti and Stayton, 
1995). However, our observation that biotin-streptavidin dissociation occurs at an 
accelerated rate in vivo is not unprecedented: avidin-biotin complexes have been 
previously reported to dissociate after their intraperitoneal injection into live animals 
(Fraenkel-Conrat and Fraenkel-Conrat, 1952; Wei et al., 1971; Lee et al., 1972; Lee et al., 
1973b; Lee et al., 1973a). One potential molecular mechanism for enhanced dissociation 
comes from an older study that reported that although the avidin-biotin complex is highly 
resistant to elevated temperature, acidic or basic pH and proteases, the weak oxidizing 
environment provided by 0.3% H2O2 can readily cause dissociation (Gyorgy, 1943), 
which could allow the specific liberation of the streptavidin-Alexa tag from the AChR-
BTX-biotin complex without affecting the AChR-BTX bond. A second potential 
mechanism for enhancing unbinding is suggested by recent studies conducted on purified 
proteins. When added to complexes of biotin and streptavidin, two different classes of 
proteins have been demonstrated to have the ability to rapidly displace the streptavidin 
from the biotin (Subramanian et al., 1997; Morris and Raney, 1999). In both cases the 
extra protein (a helicase in one study and a monoclonal antibody in the other) can be 
thought of as a chaperone, placing the streptavidin in a non-native conformation that 
enhances unbinding. It seems plausible that the combination of low pH, an oxidizing 
environment, and perhaps some modification in the conformation of streptavidin by 
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unknown factors within recycling vesicles could be responsible for the observed 
dissociation of streptavidin-Alexa from biotin. This mechanism would also be consistent 
with the absence of dissociation on the cell surface, as this is a relatively reducing 
environment at nearly neutral pH.  
The cellular location of dissociation of streptavidin from biotin 
 For several reasons, we believe that the dissociation of streptavidin from biotin 
takes place within intracellular vesicles rather than on the cell surface. First, we saw no 
evidence for streptavidin-biotin dissociation occurring on the cell surface of fixed muscle 
tissue (even when transplanted into an in vivo milieu), from AChR ghost clusters or from 
clusters of AChRs on living aneural muscle cells in culture. Second, we could readily 
observe AChR-BTX-biotin complexes that had been stripped of streptavidin in 
intracellular vesicles near synaptic sites in sternomastoid muscles. Third, when the rate of 
internalization of receptors was greatly decreased by electrical stimulation of the muscle, 
we could no longer detect dissociation of streptavidin from biotin. Finally, when the same 
labeling protocol was applied to AChE, a component of the synaptic cleft localized in the 
extracellular matrix rather in the plasma membrane, there was no evidence of 
streptavidin-biotin dissociation. This last observation implies that AChE is recycled very 
slowly or not at all. Insertion of AChE into the basal lamina requires collagen (ColQ) 
(Feng et al., 1999), so one possible explanation for the failure to recycle is that AChE-
Fasciculin2-biotin-streptavidin complexes are internalized after detaching from ColQ and 
therefore unable to insert back into the basal lamina. Whatever the reason for the lack of 
streptavidin unbinding from AChE complexes over time, these findings provide 
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compelling evidence that local surface events are not responsible for the biotin-
streptavidin dissociation observed with AChRs at the living neuromuscular synapse. 
 A final reason for favoring vesicles as the site of the biotin-streptavidin 
dissociation is that a vesicular intermediate provides a ready explanation for the 
observation that the ability to recycle receptors to the cell surface can be dissociated from 
the ability to endocytose. Under two situations in which there was no synaptic activity 
(aneural cultures of C2C12 myotubes and in vivo synapses chronically blocked with 
curare), internalization of receptors was readily detected as expected from previous 
results (St John and Gordon, 2001) and yet we saw no indication that there was any 
recycling (no vacant streptavidin binding sites on the cell surface). Regarding the failure 
to observe receptor recycling in cultured C2C12 myotubes, it has been shown previously 
that a large subsurface “hidden” pool of receptors exists in cultured chick and rat 
myotubes, but that such a pool is absent in innervated muscle (Devreotes and Fambrough, 
1975).  This pool comprises up to 30% of the total AChR complement of cultured 
myotubes, and was found to derive partially from the surface of the muscle as opposed to 
newly synthesized receptors (Devreotes and Fambrough, 1975). As with AChRs at 
inactive synapses in living mice, these cultured muscle fibers are apparently lacking a 
signal that allows the internalized receptors to return to the cell surface.  
Both the in vitro and in vivo results could be readily explained if the insertion of 
vesicles containing receptors available for recycling are delivered to the cell surface only 
when there is synaptic activity. An obvious candidate for mediating the activity 
dependent signal is intracellular calcium, as it  is the most common signal that regulates 
exocytosis in both secretory and nonsecretory cells (Chavez et al., 1996). At central 
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nervous system synapses, Ca2+ influx into the postsynaptic cell through NMDA receptors 
is involved in AMPA receptor recycling in cortical and hippocampal neurons (Carroll et 
al., 1999b; Luscher et al., 1999). Such alteration in AMPA and NMDA receptor numbers 
in the postsynaptic density are proposed to account for changes in synaptic strength 
(Malinow and Malenka, 2002; Malinow, 2003). Indeed, the activity-dependent cycling of 
AMPA receptors at the post-synaptic membrane underlies many aspects of synaptic 
plasticity (Malinow and Malenka, 2002; Malinow, 2003; Park et al., 2004).  At the NMJ, 
AChRs allow the entry of calcium in addition to sodium and potassium, so it is 
conceivable that blocking the receptors could inhibit Ca2+ influx and thus block a signal 
required for receptor recycling.  
What is the extent of AChR recycling at normally functioning synapses? 
Our experiments have demonstrated that AChR recycling occurs at the 
neuromuscular junction of living mice, and that chronically inhibiting synaptic activity 
with curare drastically decreases the amount of detectable recycling. Although 
measurements of changes in fluorescence intensity over time were made with great 
precision, there are several important caveats to the interpretation of our results that cause 
us to be cautious about extrapolating these data to estimate the rates of internalization and 
recycling of native receptors when activity is unmodified.  
First, only receptors that have been internalized have the possibility of recycling. 
If the internalization rate is slow, it will be difficult or impossible to detect recycling, 
even if the cellular mechanisms that cause recycling are fully functional. 
Second, it is necessary to bind the bulky ligands BTX-biotin and streptavidin-
Alexa in order to detect recycling. It is unclear to what extent the binding of streptavidin 
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would alter the life history of receptors. For instance, it is widely accepted that antibody 
binding to AChR can accelerate the rate of internalization and degradation (Fumagalli et 
al., 1982), perhaps as a consequence of crosslinking or due to other unknown factors. 
Streptavidin has four biotin binding sites, and so has the potential to cross link biotins on 
multiple toxin molecules, and thus indirectly crosslink receptors. However, the time 
course of the loss of fluorescence on cultured myotubes (where recycling was not 
observed) was not significantly different when receptors were directly labeled with BTX-
Alexa or indirectly labeled with α-BTX-biotin and then with streptavidin-Alexa. This 
indicates that either steric factors prevented the streptavidin from crosslinking receptors, 
or that receptors crosslinked by streptavidin do not have an altered rate of internalization 
beyond any effect of BTX alone.  
Third, the amount of recycling we detect is a minimum estimate and the actual 
amount could be greater. There are two possible ways that receptors could recycle 
without being detected by the methods we used. Any receptor that is endocytosed and 
returned to the cell surface without losing either its BTX-biotin or its streptavidin Alexa 
will be counted as part of the preexisting pool, even though it has recycled. Similarly, any 
receptor that loses its BTX-biotin and then recycles will be counted as part of the new 
pool. At present there are no available methods that would allow us to determine whether 
either of these two types of events occur at a sufficient frequency to significantly increase 
the actual recycling rate above what we measured. Regardless of these caveats, it is clear 
that under the conditions used for some of the experiments presented in this paper, at 
least 25% of the synaptic receptors on the cell surface are recycled over a 4-day period.  
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The existence of a recycled pool of AChRs requires that a number of earlier 
experiments on the life history of AChRs be reinterpreted. For instance, a substantial 
number of experiments using fluorescently labeled BTX have shown that the half-life of 
fluorescence loss at synapses in living mice is approximately 7 days after a one time 
blockade with bungarotoxin (Salpeter and Loring, 1985; Andreose et al., 1993; Caroni et 
al., 1993; Akaaboune et al., 1999; Akaaboune et al., 2002). This had been interpreted as 
the half-life of receptors on the cell surface, but our results suggest that each receptor can 
recycle back to the cell surface (perhaps several times) before it is degraded, and that 
junctional AChRs are therefore being internalized from the surface at a significantly 
faster rate (t1/2~ 4 days after one-time blockade) than previously mentioned. The results 
reported here suggest that despite the stability of the synaptic structure over the lifetime 
of the animal (Balice-Gordon and Lichtman, 1990), receptors are highly dynamic and are 
constantly exchanged between the plasmalemma and internal compartments, in addition 
to being frequently shuttled between junctional and extra-junctional regions (Akaaboune 
et al., 2002).    
Together, our results suggest a model for the regulation of the postsynaptic 
receptor density at the neuromuscular junction in live animals involving two separate 
pathways: a receptor recycling pathway and a new receptor pathway. When postsynaptic 
transmission is functional, both the recycled and the new receptor pathways contribute 
significantly to the postsynaptic density (Figure 3.9 A). In the absence of postsynaptic 
activity, however, internalized AChRs are shifted from a recycling pathway to a 
degradative pathway (Figure 3.9 B). The new receptor insertion pathway is also affected 
by the absence of postsynaptic activity, but continues to deliver receptors at a reduced 
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rate. We do not know, however, whether new and recycled receptors are added directly to 
the junction or are inserted into the perijunctional region and then migrate into the 
junction to be anchored. It would be of considerable interest to see whether different 
patterns of activity can alter the proportion of new and recycled receptors at synapses in 
live animals.  
 
Figure 3.9. A proposed model suggesting the way activity affects the insertion of recycled and new 
AChRs at the neuromuscular junction. (A) During normal synaptic transmission, the recycled (4) and 
new receptor (1) pathways contribute equally to the synaptic density. (B) In the absence of postsynaptic 
activity, the recycled and new receptor pools decrease. After internalization (2) the receptors 






Figure S3.1. There was no significant difference between the rate of loss of AChR labeling 
assessed with fluorescent BTX or with fluorescent Streptavidin/biotin-BTX. (A) C2C12 myotubes 
were saturated with bungarotoxin-Alexa 594 (top panels) and individual clusters were imaged. Eight 
hours later the same clusters were re-imaged and fluorescence was quantified. In the bottom panels, 
C2C12 myotubes were saturated with bungarotoxin-biotin followed immediately by streptavidin-Alexa 
594. Individual clusters were imaged after labeling and at 8 hours and their fluorescence was assayed. 
(B) Graph represents the fluorescence remaining at BTX-Alexa (38% ±12.0 SD, n= 11 clusters/3 
cultures) or BTX-biotin-streptavidin-Alexa (33% ±10.0 SD, n= 14 clusters/3 cultures). The amount of 
fluorescence remaining detected with the two labeling schemes was not significantly different (p > 0.2). 








Figure S3.2. Streptavidin/biotin BTX dissociation does not occur on stimulated denervated 
muscle. (A) Denervated muscle was labeled with bungarotoxin-biotin/streptavidin-Alexa 594 to 
saturation, and the fluorescence at an individual synapse was imaged and quantified (first panel). After 
initial imaging the muscle was stimulated for the duration of the experiment. After 8 hours the same 
synapse was located and imaged and the fluorescence was again quantified (second panel). To identify 
any receptors that had been recycled during the period of stimulation, new streptavidin-Alexa 594 was 
added to the muscle and the synapse was again imaged and fluorescence was quantified (third panel). 
(B) Control denervated muscle not stimulated but labeled and imaged exactly as described in A. (C) 
Summary of the data obtained from many synapses as in (A) and (B). Note that stimulation of the 
sternomastoid muscle prevented fluorescence loss and that there was no evidence for recycling AChR, 
while the fluorescence in unstimulated muscle NMJs lost ~20% of their original fluorescence over 8 
hours, and the addition of new streptavidin-Alexa 594 resulted in a significant increase in fluorescence 
intensity. Values represent mean ±SEM. 
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Abstract 
At the peripheral neuromuscular junction (NMJ), a significant number of nicotinic 
acetylcholine receptors (AChRs) recycle back into the postsynaptic membrane after 
internalization to intermingle with not yet internalized “pre-existing” AChRs. However 
the way these receptor pools are maintained and regulated at the NMJ in living animals 
remains unknown. Here, we demonstrate that recycled receptors in functional synapses 
are removed ~4 times faster than “pre-existing” receptors and that most removed recycled 
receptors are replaced by new recycled ones. In denervated NMJ, the recycling of AChRs 
is significantly depressed and their removal rate increased, while direct muscle 
stimulation prevents their loss. Furthermore, we show that protein tyrosine phosphatase 
inhibitors cause the selective accumulation of recycled AChRs in the peri-synaptic 
membrane without affecting the “pre-existing” AChR pool. The inhibition of 
serine/threonine phosphatases, however, has no effect on AChR recycling. These data 
show that recycled receptors are remarkably dynamic and suggest a potential role for 
tyrosine dephosphorylation in the insertion and maintenance of recycled AChRs at the 
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postsynaptic membrane. These findings may provide insights into long-term recycling 
processes at less accessible synapses in the central nervous system in vivo.  
Introduction 
At central synapses, recycling of postsynaptic receptors plays a critical role in 
synaptic plasticity. For example, during long-term potentiation, synaptic strength is 
enhanced by an increased recruitment of recycled AMPA receptors from intracellular 
endosomal compartments to the postsynaptic membrane (Contractor and Heinemann, 
2002; Ehlers, 2000; Lee et al., 2004; Luscher et al., 1999; Park et al., 2004). At the 
peripheral neuromuscular junction (NMJ) it was long assumed that acetylcholine 
receptors (AChRs) remain stable in the post-synaptic membrane until they are 
internalized and degraded in the lysosomes (Gardner and Fambrough, 1979). In this 
scheme, insertion of newly synthesized receptors would be responsible for maintaining 
AChR density in the post-synaptic membrane over time. Recent work from our lab has 
shown, however, that a significant number of internalized AChRs are not degraded, but 
instead return back into the postsynaptic membrane where they intermingle with AChRs 
that have not yet been internalized and retain their initial fluorescent tag (referred to 
hereafter as “pre-existing” AChRs) (Bruneau et al., 2005). However, the way these AChR 
pools are maintained and regulated remains to be determined.  
The involvement of phosphorylation in the trafficking, insertion and maintenance 
of ionotropic receptors in central synapses has been extensively studied, and has been 
found to play an important role in regulating synaptic changes that lead to either long-
term potentiation or long-term depression (Carroll et al., 1999; Ehlers, 2000; Hayashi et 
al., 2000; Lee et al., 2000; Malinow and Malenka, 2002). At the neuromuscular junction, 
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a large body of work demonstrates that phosphatases are involved in AChR anchoring 
and clustering in vivo and in vitro (Grady et al., 2003; Huganir et al., 1984; Li et al., 
2004; Mei and Si, 1995; Wallace, 1994; Wallace et al., 1991), however the role of 
phosphorylation/dephosphorylation events in AChR recycling at the neuromuscular 
junction in vivo has not previously been investigated.  
In order to investigate the dynamics of recycled and “pre-existing” AChR pools 
and the potential role of phosphorylation/dephosphorylation in AChR recycling, we 
monitored recycled and “pre-existing” AChRs by using a sequential labeling method that 
we previously used to selectively identify recycled and “pre-existing” receptor pools in 
the postsynaptic membrane (Bruneau et al., 2005). In this work, we report that recycled 
receptors are removed more quickly than “pre-existing” receptors from the same 
postsynaptic membrane of functional synapses, and demonstrate that denervation 
decreases the insertion of recycled AChRs and increases their removal rate. In addition, 
we found that tyrosine phosphatase inhibitors, but not serine/threonine phosphatase 
inhibitors, cause the aberrant peri-synaptic accumulation of recycled AChRs. 
Materials and Methods 
Live animal imaging. All animal usage followed methods approved by the University of 
Michigan Committee on the Use and Care of Animals. Adult female mice (20-27 grams, 
NSA, Harlan Sprague Dawley, Indianapolis, IN) were anesthetized with an intra-
peritoneal injection of ketamine and xylazine (KX) (17.38 mg/ml). Sternomastoid muscle 
exposure and neuromuscular junction imaging was performed as previously described in 
detail (Akaaboune et al., 1999; Lichtman et al., 1987; van Mier and Lichtman, 1994). 
Briefly, the anesthetized mouse was placed on its back on the stage of a customized 
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epifluorescence microscope, and neuromuscular junctions were viewed under a coverslip 
with water immersion objectives (20X and 60X UAPO 0.7 NA, Olympus BW51, Optical 
Analysis Corporation, NH) and a digital CCD camera (Retiga EXi, Burnaby, BC, 
Canada). Mice were intubated and ventilated for the duration of the imaging sessions. For 
imaging at multiple time points, the mouse was sutured after each session and allowed to 
fully recover before the next imaging session.  
Labeling of distinct AChR pools. The labeling protocol was performed as described by 
Bruneau et al., 2005. Briefly, the sternomastoid muscle was bathed first with fully 
substituted BTX-biotin (5 µg/ml, 1 hour, Molecular Probes, Eugene, OR) to label AChRs 
and then with streptavidin conjugated to Alexa 488 (green) (10 µg/ml, 3 hours, Molecular 
Probes, Eugene, OR) to saturate all biotin sites. To ensure that all biotin sites were 
saturated, a distinct color of streptavidin-Alexa (streptavidin-Alexa 594, 10 µg/ml, 10-20 
minutes) was added to the sternomastoid muscle, and synapses were imaged. The absence 
of (red) streptavidin-Alexa 594 staining indicated that all biotin sites were initially 
saturated with streptavidin-Alexa 488. Three to four days later the mouse was re-
anesthetized, and the sternomastoid muscle was re-exposed and bathed with streptavidin-
Alexa 594 to label the AChRs that had recycled back to the muscle surface as AChR-
BTX-biotin complexes. The muscle was washed out continuously for 15 minutes with 
Ringer’s solution. A brief chase of unlabeled streptavidin (10 minutes) was added to the 
sternomastoid muscle to prevent the unlikely binding to recycled AChRs of any residual 
fluorescent streptavidin that remained in the milieu after the extensive washing. This 
labeling procedure would prevent any erroneous estimation of receptor removal. The 
doubly-labeled superficial synapses were then imaged (IPLAB software, Scanalytics, 
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VA). At subsequent time points, the same synapses were relocated and imaged. In this 
way, we were able to distinguish the “pre-existing” (BTX-biotin labeled receptors 
retaining their initial streptavidin) and recycled receptor pools. It is worth noting that at 
the time of recycled AChRs labeling, a significant number of receptors in the NMJ are 
new, functional receptors, which are sufficient to allow normal synaptic transmission 
(Bruneau et al., 2005; Lingle and Steinbach, 1988). All controls for the specificity of 
biotin-streptavidin dissociation were worked out previously by Bruneau et al., 2005 
 To determine the loss rate of newly synthesized receptors, the sternomastoid 
muscle was incubated with unlabeled-BTX (5 µg/ml, 1.5 hours) to saturate all surface 
receptors (a second dose of fluorescent-BTX was used to verify that all AChRs were 
saturated). Four to five days after initial labeling, newly inserted receptors were labeled 
with BTX-biotin at a sub-saturating dose (5 μg/ml for 20 minutes) so that synaptic 
transmission remained functional, followed by a saturating dose of streptavidin-Alexa 
488 (green). Superficial synapses were imaged and fluorescence loss was monitored over 
days. 
Surgical procedures. Sternomastoid muscles were denervated by excising a 5 mm piece 
of the sternomastoid nerve to prevent re-innervation. To determine the effect of 
denervation on the number of receptors recycled at the postsynaptic membrane, mice 
denervated 6-8 days earlier were anesthetized and the sternomastoid muscle was exposed 
and labeled with biotin-bungarotoxin followed with a single saturating dose of 
streptavidin-Alexa 594 and superficial synapses were imaged as described above. Three 
days later, the animal was re-anaesthetized and the same synapses were imaged and the 
loss of fluorescence was measured. The sternomastoid muscle was bathed again with 
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fresh streptavidin-Alexa 594 (to label recycled AChRs) and synapses were imaged and 
the fluorescence intensity was assayed. For comparison, a similar labeling protocol was 
used for innervated synapses.  
 To determine the removal rate of recycled and “pre-existing” AChRs in 
denervated muscle, the sternomastoid muscle of mice denervated 6-8 days earlier was 
labeled with biotin-bungarotoxin followed with a single saturating dose of streptavidin-
Alexa 488. Three days later the sternomastoid was exposed and synapses were labeled 
with a single saturating dose of streptavidin-Alexa 594 (to label all receptors that had 
recycled over that time) and then superficial synapses were imaged and their fluorescence 
intensities were measured, and the decrease in fluorescence of both AChR pools was 
monitored over time.  
 To determine the effect of muscle action potentials on AChR turnover, 
immediately after recycled receptor labeling in denervated NMJs, the muscle was directly 
stimulated with a Grass SD5 stimulator connected to two platinum wires at either side of 
the muscle. The stimulus pulses (3 ms bipolar pulses of 6-9 V at 10 Hz for 1 second 
duration every 2 seconds) elicited maximal twitching and therefore action potentials in all 
muscle fibers. Mice were continuously ventilated and maintained under anesthesia by 
intraperitoneal injections of KX every 2 hours for the duration of the experiment. To 
minimize evaporation a coverslip was placed over the exposed muscle. 
Quantitative fluorescence imaging. The fluorescence intensity of labeled receptors at 
neuromuscular junctions was assayed using a quantitative fluorescence imaging 
technique, as described by Turney and colleagues (Turney et al., 1996), with minor 
modifications. This technique incorporates compensation for image variation that may be 
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caused by spatial and temporal changes in the light source and camera between imaging 
sessions by calibrating the images with a non-fading reference standard. A key feature of 
the quantitative imaging approach used in the current study is that it involves repetitive 
imaging of the same fluorescent ligands (streptavidin-Alexa 594 and streptavidin-Alexa 
488). Thus, as long as we verified that labeling had reached saturation and that the image 
pixel intensity was not saturated, it was relatively trivial to get an accurate quantitative 
measurement of the relative number of AChRs.   
Pharmacology. The agents tested were prepared as a stock solution and 500 µl of the 
stock was placed directly onto the sternomastoid muscle for 9 hours. During the 
experiment, the animal was intubated with a ventilator to avoid asphyxiation. To inhibit 
tyrosine phosphatase activity, we used 2 agents: phenylarsine oxide (2 mM, Sigma, St. 
Louis) and pervanadate (5-10 mM). Pervanadate solution was prepared by mixing 1.7% 
H2O2 and sodium orthovanadate (Sigma, St. Louis) at 1:50 for 10 minutes before adding 
it to the sternomastoid muscle (Madhavan et al., 2005). To inhibit serine/threonine 
phosphatases, we used okadaic acid (10 µM - 100 µM, Sigma, St. Louis). To verify the 
effectiveness of okadaic acid in vivo, at the end of the imaging session, the sternomastoid 
muscle that had been bathed with okadaic acid was removed from the mouse and 
homogenized in RIPA buffer. The supernatant was then exposed to a direct fluorescence-
based assay for detecting serine/threonine phosphatase activity (RediPlateTM 96 EnzChek 
serine/threonine phosphatases Assay Kit (Molecular Probes, Eugene, OR)). The 
serine/threonine phosphatase assay was done according to the protocol provided with the 
kit. Briefly, appropriate buffers for the serine/threonine phosphatases PP1 and PP2A were 
added to a 96-well microplate preloaded with inhibitors of phosphatases other than 
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serine/threonine phosphatases and the fluorogenic substrate DiFMUP (6,8-difluoro-4-
methyl-umbelliferyl phosphate), which generates DiFMU. The serine/threonine 
phosphate substrate (DiFMUP) was then fully solubilized and homogenates from treated 
and untreated muscle were added to the wells. The fluorescence emitted by DiFMU was 
then measured using a fluorescence microplate reader using excitation at 355 ± 20 nm 
and emission 460 ± 12.5 nm.  
Confocal Microscopy. The sternomastoid muscle was saturated with biotin-
bungarotoxin followed by a single saturating dose of streptavidin-Alexa 488 (10 µg/ml, 3 
hours). Three to four days later the animal was re-anaesthetized and streptavidin-Alexa 
594 was added to the sternomastoid muscle to label recycled AChRs. Two to three days 
later the animal was perfused transcardially with 2% PFA and the sternomastoid muscle 
was removed and longitudinally sectioned. Twenty µm muscle sections were blocked 
with 10% BSA and 0.5 % Triton X-100 and then bathed with monoclonal anti-receptor 
antibody (mAb 35) followed by an anti-rat secondary antibody conjugated to Alexa 647. 
Muscle sections were scanned with a confocal microscope (Olympus fluoview) and 
imaged. The z-stacks were then collapsed and contrast was adjusted with Photoshop to 
maximally resolve intracellular fluorescent spots.   
Results 
Recycled and “pre-existing” AChR removal at the neuromuscular junction of living 
mice  
Recent work from our lab has shown that a significant number of receptors 
recycle back to synapses after internalization (Bruneau et al., 2005); here we wanted to 
know whether recycled receptors are as stable in the synapse as “pre-existing” receptors 
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(receptors retaining their streptavidin-Alexa 488 after initial labeling). To this end, the 
sternomastoid muscle of living mice was labeled with bungarotoxin-biotin (BTX-biotin), 
followed by a single saturating dose of streptavidin-Alexa 488 (strept-488) to saturate all 
biotin sites. To ensure that all biotin sites were labeled, the muscle was exposed to a 
second color of fluorescent streptavidin (strept-594). Images of superficial synapses 
showed no staining with strept-594, indicating that all biotin sites were saturated with 
strept-488. The animal was then allowed to recover. Three to four days after the initial 
labeling, strept-594 was added to label recycled receptors that had lost their strept-488 
but retained BTX-biotin and images were taken immediately (day 0). The dissociation of 
streptavidin from AChR-BTX-biotin does not occur spontaneously on the muscle surface 
but rather only after the complex (AChR-BTX-biotin/strept-488) is internalized (Bruneau 
et al., 2005). Both “pre-existing” AChRs that retained BTX-biotin/strept-488 after the 
initial labeling and recycled AChRs labeled with BTX-biotin/strept-594 could then be 
imaged separately and the changes in their fluorescence intensities monitored over time. 
As shown in Figure 4.1A, recycled and “pre-existing” AChRs were intermingled in the 
same postsynaptic membrane. One to three days after labeling recycled AChRs with 
strept-594, both recycled and “pre-existing” AChRs were re-imaged once or multiple 
times and then their fluorescence intensities were assayed. We found that after 1 day the 
fluorescence intensity of recycled receptors (receptors tagged with BTX-biotin/strept-
594) decreased to 59% (±5 s.d., n=25) of their original fluorescence, corresponding to a 
t1/2 of ~ 1.3 days. At 2 and 3 days, the remaining fluorescence intensities were 36% (±6 
s.d., n=20) and 16% (±2 s.d., n=15) of original fluorescence, respectively. At the same 
synapses over the same times, however, the fluorescence intensity of AChRs labeled with 
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BTX-biotin/strept-488 decreased to only 84% (±6 s.d., n=20) of original fluorescence 
after 1 day (t1/2 ~ 4 days), and after 2 and 3 days fluorescence decreased to 68% (±9 s.d., 
n=10) and 54% (±4 s.d., n=15), respectively (Figure 4.1 B,C). Similar results were 
obtained if strept-594 was used initially to label “pre-existing” receptors and strept-488 
was used to label recycled AChRs.  
 
To examine the removal rate of newly inserted receptors, the sternomastoid 
muscle was saturated with BTX and the animal was allowed to recover. Four to five days 
later the sternomastoid was then bathed with a low dose of BTX-biotin/strept-488 to label 
newly synthesized receptors. The superficial synapses were imaged and re-imaged 1 and 
Figure 4.1. Recycled and “pre-existing” AChRs are removed at different rates from the same 
synapse. The sternomastoid muscle was labeled with BTX-biotin/strept-488 and 3-4 days later was 
incubated with strept-594 to selectively label recycled AChRs. (A) High resolution image of a 
neuromuscular junction branch shows that recycled and “pre-existing” (receptors retaining their strept-
Alexa 488 after initial labeling) AChRs are intermingled in the postsynaptic membrane. Scale bar, 
20µm. (B) Example of mouse neuromuscular junction where “pre-existing” and recycled AChRs were 
labeled with distinct fluorophores and both fluorescence intensities were measured immediately after 
strept-594 labeling of recycled AChRs (day 0) and 2 days later. The total fluorescence intensity of each 
AChR pool is normalized to 100% at initial imaging. Pseudo-color images provide a linear 
representation of the density of AChRs. Scale bar, 20µm. (C) Graph summarizes the results obtained 
from all junctions with the approach shown in (B). Each data point represents the mean percentage of 
fluorescence intensity (±s.d.). Note that recycled receptors are removed significantly faster than “pre-
existing” receptors. 
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2 days later. We found that the fluorescence from newly synthesized receptors decreased 
to 79% (±5 s.d., n=14) of original fluorescence after 1 day, and to 69% (±10 s.d., n=7) of 
original fluorescence after 2 days. These data indicate that the removal rate of newly 
synthesized receptors is significantly slower than recycled receptors (p<0.0001). 
Given the rapid loss of recycled receptors from the postsynaptic membrane, we 
next examined whether this loss is matched by the insertion of new recycled receptors 
over the same time period. To do this, the sternomastoid muscle of 3 mice was labeled 
with BTX-biotin followed by a saturating dose of strept-488, and 3 to 4 days later the 
animal was anaesthetized and the sternomastoid muscle was bathed with a saturating dose 
of strept-594 to specifically label the recycled receptors, as described above. The 
superficial synapses were then imaged, and the animal was allowed to recover. Two days 
later, the same synapses were re-imaged and the fluorescence of each synapse was 
measured at each data point. The sternomastoid muscle was then bathed with a saturating 
dose of fresh strept-594 to label receptors that had been recycled over the given time 
period. When we measured the fluorescence intensity at 2 days, we found the 
fluorescence remaining from the recycled pool (labeled with strept-594) was 35% (±6 
s.d., n=17) of the original fluorescence. When re-labeled with new strept-594, the 
fluorescence intensity returned to 99% (±17 s.d., n=10) of the initial recycled AChR 
fluorescence (Figure 4.2 A,B). This result indicates that the insertion of new recycled 
receptors matches the loss of recycled receptors from the postsynaptic membrane.   
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Targeting of recycled AChRs to stable fluorescent intracellular vesicles after 
internalization  
Previously we have shown that receptors that are removed from synapses are 
internalized in intracellular endocytic vesicles (Akaaboune et al., 1999; Bruneau et al., 
2005). Since recycled and “pre-existing” receptors intermingle at the same postsynaptic 
Figure 4.2. Insertion of newly recycled AChRs matches the removal of recycled receptors. The 
sternomastoid muscle was labeled with BTX-biotin followed by a saturating dose of strept-488, and 3 to 
4 days later the animal was anaesthetized and the sternomastoid muscle was bathed with a saturating 
dose of strept-594 to specifically label the recycled receptors and superficial synapses were immediately 
imaged (d0). The same synapses were imaged again 2 days later and the loss of recycled receptors was 
determined. The sternomastoid muscle was bathed with fresh strept-594 and synapses were relocated 
and imaged to determine the insertion of newly recycled AChRs. Scale bar, 20µm. (A) Example of a 
mouse neuromuscular junction that was imaged three times over 2 days to determine the loss and 
insertion of recycled AChRs. (B) Graph summarizes the results of recycled AChR loss and insertion 
after 2 days obtained from junctions with the approach shown in (A) (±s.d.). Note that nearly all AChRs 
from the recycled pool that were lost over 2 days were replaced by newly recycled receptors that had re-
inserted into the NMJ over this time.  
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membrane but turn over at such different rates (Figure 4.1), we wanted to know whether 
recycled and “pre-existing” receptors, after their removal from the postsynaptic 
membrane, are internalized in the same or distinct intracellular vesicles. To examine this, 
the sternomastoid muscle was labeled with BTX-biotin/strept-488 (green), and 3-4 days 
later the recycled receptors were labeled with strept-594 (red), as described in Methods. 
When recycled and “pre-existing” AChRs were re-imaged 2 or more days later, we were 
surprised to find that 100% of the vesicles that contained red fluorescence from recycled 
receptors also contained green fluorescence from “pre-existing” receptors (n= 50 
synapses) (Figure 4.3 A). This result prompted us to monitor the formation and 
accumulation of both green and red intracellular puncta using time-lapse imaging. To do 
this, the sternomastoid muscle was labeled with BTX-biotin/strept-488, and 3-4 days later 
the receptors that had recycled over this time were labeled with strept-594, as described 
above. When superficial synapses were imaged immediately after strept-594 (red) 
labeling, the AChRs labeled with green strept-488 were concentrated in the postsynaptic 
membrane and also in internal compartments represented by small spots of fluorescence 
in the vicinity of the junction (Figure 4.3 B, top panels). When the same synapse was 
imaged 8 hours later, we found that some of the green spots remained while others had 
disappeared. At this time point faint red fluorescent spots began to be detected, but 
appeared only at the stable spots of green fluorescence (Figure 4.3 B, middle panels). At 
28 hours, while many of the green fluorescent spots had disappeared, stable spots that 
contained both strept-488 and strept-594 remained (Figure 4.3 B, bottom panels). These 
results indicate either that the removed recycled receptors were directly and specifically 
targeted to stable vesicles already containing internalized AChR-BTX-biotin/strept-488 
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complexes, or that the fluorescent puncta observed in the intracellular vesicles were from 
streptavidin-Alexa tags that had been removed from both receptor pools after 
internalization (see discussion).  
 
Figure 4.3. Fluorescent tags from recycled receptors are endocytosed and targeted to vesicles 
containing strept-488 from “pre-existing” AChRs. Sternomastoid muscle was labeled with BTX-
biotin/strept-488, and recycled receptors were labeled 3 days later with strept-594. (A) Example of 
recycled and “pre-existing” AChRs imaged 2 days after recycled receptor labeling. Note that 100% of 
the vesicles containing red fluorescence from recycled AChRs also have green signals from “pre-
existing” AChRs (arrows), while some of the green fluorescent spots lack red signal (arrowheads). 
Scale bar, 20µm. (B) Time-lapse imaging of a mouse neuromuscular junction labeled as in (A) and then 
imaged multiple times over the next 28 hours. Note that a number of the vesicles containing strept-488 
from the “pre-existing” AChRs at time 0 are stable over the next 28 hours (arrows), while others are 
transient. The strept-594 labels from recycled receptors are selectively targeted to the stable vesicles 
containing fluorescent label from “pre-existing” receptors. Scale bar, 20µm.  
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If the red and green fluorescence observed in stable vesicles are from streptavidin-
Alexa tags that have been removed from their receptor complexes and then sequestered, 
then we would expect that at least a subset of these vesicles may lack AChRs. To 
investigate this possibility, the sternomastoid muscle was labeled with BTX-biotin/strept-
488 (green) and three days later was incubated with strept-594 (red) to label recycled 
receptors. Two days later, the animal was perfused with paraformaldehyde and the 
muscle was dissected, sectioned and immuno-stained with the anti-AChR antibody mAb 
35 (pseudo-color, blue). Interestingly, some green/red fluorescent vesicles were devoid of 
receptors, suggesting that the streptavidin-Alexa tags had indeed been removed and 
sequestered, possibly in degradative vesicles. Other vesicles contained fluorescent 
streptavidin tags and receptors, potentially indicating complexes that were in the process 
of recycling or degradation. A third subset of puncta contained receptors only without 
any fluorescent streptavidin tags, indicating receptors in the process of insertion, or 
receptors in the later stages of recycling that already had their strept-Alexa tags removed 
(Figure 4.4).  
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Figure 4.4. Confocal images of a triply-labeled neuromuscular junction. The sternomastoid muscle 
of a live animal was labeled with BTX-biotin/strept-488 (green) and bathed 3 days later with strept-594 
(red) to label recycled receptors. Two days after recycled receptor labeling the animal was perfused 
with 2% PFA, the sternomastoid muscle was sectioned and immunostained with anti-AChR. Green 
arrows indicate accumulation of only green fluorescent streptavidin that has been removed from “pre-
existing” AChRs after internalization, which may correspond to degradative vesicles. Yellow arrows 
indicate accumulation of green and red streptavidin tags removed from pre-existing and recycled 
receptors after internalization, which likely also correspond to degradative vesicles. Blue arrows 
indicate vesicles containing AChRs, but lacking any streptavidin Alexa tags. These vesicles may 
correspond to internalized AChRs in later stages of recycling and/or degradation, or newly synthesized 
receptors in the process of insertion. White arrows indicate vesicles containing receptors and their 
streptavidin tags after internalization. The colors in the overlay of the three fluorescent labels were 
altered and adjusted in Photoshop to maximize contrast. Inset from top panels shown in panels below. 
Scale bar, 20µm. 
These results, combined with the observation from time-lapse imaging (Figure 4.3) suggests 
that stable vesicles may contain fluorescent products (indicated by yellow arrows) and the more 
dynamic vesicles may correspond to cycling AChRs (indicated by white arrows). 
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Effect of denervation and muscle stimulation on recycled AChR dynamics  
Given the rapid removal rate of recycled AChRs, we next asked whether this loss 
rate could further be affected by muscle denervation. We first asked whether denervation 
has any effect on the insertion of recycled AChRs into the postsynaptic membrane. To 
this end, innervated NMJs and junctions denervated 6-8 days earlier were labeled with a 
single saturating dose of BTX-biotin and then all biotin sites were saturated with strept-
594 (red). The superficial synapses were imaged and 3 days later the animal was re-
anesthetized, the sternomastoid muscle was exposed, and the same synapses were 
relocated and re-imaged to measure the loss of their original fluorescence. To quantify 
the number of recycled AChRs that had been inserted after initial labeling, new strept-
594 (red) was added to the sternomastoid muscle and the same synapses were re-imaged. 
Interestingly, we found that only 8% (±3.8 s.d., n=20) of the original fluorescence had 
recovered at denervated synapses after 3 days (Figure 4.5 A,B), which is significantly 
less than the insertion rate of recycled receptors in innervated junctions (25% of original 




Next, we asked whether recycled and “pre-existing” AChRs have similar removal 
rates in denervated muscle. To test this idea directly, junctions denervated 6-8 days 
earlier were labeled with BTX-biotin/strept-488. The animals were allowed to recover 
and three days later the recycled AChRs were labeled with strept-594, and superficial 
synapses were imaged immediately and re-imaged 1 and 2 days later. We found that after 
Figure 4.5. Muscle denervation affects the contribution of recycled AChRs. (A) Example of a 
denervated neuromuscular junction that was labeled with BTX-biotin/strept-594 and imaged 
immediately. Three days later the same synapse was imaged again (to measure the loss of fluorescence) 
and incubated with strept-594 to selectively label recycled AChRs. Note that 60% of original 
fluorescence was lost after 3 days, while very little fluorescence was gained after strept-594 was added 
(6% of original fluorescence), indicating that recycling of AChR is significantly decreased in 
denervated muscle. All three panels are displayed on the same intensity scale. (B) Graph summarizes 
results obtained from many junctions with the approach shown in (A). Each data point represents the 
mean percentage of fluorescence intensity (±s.d.). (C) Example of an innervated mouse synapse 
measured over 3 days, showing that a significant number of recycled AChRs return back to the 
postsynaptic membrane. (D) Graph summarizes measurements obtained from many synapses.   
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only 1 day the strept-594 fluorescence intensity (labeled recycled AChRs) decreased 
dramatically to 35% (± 5 s.d., n=17) of original fluorescence (corresponding to a t1/2 ~15 
hours, nearly 2 times faster than the t1/2 of recycled AChRs at innervated synapses). Loss 
of fluorescence continued, decreasing to 16% (±3 s.d., n=9) after 2 days. At the same 
time the strept-488 fluorescence from “pre-existing” receptors decreased to 70% (±6 s.d., 
n=10) after 1 day (t1/2 ~ 1.9 days, also nearly 2 times faster than the t1/2 at innervated 
synapses) and 43% (±6 s.d., n=9) of their original fluorescence after 2 days (Figure 4.6 
A,B). These results indicate that denervation increases the already rapid removal of 
recycled receptors from the postsynaptic membrane, and has a similar effect on both 
recycled and “pre-existing” AChRs, nearly doubling the rate of removal of each receptor 




Since the above experiments indicate that muscle activity is important for receptor 
stability, we next tested whether direct muscle stimulation could prevent the rapid 
removal of recycled AChRs from the postsynaptic membrane. Denervated sternomastoid 
muscle was saturated (6-8 days after denervation) with BTX-biotin/strept-488, and 3 days 
later was saturated with strept-594 to specifically label recycled AChRs. Superficial 
synapses were imaged and muscle action potentials were then elicited via stimulating 
Figure 4.6. Denervation increases the removal rates of recycled and “pre-existing” AChRs at the 
neuromuscular junction. AChRs at denervated neuromuscular junctions were labeled with BTX-
biotin/strept-488, and recycled AChRs were labeled 3 days later with strept-594. Fluorescence signals 
from both receptor pools were then imaged, and imaged again 1 day later. (A) Example of a denervated 
neuromuscular junction in which recycled AChRs were monitored over 1 day. (B) Graph shows the 
lifetime of recycled and “pre-existing” AChRs from the same synapses as assessed by the change in 
fluorescence intensities over a 1 day period. Note that in innervated synapses recycled AChRs had an 
average t1/2 of 28 hours, whereas “pre-existing” AChRs had an average t1/2 of ~102 hours. In 
denervated synapses, recycled AChR half-life dropped to ~15 hours and “pre-existing” AChR half-life 
decreased by the same proportion to ~48 hours.   
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electrodes placed at either end of the muscle (3 ms bipolar pulses of 6 to 9 V at 10 Hz for 
1 s duration every 2 s for the entire 8 hour period). For the duration of the experiment, the 
mouse was intubated and ventilated to prevent asphyxia. The result was dramatic: the loss 
of recycled AChRs observed in denervated muscles over the 8 hours (66% of original 
fluorescence remaining ±5 s.d., n=8) was almost completely prevented after stimulation 
of denervated muscles (94% of original fluorescence remaining ±6 s.d., n=16) (Figure 4.7 
C-E). This result indicates that muscle action-potentials are sufficient to prevent the loss 
of recycled receptors.    
 
Figure 4.7. Muscle stimulation prevents loss of recycled AChRs from denervated NMJs. (A) Three 
days after initial labeling with BTX-biotin/strept-488, recycled AChRs on denervated muscle were 
labeled with strept-594 and immediately imaged and imaged again 8 hours later and the loss of 
fluorescence was measured. (B) Example of a NMJ illustrating that stimulation of denervated muscle 
prevents the loss of recycled receptors from the synapse. Scale bar, 20µm. (C) Graph summarizes 
results obtained from many synapses. Note that after 8 hours ~66% of fluorescence from recycled 
receptors remained in denervated synapses; however when denervated muscle was chronically 
stimulated, this loss of fluorescence was nearly abolished.     
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Proper localization of recycled receptors requires tyrosine phosphatase activity  
Because phosphorylation and dephosphorylation events are associated with 
postsynaptic receptor cycling in central synapses (Ehlers, 2000; Esteban et al., 2003; 
Malinow and Malenka, 2002), we next tested whether AChR recycling also depends upon 
phosphorylation/dephosphorylation events. To do this, the sternomastoid muscle was 
labeled with BTX-biotin/strept-488 (green), and then the muscle was bathed continuously 
with a phosphatase inhibitor. The mice were anesthetized and ventilated to prevent 
asphyxia. After 9 hours of incubation with the drug, strept-594 (red) was added to the 
sternomastoid muscle to label receptors that had been recycled back to the membrane 
after initial labeling. We found a striking alteration in receptor localization at synapses 
when the muscle was treated with phenylarsine oxide (PAO), a known inhibitor of 
tyrosine phosphatases (Fletcher et al., 1993; Moult et al., 2006; Moult et al., 2002). In 
contrast to untreated control muscles where the recycled surface receptors are restricted 
to the junctional area as the original receptors, PAO treatment resulted in red labeling in 
the peri-synaptic region as well as the junctional region (Figure 4.8 B,C). The presence of 
red signal in the peri-synaptic region is specific to recycled receptors labeled with strept-
594 (red) because at 9 hours no “pre-existing” receptors (green) were detected outside of 
the original synapse (Figure 4.8 A). In another set of experiments we used another 
common tyrosine phosphatase inhibitor, pervanadate (Madhavan et al., 2005; Moult et 
al., 2006). This treatment caused the same peri-synaptic staining of recycled AChRs 
(Figure 4.8 E,F) without affecting the synaptic localization of “pre-existing” AChRs 
(Figure 4.8 D). These results indicate that tyrosine phosphatase activity is involved in 
proper localization of recycled receptors.    
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To investigate the potential role of serine/threonine phosphatases on receptor 
recycling, the sternomastoid muscle of 4 mice was labeled (as described above) and then 
bathed with different concentrations of okadaic acid (10 µM – 100µM), a specific 
inhibitor of serine/threonine phosphatases 1 and 2A (Pahan et al., 1998). Nine hours later, 
when the muscle was labeled with strept-594, specific staining was observed only in the 
junctional zone, indicating that the targeting of recycled receptors does not require 
serine/threonine phosphatases (Figure 4.8 G-I). The effectiveness of this drug in vivo was 
tested at the end imaging session by removing and homogenizing the sternomastoid 
muscle and testing the activity of PP1 and P2A phosphatases using a serine/threonine 
phosphatase assay kit. When the muscle was incubated in 10µM of okadaic acid, most of 
the serine/threonine phosphatase activity (>70%) was inhibited compared to untreated 
muscle. When 100 µM was used all serine/threonine phosphatases activity was inhibited 
and the muscle also presented some signs of swelling.  
Discussion 
In this study we report that at fully functional synapses, recycled AChRs turn over 
more rapidly than “pre-existing” or newly synthesized AChRs that are co-localized in the 
same postsynaptic membrane. The absence of muscle activity significantly decreases the 
number of recycled AChRs and increases the already rapid removal rate of recycled 
AChRs, while direct muscle stimulation completely prevents receptor loss. In addition, 
this work provides evidence for the possible involvement of tyrosine dephosphorylation 




Figure 4.8. Tyrosine phosphatase inhibition causes the accumulation of recycled receptors in the 
peri-synaptic membrane. (A) Example of a living adult mouse neuromuscular junction previously 
saturated with BTX-biotin/strept-488 (green) at time 0 and viewed at high detector gain. The muscle 
was continuously bathed in tyrosine phosphatase inhibitor (PAO), and imaged 9 hours later. (B) The 
junction was then incubated with strept-594 (red) to determine if PAO affects AChR recycling. Peri-
synaptic areas were labeled with red strept-594 (arrows), indicating that some of the recycled receptors 
were miss-targeted when tyrosine phosphatases were inhibited pharmacologically. (C) Overlay of “pre-
existing” and recycled receptors. Similar results were obtained when an alternate tyrosine phosphatase 
inhibitor, pervanadate, was instead applied to the sternomastoid muscle (D-F). Note that while recycled 
receptors (red) appear in the peri-synaptic area after tyrosine phosphatase inhibition, “pre-existing” 
receptors (green) remain restricted to the synapse. (G-I) Example of an adult mouse neuromuscular 
junction labeled using the same labeling procedure as above and bathed for the duration of the 
experiment with okadaic acid, a serine/threonine phosphatase inhibitor. Recycled receptors were 
identified by adding strept-594 (red) after 9 hours. Note that recycled receptors were properly targeted 
to the synapse. (I) Overlay of “pre-existing” and recycled receptors. Images were adjusted for 
brightness and contrast using Adobe Photoshop. 
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One interesting finding of this work is that the lifetime of recycled receptors is far 
shorter than that of initially labeled and “pre-existing” AChRs, even though all these 
AChRs are intermingled in the same postsynaptic membrane. It is unlikely that the 
difference in receptors lifetime obtained in our studies is due to BTX binding itself, since 
we are comparing the removal rates of receptors that are both tagged with BTX. 
However, it must be acknowledged that the use of BTX, which specifically and 
irreversibly binds to AChRs, also blocks AChRs function. Although there is no direct 
evidence about whether bungarotoxin binding itself changes the behavior of AChRs, a 
number of previous studies suggest that labeled receptors behave normally as long as the 
neuromuscular junction activity is not totally blocked (Akaaboune et al., 1999; Lingle et 
al., 1988). While it has been shown previously that gamma and epsilon subunits of 
AChRs are able to turn over at different rates, it is also unlikely that differences in loss 
rates are due to differences in the subunit composition of receptors (gamma vs. epsilon) 
because innervated adult synapses only express the epsilon subunit (Burden, 1977; 
Missias et al., 1996; Yumoto et al., 2005). This implies that an unknown mechanism 
exists which specifically alters recycled AChR stability.  
It is possible that during the process of receptor intracellular trafficking (in early 
endosomes or specialized recycling endosomes) alterations or modifications of AChR 
subunits or receptor-associated proteins may occur. Such alterations might affect the 
interaction of receptors with postsynaptic scaffolding proteins, which in turn may affect 
their stability once inserted in the postsynaptic membrane. For example, it has been 
suggested that phosphorylation events are involved in the stabilization of AChRs (Caroni 
et al., 1993) and inhibition of these events has been shown to increase receptor removal 
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and prevent receptor clustering, despite ongoing muscle activity (Ferns et al., 1996; 
Fuhrer et al., 1997; Wallace, 1994; Wallace et al., 1991). At central synapses, it has been 
shown that a coordination of phosphorylation and dephosphorylation events may regulate 
synaptic strength (Moult et al., 2006; Raymond et al., 1993; Raymond et al., 1994; Roche 
et al., 1994); it is possible that similar mechanisms may be involved at the neuromuscular 
junction. This possibility is supported by our results, which show that inhibition of 
tyrosine phosphatase activity can cause selective disruption of receptor recycling, 
resulting in labeling outside of the usually sharp NMJ boundary, while “pre-existing” 
receptors remain intact within the NMJ. This suggests that phosphorylation of receptors 
or associated proteins at tyrosine sites during trafficking might cause miss-targeting of 
recycled receptors or increase their mobility once they have recycled into the 
postsynaptic membrane. It is also conceivable that tyrosine phosphatase inhibitors could 
selectively increase the insertion and accumulation of recycled receptors to the peri-
junctional region.  Interestingly, previous work has made the same observation in 
synapses of frog nerve/muscle co-cultures treated with tyrosine phosphatase inhibitors, 
which they attributed to the dissociation and migration of “pre-existing” receptors into 
the peri-synaptic region (Dai and Peng, 1998). Because we were able to distinguish 
between “pre-existing” and recycled pools of receptors, our results argue that tyrosine 
phosphatase inhibition does not cause dissociation of “pre-existing” receptors, but rather 
specifically interferes with the delivery of internalized receptors back into the NMJ or 
their maintenance at the postsynaptic membrane.  
Muscle activity appears to be critical for the insertion and stability of recycled 
AChRs in the postsynaptic membrane. Our results indicate that the contribution of 
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recycled AChRs is significantly depressed in denervated muscle synapses compared to 
innervated synapses. The inhibition of recycling is not affected within the first week of 
denervation, however (data not shown).  It is possible that during the first week of muscle 
denervation, the insertion of recycled receptors is maintained by spontaneous release of 
acetylcholine neurotransmitter by Schwann cells (Brett et al., 1982; Dennis and Miledi, 
1974), which might explain why the number of synaptic receptors only begins to decline 
~9 days after muscle denervation (Andreose et al., 1995). Consistent with this, we have 
previously shown that spontaneous release of neurotransmitter is sufficient to prevent the 
loss of receptors from synapses (Akaaboune et al., 1999). This result suggests that the 
decrease in receptor number at denervated muscle synapses over time could be attributed 
to the decrease in delivery of the recycled receptor pool back to the postsynaptic 
membrane. Interestingly, the absence of muscle activity following denervation not only 
increases the removal rate of “pre-existing” AChRs but also accelerates the already rapid 
removal of the receptors that have recycled back into the membrane. This indicates that 
recycled receptors, despite their rapid loss, can still be controlled by synaptic activity. In 
agreement with our previous findings, which showed that stimulation of denervated 
muscle prevents the removal of “pre-existing” AChRs (Bruneau et al., 2005), we found 
here that muscle stimulation also prevents the removal of recycled receptors. Consistent 
with these results, muscle stimulation alone has been reported to reversibly increase the 
metabolic stability of receptors at synapses that are denervated early in development and 
can prevent the decrease of AChR half-life observed at surgically denervated and blocked 
endplates (Akaaboune et al., 1999; Brenner and Rudin, 1989; Rotzler and Brenner, 1990). 
However, the way in which neuromuscular transmission or muscle action potentials 
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regulate AChR behavior is not understood. It is possible that muscle contraction caused 
by direct stimulation causes an increase of calcium influx either through ligand-gated or 
L-type channels, or that it causes calcium release directly from intracellular stores. In 
support of this idea, previous studies have shown that blockade of L-type channels affects 
AChR stability (Rotzler et al., 1991).  
At functional neuromuscular synapses, recycled receptors are continually inserted 
into the post synaptic membrane. However, it is unclear what proportion of the recycled 
receptor pool derives from “pre-existing” or previously recycled AChRs and how many 
times receptors are able to recycle back before being degraded. If receptors recycle only 
one time, then a fraction of the pre-existing pool must enter the recycling pathway over 
time to maintain the recycled receptor pool. The observation that red streptavidin from 
recycled AChRs co-localizes in intracellular vesicles with the previously internalized 
green fluorescent label from “pre-existing” receptors is intriguing (see Figs 4.3, 4.4). This 
result suggests two possibilities: first, recycled AChRs could have a tag that directly 
shuttles them to stable degradation vesicles containing previously internalized “pre-
existing” AChRs. In this scheme, it is tempting to speculate that the stable spots of 
fluorescence are part of the accumulated degradation products, implying that AChRs 
might recycle only one-time before being targeted for degradation. Alternatively, it is 
possible that AChRs may recycle more than one time and that the stable fluorescent 
vesicles may correspond to accumulations of fluorescent tag that recycled and “pre-
existing” AChRs lose intracellularly while in the process of recycling. The absence of 
receptors in some vesicles suggests that these are indeed sites of degradation which may 
correspond to stable vesicles observed in time-lapse imaging; the more dynamic vesicles 
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are either in the process of recycling or early in the degradation pathway. While this 
result suggests that receptors may be able to cycle many times, losing their streptavidin 
tag each time, the question of how many times a receptor can cycle before being 
degraded is not resolved here and requires the development of new techniques to study.  
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Acetylcholine Receptor Clustering is required for the Accumulation and 
Maintenance of Post-Synaptic Scaffolding Proteins 
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Introduction 
The maintenance of a high density of post-synaptic receptors is essential for 
proper synaptic function. At the neuromuscular junction, acetylcholine receptor (AChR) 
aggregation is induced by nerve clustering factors and mediated by scaffolding proteins 
(Sanes and Lichtman, 2001). While the mechanisms underlying AChR clustering have 
been extensively studied (Gautam et al., 1999; Lin et al., 2001; Beeson et al., 2006; 
Okada et al., 2006), the role that the receptors themselves play in the clustering process 
and how they are organized with scaffolding proteins is not well understood.  
Here we report that the exposure of AChRs labeled with Alexa 594 conjugates to 
relatively low-powered laser light caused an effect similar to chromaphore-assisted light 
inactivation (CALI) (Jay, 1988; Beermann and Jay, 1994), which resulted in the 
unexpected dissipation of the illuminated AChRs from clusters on cultured myotubes. 
This technique enabled us to demonstrate that AChR removal from illuminated regions 
induced the removal of scaffolding proteins and prevented the accumulation of new 
AChRs and associated scaffolding proteins. Further, the dissipation of clustered AChRs 
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and scaffold was spatially restricted to the illuminated region and had no effect on 
neighboring, non-illuminated AChRs. These results provide direct evidence that AChRs 
are essential for the local maintenance and accumulation of intracellular scaffolding 
proteins, and suggest that the scaffold is organized into distinct modular units at AChR 
clusters. 
Materials and Methods 
GFP fusion construct. The rapsyn-GFP fusion construct was kindly provided by Dr. 
Jonathan Cohen (Harvard Medical School).  
Cell culture. C2C12 myoblasts (ATCC, Manassas, VA) were grown on uncoated or 
laminin-coated dishes, as described previously (Bruneau et al., 2005b; Bruneau and 
Akaabourne, 2007). Cells were transfected at 70-100% confluence with 1 μg of rapsyn-
GFP using FUGENE6 transfection reagent (Roche, Basel, Switzerland) and differentiated 
the next day. Cells were imaged 3-4 days after differentiation. Mouse primary myotubes 
were grown in 20% FBS, differentiated in 10% FBS/10% HS and imaged 1 week later. 
Live cell imaging. Primary mouse muscle cells or C2C12 myotubes were incubated for 
1.5 h in 5 μg/ml of fluorescent bungarotoxin (bungarotoxin-Alexa 488, 555, 
tetramethyrhodamine, 594 or 647), or in bungarotoxin conjugated to biotin (1.5 h, 5 
μg/ml) followed by streptavidin-Alexa 488 or 594 (1.5 h, 10 μg/ml). Since anti-AChR 
(mAb35) antibody is too large to label AChRs that are induced to cluster by laminin 
(clusters form between the laminin and muscle membrane), non-laminin dishes plated 
with C2C12 myotubes were labeled with anti-AChR (2.5 hours) followed by anti-rat-
Alexa 594 secondary antibody (2.5 hours). This effectively labeled clustered AChRs that 
were not between the muscle membrane and dish surface. After labeling, cells were 
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washed and then imaged under an upright epifluorescent or scanning confocal 
microscope. Each laser-illumination experiment was performed at least once in the 
presence of unlabeled bungarotoxin to ensure that photo-unbinding was controlled for. 
After initial images were taken, the fluorescence was removed from individual clusters 
either with an 8 mW Argon laser (488 nm) mounted to the epifluorescent microscope 
(laser beam was passed through a neutral density filter and focused to a < 5 μm spot, with 
a beam power of 2 mW at the specimen plane, as measured by a laser power meter 
(Lasercheck, Edmond Optics, Barrington, NJ)), or a diode-pumped solid state (DPSS) 
scanning laser (561 nm) on a confocal microscope (imaged at 400 Hz and 1024x1024 
resolution, < 2 mW at specimen plane). From 6 - 20 hours after laser illumination, cells 
were labeled again with either the same fluorescent bungarotoxin, or bungarotoxin 
conjugated to a distinct fluorescent ligand.  
To assay  the effect of temporary membrane damage on AChR dissipation from 
clusters, FM1-43 (25 nM) was added to cultures prior to imaging and images were taken 
every minute after laser illumination for ~ 10 minutes (Bansal et al., 2003). 
For time-lapse imaging of rapsyn-GFP, myotubes were transfected with rapsyn-
GFP and then AChRs were labeled with bungarotoxin-Alexa 594 (1.5 h, 5 μg/ml). 
Individual clusters were then exposed to either the confocal Argon laser bleach the 
rapsyn-GFP, or to the DPSS to illuminate the Alexa 594. Images were then taken every 
hour after the addition of new doses of bungarotoxin-Alexa 594. After 6 hours the cells 
were fixed and labeled with anti-AChR antibody. 
Immunofluorescence. Myotubes were fixed at various times after laser exposure with 
2% paraformaldehyde and then treated for 20 minutes with 1% triton X-100 and 10% 
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bovine serum albumin in phosphate buffered solution. Cells were then incubated with 
mouse anti-rapsyn (mAb 1234, Sigma, St. Louis, MO), mouse anti-β-dystroglycan or 
mouse anti-utrophin (MANDAG2 clone 7D11 and MANCHO3 clone 8A4, 
Developmental Studies Hybridoma Bank, Iowa City, IA) primary antibody overnight and 
goat anti-mouse-Alexa594 or 488 secondary antibodies (Invitrogen Molecular Probes, 
Eugene, OR), as well as rat anti-receptor primary (mAb 35, Developmental Studies 
Hybridoma Bank) and anti-rat-Alexa647 secondary (Invitrogen Molecular Probes) 
antibodies. For experiments in which phalloidin-FITC was used, the phalloidin-FITC (1 
μg/ml, 15 minutes) was added after antibody labeling. Cells were then imaged either with 
a 20x UAPO 0.7 NA objective (Olympus BW51, Optical Analysis Corporation, NH) of 
an upright fluorescent microscope using a digital CCD camera (Retiga EXi, Burnaby, 
BC, Canada), or with a 40x immersion objective on a scanning confocal microscope 
(TCS SP5, Leica Microsystems, Wetzlar, Germany). For quantitative 
immunofluorescence determination, the background fluorescence from images was 
approximated by selecting a boundary region around the cluster and subtracting it from 
the original image; the mean total fluorescence intensity (which corresponds to density) 
was then measured, as previously described (Turney et al., 1996; Akaaboune et al., 
1999). The mean fluorescence from the bleached cluster was compared to the mean 
fluorescence of at least one of the closest neighboring, unbleached clusters. Image 
analysis was performed using a procedure written for Matlab (The Mathworks, Natick, 




Characterization of photo-dissipation of AChRs from individual clusters 
Evidence for laser-induced AChR dissipation was obtained from the following 
experiments: AChRs on primary mouse myotubes (Supplementary Fig. S5.1) or on 
C2C12 myotubes cultured on plastic or laminin-coated plates were saturated with 
bungarotoxin-Alexa 594 (BTX-594), and entire clusters or small regions of individual 
clusters were bleached either with an Argon (488 nm) laser mounted to an upright 
epifluorescent microscope or with a DPSS (561 nm) scanning laser on a confocal 
microscope. When the cells were imaged 6 hours later (or 20 hours later, see 
Supplementary Figure S5.2), we were surprised to find that there was neither recovery of 
fluorescence at bleached clusters from laterally migrating BTX-594 labeled receptors, nor 
any new receptor labeling above background (after the addition of a distinctly colored 
fluorescent BTX conjugate), even if not all of the fluorescence was removed (Figure 
5.1A, arrowheads) (see also Supplementary Figure S3). At the same time, the 
accumulation of receptors occurred normally at neighboring unbleached clusters (Figure 
5.1A). Further, when only small regions within BTX-594 labeled receptor clusters were 
illuminated with a focused laser, only background AChR staining was observed at the 
bleached region after the addition of the same or distinctly colored fluorescent BTX (see 
arrowheads, Figure 5.1B), while the accumulation of newly synthesized receptors at 
neighboring, unbleached clusters and unbleached regions within the illuminated cluster 
were completely unaffected (Figures 5.1A and B). The same effect was observed when 
AChRs were labeled with bungarotoxin conjugated to biotin (BTX-biotin) and 
streptavidin-Alexa-594 (strept-594) (Figure 5.1C), while AChRs labeled with anti-AChR 
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antibody (mAb35) and secondary antibody conjugated to Alexa 594 were not disrupted 
by laser illumination (Figure 5.1D). This indicates that the distance between Alexa 594 
and the AChR may be crucial to Alexa 594-mediated AChR dissociation. Finally, 
dissipation of BTX-594 labeled receptors also occurred on clusters that had been treated 
with c-terminal agrin (data not shown), indicating that the dissipation of AChRs can 
occur even in the presence of a neural clustering factor. 
To test whether the removal of AChRs was specific to the Alexa 594 fluorophore, 
cultured C2C12 myotubes were labeled with BTX-488 or BTX-555 and receptor clusters 
were imaged and then laser illuminated for long enough to bleach all the fluorescence 
from individual clusters (~ 3 seconds per cluster). Six hours after original bleaching we 
found that the recovery of original fluorescence from the lateral migration of surface 
receptors, and the accumulation of new receptors that were subsequently labeled with a 
distinct BTX conjugate, were both readily apparent around the circumference of the 
bleached clusters, as previously reported (Bruneau et al., 2005b) (Figures 5.1E and F) (it 
should be noted that continued exposure of BTX-488 or BTX-555 labeled clusters to 
high-intensity laser light for >60 seconds sometimes resulted in partial disruption of the 
cluster). Similarly, receptor accumulation at bleached sites was normal if receptors were 




Figure 5.1. Alexa 594-mediated dissipation of illuminated AChR clusters on cultured myotubes. 
C2C12 myotubes were incubated in fluorescent bungarotoxin-Alexa 488, 555 or 594 or bungarotoxin-
biotin/streptavidin-Alexa 594, and individual labeled clusters on the myotube surface were imaged and 
then illuminated with an Argon laser (488 nm). Six hours later, the cells were incubated in 
bungarotoxin-Alexa 647 (BTX-647) or BTX-594 and then imaged again to identify newly synthesized 
receptors inserted over this time. (A) Example of a myotube labeled with BTX-594 in which 3 clusters 
were illuminated for various times to cause different amounts of bleaching (arrowheads). Six hours 
later, after the addition of BTX-647, no originally labeled or newly inserted receptors had accumulated 
at any of the illuminated cluster sites, while high density accumulation at unbleached control clusters 
was normal. (B) Small regions within AChR clusters on myotubes labeled with BTX-594 were 
illuminated and then re-labeled 6 hours later with new BTX-594. Note that the accumulation of newly 
synthesized AChRs was only prevented at the illuminated spots, indicating that the disruption of AChR 
clustering following laser illumination is a local effect. (C) The accumulation of newly synthesized 
receptors was also prevented when AChR clusters labeled with bungarotoxin-biotin/streptavidin-Alexa 
594 were illuminated. Note that the direct internalization and accumulation of streptavidin-Alexa 594 in 
intracellular puncta after labeling dramatically increases intracellular fluorescence. (D) When AChRs 
on living myotubes were labeled with anti-AChR antibody and secondary antibody conjugated to Alexa 
594, bleached, and then labeled 6 hours later with BTX-647, we found that AChRs were inserted 
normally. (E and F) Examples of myotubes that were labeled with bungarotoxin-Alexa 488 or 555 and 
then illuminated with the same Argon laser used above. Six hours after laser exposure the illuminated 
clusters had recovered significant amounts of fluorescence around the periphery of the cluster (as 
previously reported (Kummer et al., 2004; Bruneau et al., 2005b)) both from the lateral migration of 
originally labeled receptors, and the insertion of new receptors, indicating that laser illumination of 
BTX-488 or BTX-555 labeled AChRs did not noticeably alter AChR accumulation. Scale bar = 20 μm. 
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The dissipation of BTX-594 labeled AChRs from clusters was not due to laser 
damage of the muscle membrane (Supplemental Figure S5.4), however when an AChR 
antibody which does not compete for AChR binding with bungarotoxin was added 
immediately after AChR-BTX-594 illumination, the fluorescent intensity at bleached 
clusters was decreased to ~60% that of neighboring, unbleached clusters, implying that 
AChR dissipation might be mediated by a change in receptor conformation 
(Supplemental Figure S5.5). 
AChRs are required for the maintenance and accumulation of post-synaptic 
scaffolding proteins at individual clusters.  
To investigate whether receptors are necessary for the maintenance of the post-synaptic 
scaffold, we examined the localization of rapsyn, β-dystroglycan, utrophin and actin 
following laser illumination of BTX-594 labeled receptor clusters. We focused on these 
proteins because they have been shown to serve as a link between the AChR and the 
intracellular cytoskeleton (James et al., 1996; Sanes and Lichtman, 2001; Galkin et al., 
2002; Huebsch and Maimone, 2003; Dobbins et al., 2006). To do this, receptors on 
cultured myotubes were labeled with BTX-594 and then entire clusters or small regions 
within individual clusters were illuminated with the DPSS (561 nm) laser of a scanning 
confocal microscope. Six hours later, cells were fixed and immunostained with anti-
AChR (mAb35) antibody, and one of the following: anti-rapsyn, anti-β-dystroglycan, 
anti-utrophin, anti-actin (JLA20) (which we found to bind specifically to scaffold-
specific actin) or phalloidin-FITC (which has been shown previously to bind to 
cytoskeletal actin (Shepard et al., 2004)) (Supplementary Figure S5.6). We found that the 
removal of the BTX-594 labeled AChRs from the entire illuminated cluster or from a 
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small illuminated region within a cluster was accompanied by the disappearance of 
rapsyn, β-dystroglycan, utrophin and scaffold-specific actin from the same bleached sites 
(Figures 5.2A-D). The underlying cytoskeleton (labeled with phalloidin-FITC), however, 
was unaffected (Figure 5.2E). Illumination of BTX-488 labeled AChRs at individual 
clusters either with the Argon laser, or exposure of these clusters to the confocal DPSS 
laser for the same amounts of time that were used for BTX-594 mediated dissipation, had 
no effect on the migration of AChRs into bleached regions, or the accumulation of either 
AChRs or rapsyn at the cluster after 6 hours (Figure 5.2F). These data indicate that 
AChRs are required for the maintenance and accumulation of rapsyn, β-dystroglycan, 
utrophin and actin molecules at clusters in the muscle membrane. 
Figure 5.2. Laser illumination of bungarotoxin-Alexa 594 labeled clusters results in the complete 
dissipation of the AChR scaffold. Myotubes were labeled with bungarotoxin-Alexa 594 and then 
individual clusters (open bracket) and regions of individual clusters (arrowheads) were illuminated with 
a scanning confocal microscope using DPSS (561 nm) laser emission. Six hours later the myotubes 
were fixed and labeled with anti-AChR antibody and one of the following: anti-rapsyn (Rap), anti-β-
dystroglycan (DG), anti-utrophin (Utr), anti-actin (Act) or Phalloidin-FITC. (A-D) Since antibodies 
label both existing proteins and the proteins inserted during the 6 hour incubation, complete lack of 
staining from Rap, DG, Utr and Act at whole illuminated clusters or illuminated regions within clusters 
indicates that the elimination of AChRs results in the local dissipation of the intracellular scaffold, and 
also prevents the insertion of new scaffolding proteins. (E) The presence of normal phalloidin staining 
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Time-lapse imaging of intracellular scaffolding protein dissipation 
To examine the time-course of removal of labeled AChRs and AChR-scaffold proteins 
from illuminated clusters, we monitored AChR and associated scaffolding proteins at 
various time points after laser illumination. As an initial step, we examined the removal 
of rapsyn from illuminated clusters by transfecting myotubes with rapsyn-GFP and then 
labeling the AChRs on these cells with BTX-594. The GFP or the Alexa 594 from 
individual clusters was then excited using the Argon or DPSS lasers of a confocal 
microscope, respectively. In this way we were able to simultaneously follow rapsyn-GFP 
removal over time from clusters that were illuminated with the DPSS (561 nm) laser 
(which induced BTX-594-labeled AChRs to dissipate, but did not bleach the rapsyn-
GFP) and determine the insertion of rapsyn-GFP into clusters that were illuminated 
briefly with the Argon (488 nm) laser (which bleached the GFP but left labeled AChRs 
relatively unbleached) on the same myotube. At clusters where only AChR-Alexa 594 
was excited, time-lapse imaging revealed that rapsyn-GFP fluorescence decreased rapidly 
after only 1.5 hours, and was nearly undetectable after 3.5 hours. In contrast to visible 
internalized Alexa 594 puncta, no internal GFP signal was seen at these clusters. At the 
same time, insertion of rapsyn-GFP into clusters in which the GFP (and not the Alexa 
594) was bleached with the Argon laser was normal and similar to previous reports 
(Bruneau and Akaabourne, 2007) (Figure 5.3). These data indicate that net rapsyn 
dissipation (the combination of rapsyn removal and the prevention of new rapsyn 
after 6 hours at illuminated sites in which AChR clusters have been induced to dissipate indicates that 
the underlying cytoskeleton is unaffected by this laser illumination. Note that for (A-E) different levels 
of illumination/bleaching were able to induce complete dissipation. (F) Clusters labeled with 
bungarotoxin-Alexa 488 were also bleached with either the Argon (488 nm) or DPSS (561 nm) laser of 
the scanning confocal microscope and then fixed and labeled as above. Note that complete bleaching of 
the Alexa 488 with the Argon laser or exposure of the cluster to the DPSS laser (for the same amount of 
time used to dissociate clusters in (A-E)) did not result in receptor dissipation. Each confocal image was 
taken on a single plane on the muscle surface. Scale bars = 20 μm.
 139
insertion) occurs very rapidly from clusters following photo-dissipation of clustered 
AChRs.  
Figure 5.3. Time-lapse imaging of rapsyn-GFP following laser-induced AChR dissipation. 
Myotubes were transfected with rapsyn-GFP and labeled with bungarotoxin-Alexa 594. Individual 
clusters were imaged and then illuminated either with a brief exposure to the Argon (488 nm) laser to 
bleach the GFP fluorescence (green arrowheads) or more prolonged exposure to the DPSS (561 nm) 
laser to excite Alexa 594 fluorescence (red arrowheads). The same clusters were then imaged from 0 to 
3.5 hours later after fresh applications of new bungarotoxin-Alexa 594 between imaging time points. 
Cells were then fixed and labeled with anti-AChR antibody after 6 hours. At clusters in which only 
rapsyn-GFP was bleached (green arrowhead), rapsyn-GFP fluorescence rapidly recovered, and 
fluorescence had nearly reached original levels when cells were fixed 6 hours later. At clusters in which 
the Alexa 594 fluorescence was illuminated and AChRs were therefore induced to dissociate (red 
arrowheads), rapsyn-GFP fluorescence rapidly decreased over time as rapsyn dissipated from the 
bleached cluster, and rapsyn-GFP was completely absent from the cluster site after cells were fixed at 6 
hours. The absence of anti-AChR staining at 6 hours indicates that complete cluster dissipation had 
occurred. Each confocal image was taken on a single plane of the muscle surface. Scale bar = 20 μm. 
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 To confirm the above results and extend them to the other scaffolding proteins, 
BTX-594 labeled receptor clusters were illuminated, fixed 1 hour later and then 
immunostained with anti-rapsyn, anti-utrophin, anti-β-dystroglycan or anti-actin (JLA20) 
antibodies. We found that rapsyn, utrophin, β-dystroglycan and actin 
immunofluorescence at bleached clusters had all decreased after only 1 hour to nearly 
half the amount at neighboring, unbleached control clusters (48 ± 13%, n=7; 53 ± 6%, 
n=6; 51 ± 10%, n=19; and 51 ± 8%, n=13, respectively) (Figures 5.4A and B). When 
cells were fixed immediately after bleaching, negligible changes in antibody binding for 
scaffolding components were seen (see supplementary Figure S5.5 and data not shown). 
When cells were fixed 2 hours after illumination, bright intracellular puncta made 
quantification difficult, and at time points after 2 hours the immunofluorescence from all 
antibodies was too dim to quantify; immunofluorescence was completely absent at 




Figure 5.4. Rapsyn, β-dystroglycan, utrophin and actin are all removed at similar rates from 
illuminated clusters. Myotube cultures were labeled with bungarotoxin-Alexa 594 and imaged, and 
then individual clusters were illuminated with an Argon (488 nm) laser. One hour later the cells were 
fixed, immunostained with antibodies for rapsyn, β-dystroglycan, utrophin and actin, and imaged again. 
The average immunofluorescence from each bleached cluster was then compared to the average 
immunofluorescence at a neighboring, unbleached control cluster. (A) Representative images from 
individual myotubes show that after 1 hour, approximately half of the population of each scaffolding 
protein at bleached clusters had been removed. (B) Graph represents the quantification of 
immunofluorescence from all antibodies 1 hour after illumination. Note that the immunofluorescence 
from each protein decreased similarly. All data represented as mean ± SD. Scale bar = 20 μm. 
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Discussion 
This work demonstrates that low-power laser illumination of the Alexa 594 
fluorophore conjugated to bungarotoxin not only causes the removal of the AChRs and 
simultaneous or subsequent loss of scaffold proteins from illuminated regions, but also 
prevents the accumulation of new synaptic proteins at that region. This phenomenon is 
spatially restricted to the illuminated region, leaving unbleached regions of the same 
cluster unaffected.  
The effect observed here is similar to chromaphore-assisted light inactivation 
(CALI) in which illumination of a specific protein/fluorophore pair causes the 
inactivation of the labeled protein. CALI has been shown to result from the generation of 
free radicals which alter proteins only within a very close proximity (less than 100 Å) 
(Beck et al., 2002; Marek and Davis, 2002). Consistent with this, we found that the Alexa 
594 mediated dissipation only occurred if the fluorophore was relatively close to the 
AChR (separated by BTX or BTX-biotin-streptavidin), but not if the fluorophore was 
conjugated to a secondary antibody. Further, even if the laser light was intense enough to 
temporarily damage the muscle membrane, it still did not alter AChR clustering in 
regions immediately adjacent to the illuminated region. 
Although it is not clear how illumination of the Alexa 594 fluorophore is able to 
induce the dissipation of clustered receptors, it is possible that the absorption of photons 
by the fluorophore could cause structural modification of the AChR (as suggested by 
Supplementary Figure S5.5). While it is possible that the illuminated and structurally 
modified AChRs remain stuck in the membrane, our data are more consistent with a 
model in which subsequent un-tethering of affected AChRs from the cluster site could 
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then lead to an AChR density below a critical level necessary to signal the accumulation 
of AChRs, which would lead to the dispersal of all clustered AChRs at the illuminated 
region, and the prevention of newly synthesized AChR accumulation. Whatever the 
mechanism by which laser illumination causes Alexa 594-labeled AChR dissipation, we 
used this as a tool to directly investigate the role of the AChR in the maintenance and 
integrity of the intracellular scaffold. When receptors were induced to disperse, all other 
proteins of the scaffold examined were also removed from the cluster, and newly 
synthesized proteins were not accumulated at the illuminated region. Consistent with this 
observation, rapsyn fails to cluster in AChR-deficient muscles in zebrafish (Ono et al., 
2001; Ono et al., 2004) and in C2C12 myotubes lacking AChRs (Marangi et al., 2001), 
and mice lacking the adult epsilon AChR subunit fail to form mature synapses and show 
marked decreases in scaffolding proteins (Missias et al., 1997).  
One concern with all laser illumination studies is that the laser may be causing 
non-specific cell damage. The following data indicate that this is likely not the case in the 
present study: First, although laser illumination caused AChR dissipation it did not result 
in muscle membrane damage (Supplemental Figure S5.3); second, at clusters that were 
induced to dissipate, the intracellular actin cytoskeleton was not altered after laser 
illumination (Figure 3E); third, AChRs that were within microns of the laser illumination 
(even extensive illumination that temporarily damaged the muscle membrane) were not 
affected; fourth, exposing rapsyn-GFP to high laser power for prolonged time did not 
disrupt rapsyn insertion; fifth, illumination of BTX-488 labeled AChRs with the Argon or 
DPSS scanning confocal laser using the same parameters that caused dissipation of BTX-
594 labeled AChRs did not alter AChR clustering or rapsyn localization (Figure 5.3F); 
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finally, 6 hours after laser exposure the background fluorescence from new fluorescent 
BTX at illuminated regions was similar to staining from diffuse AChRs elsewhere on the 
muscle surface (Figure 5.1, S5.1 and S5.2), and even non-labeled AChRs within 
illuminated regions were dissipated following laser illumination (Figure S5.3), indicating 
that receptors were able to move freely into and out of the laser-illuminated membrane. 
These observations suggest that laser illumination caused the selective dissociation of 
clustered receptors, which in turn resulted in the local disassembly of the intracellular 
scaffold without disrupting either the intracellular cytoskeleton or membrane integrity or 
fluidity. 
Here we show directly that AChRs are not only necessary for the clustering of 
rapsyn in mammalian myotubes, but that a threshold density of AChRs likely provides a 
critical signal which enables proteins of the dystrophin-glycoprotein complex and 
intracellular scaffold to remain aggregated and which allows the accumulation of newly 
synthesized proteins into the existing cluster. The fact that Alexa 594-mediated 
dissipation occurs only within small illuminated sections of individual clusters further 
implies that the high density of AChRs provide a local clustering signal. Together these 
data indicate that the post-synaptic scaffold may be organized not as a matrix of cross-
linked proteins, but as discrete units of intracellular scaffolding proteins associated with 
individual receptors (Supplemental Figure S5.7). Consistent with this model, local 
removal of clustered AChRs and scaffold proteins has been observed during synaptic re-
modeling during development or after nerve damage (Culican et al., 1998; Sanes and 
Lichtman, 2001). It will be interesting to see if AChR dissipation is responsible for 

















Figure S5.1. Bungarotoxin-Alexa 594 induced dissipation of AChRs from clusters on primary 
mouse myotubes. Primary muscle cells were plated on mitrigel and labeled after differentiation with 
bungarotoxin-Alexa 594. (A, B) Shown is a single fiber on which one cluster was laser illuminated 
(arrowhead). (C-E) Six hours later cells were fixed and labeled with a distinct fluorescent bungarotoxin 
conjugate to identify all new receptors inserted over this time, and anti-AChR antibody to label all 
AChRs. Note that the dissipation of AChRs and prevention of new receptor insertion occurred only at 







Figure S5.2. Cluster dissipation persists over time. (A) C2C12 myotubes were incubated with 
bungarotoxin-Alexa 594 and individual clusters or regions of clusters were imaged. (B) Individual 
clusters (arrows) or small regions within clusters (arrowheads) were then laser illuminated and re-
imaged. (C, D) Twenty hours later the myotubes were incubated with a distinct fluorescently tagged 
bungarotoxin-Alexa 488 to label receptors that had been inserted into the membrane after initial 
labeling. Note that after 20 hours most of the original fluorescence (red) was eliminated from all 
clusters (C), and that although background labeling of diffuse AChRs was present at illuminated 
regions, high intensity fluorescence from the accumulation of newly inserted AChRs (green) was absent 
only from the regions that were illuminated (D), indicating that the accumulation of newly synthesized 










Figure S5.3. Bleaching of unsaturated clusters causes complete AChR cluster dissipation. C2C12 
myotubes were incubated for variable periods of time with bungarotoxin-Alexa 594 to label only a 
proportion of the AChRs at individual clusters. (A) Images show clusters that were labeled with a sub-
saturating dose of bungarotoxin-Alexa 594 (BTX-594 incubation between 2 and 15 minutes) and then 
bleached (arrowheads). After 6 hours, a saturating dose of bungarotoxin was then applied (1.5 hours) 
and the fluorescence of unbleached control clusters at 6 hours was compared to their fluorescence at 0 
hours to determine the amount of original saturation (red boxed clusters). Percent of saturation at 
original labeling is indicated at the left. (B) Graph summarizes data from a number of clusters imaged 
as in (A). Note that for clusters in which fewer than 50% of AChRs were labeled prior to bleaching, 
complete cluster dissipation was not observed in any of the 20 clusters examined. If 50-75% of AChRs 
were labeled prior to bleaching, 2 of the 7 clusters examined were completely dissipated 6 hours after 
laser illumination. Labeling of greater than 75% of AChRs resulted in the complete dissipation not only 
of labeled and illuminated AChRs, but of all non-labeled AChRs in the illuminated region (n > 200). 
Scale bar = 20 μm. 
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Figure S5.4. Temporary muscle membrane damage is not responsible for AChR cluster 
dissipation. FM1-43 is a lipid soluble dye that does not fluoresce unless incorporated into newly 
forming membranes. This dye has been used previously to label endo-membrane following temporary 
muscle membrane damage in response to high intensity laser light (Miyake et al., 2001; Bansal et al., 
2003). In muscle fibers, FM1-43 fluorescence stabilizes after minutes due to surface membrane 
resealing, but persists in membranes that are deficient in components necessary for membrane recovery. 
To determine if laser illumination necessary to induce AChR dissipation was causing temporary muscle 
membrane damage, C2C12 myotube clusters were labeled with BTX-594 and incubated with FM1-43. 
In the presence of FM1-43, individual clusters or regions of clusters were illuminated with a DPSS (561 
nm) laser of a scanning confocal microscope and then membrane damage was assessed with the FM1-
43 assay described above. Shown here is a myotube in which temporary muscle membrane damage was 
intentionally initiated with prolonged focal laser exposure (arrowhead), as indicted by FM1-43 labeling. 
Other clusters on the same cell were exposed to the laser briefly enough to avoid membrane damage 
(open brackets), as indicated by the absence of FM1-43 labeling. Six hours later cells were fixed, 
labeled with anti-AChR antibodies and imaged with confocal microscopy. Note that the dissipation of 
bleached and unbleached AChRs and the lack of accumulation of newly synthesized AChRs at all 
illuminated regions were not due to temporary muscle membrane damage. Each confocal image was 
taken on a single plane on the muscle surface, and image brightness was adjusted using Adobe 




Figure S5.5. Exposure of bungarotoxin-Alexa 594 labeled AChRs to laser illumination decreases 
anti-receptor antibody binding. (A) C2C12 myotubes were incubated with bungarotoxin-Alexa 594 
and imaged. Individual clusters were then laser illuminated immediately after fixation in 2% 
paraformaldehyde (see arrowheads), and the muscle culture was immunostained with anti-AChR 
(mAb35) and anti-rapsyn antibodies. Quantitative immunofluorescence indicated that anti-AChR 
binding was significantly compromised in the laser illuminated cluster compared to neighboring, 
unbleached control clusters, while anti-rapsyn staining was normal. Similar results were obtained if the 
cells were instead fixed prior to laser illumination. Data from a number of experiments performed as 
above showed that labeling at bleached clusters was decreased to 58 ± 11% (S.D., n=85) of unbleached 
control clusters when bleached immediately prior to fixation, and 61 ± 13% (S.D., n=17) when bleached 
immediately after fixation. (B) C2C12 myotubes were transfected with a rapsyn-GFP fusion protein, 
and clusters expressing rapsyn-GFP were imaged. The GFP fluorescence from individual clusters was 
then laser illuminated, and cells were fixed and immunostained with anti-rapsyn antibodies. Note that 
anti-rapsyn immunofluorescence was unaffected by GFP illumination. Together these data indicate that 
the laser illumination of fluorescent Alexa 594 is able to alter antibody binding to AChRs, while 
illumination of fluorescent GFP has no effect on antibody binding to rapsyn. It is possible that the 
decrease in anti-AChR binding could be due to structural modification of the AChR induced by the 






Figure S5.6. JLA20 and Phalloidin label distinct actin populations on C2C12 muscle cells in vitro 
and sternomastoid muscle fibers in vivo. Muscle cells were labeled with anti-AChR antibody, anti-
actin antibody (JLA20) and FITC-phalloidin and then imaged with a scanning confocal microscope. (A) 
Top panels represent collapsed confocal images of a sternomastoid muscle that was fixed in the animal, 
sectioned longitudinally and then immunostained and imaged. Note that JLA20 immunostaining co-
localizes with AChRs specifically at the neuromuscular junction and is absent from the intracellular 
cytoskeleton, while phalloidin labels the actin filaments of the cytoskeleton and is absent from the 
neuromuscular junction.  (B) Bottom panels show collapsed confocal images of a C2C12 myotube 
immunostained as described above. Similar to the neuromuscular junction in the top panels, JLA20 
labeling was restricted to AChR clusters while phalloidin labeled the actin fibers of the intracellular 
cytoskeleton. The switch of cytoskeletal actin orientation in the muscle fiber from parallel to 
perpendicular represents a normal developmental transition between immature and mature muscle 











Figure S5.7. A model for the modular organization of AChRs and proteins of the post-synaptic 
scaffold. In this simplified model, each AChR is linked separately to proteins of the dystrophin-
glycoprotein complex through their interaction with rapsyn. Each AChR could then be removed as a 
unit along with the individual scaffolding proteins associated with it. In this model, local AChR density 
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Abstract 
Rapsyn, a cytoplasmic receptor-associated protein, is required for the clustering of 
acetylcholine receptors (AChRs). While AChR dynamics have been extensively studied, 
little is known about the dynamics of rapsyn. Here, we used a rapsyn-GFP fusion protein 
and quantitative fluorescent imaging to study the dynamics of rapsyn in transfected 
C2C12 myotubes. First, we found that rapsyn-GFP expression at clusters did not alter 
AChR aggregation, function or turnover. Quantification of rapsyn immuno-fluorescence 
indicated that the expression of rapsyn-GFP proteins at clusters does not increase the 
overall rapsyn density compared to untransfected myotube clusters. Using time-lapse 
imaging and fluorescence recovery after photobleaching, we demonstrated that the 
recovery of rapsyn-GFP fluorescence at clusters was very fast, with a halftime of about ~ 
1.5 h (~ 3 times faster than AChRs). Inhibition of protein kinase C (PKC) significantly 
altered receptor insertion, but it had no effect on rapsyn insertion. When cells were 
treated with the broad-spectrum kinase inhibitor staurosporine, receptor insertion was 
decreased even further. However, inhibition of protein kinase A (PKA) had no effect on 
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insertion of either rapsyn or receptors. Finally, when cells were treated with neural agrin, 
rapsyn and AChRs were both directed away from pre-existing clusters and accumulated 
together in new small clusters. These results demonstrate the remarkable dynamism of 
rapsyn, which may underlie the stability and maintenance of the post-synaptic scaffold 
and suggest that the insertion of different postsynaptic proteins may be operating 
independently.   
Introduction 
The efficacy of synaptic transmission depends upon the high density and number 
of postsynaptic neurotransmitter receptors at sites of neurotransmitter release (Sanes and 
Lichtman, 2001; Carroll and Zukin, 2002). This density can be maintained in several 
ways. For example, phosphorylation/dephosphorylation events mediated by different 
kinases are able to alter receptor synthesis and dynamics (Si et al., 1998; Sanes and 
Lichtman, 2001; Sadasivam et al., 2005; Wang et al., 2005), and a number of 
postsynaptic scaffolding proteins have been found to be essential either for the clustering 
or the maintenance of postsynaptic receptors at cluster sites at both central and peripheral 
synapses (Feng et al., 1998b; Sanes and Lichtman, 2001; Akaaboune et al., 2002; Grady 
et al., 2003; Henley, 2003; Kim and Sheng, 2004; Bruneau and Akaaboune, 2006b).   
The formation of the postsynaptic receptor density is best studied at the 
neuromuscular junction (NMJ). Among the molecules involved in the clustering of 
AChRs is rapsyn. Rapsyn (43 kD) was initially purified from the torpedo electric organ 
and is thought to be associated with AChRs in a 1:1 stoichiometry at the muscle surface 
(Frail et al., 1988; Noakes et al., 1993). Rapsyn is responsible for mediating the effect of 
agrin, a neuronal clustering factor that activates the muscle-specific kinase (MuSK) and 
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initiates AChR clustering in a tyrosine kinase-dependent manner (Apel et al., 1997; 
Fuhrer et al., 1999; Mohamed and Swope, 1999; Mittaud et al., 2001; Mohamed et al., 
2001). In mice lacking rapsyn, receptor clustering does not occur and NMJs fail to form 
(Gautam et al., 1995). Rapsyn mutations also cause AChR deficiency in patients with 
congenital myasthenia syndrome (McConville and Vincent, 2002; Ohno et al., 2002; 
Muller et al., 2006), highlighting the importance of rapsyn for the formation and 
organization of the post-synaptic receptor density. While the availability of highly 
specific receptor ligands has enabled the study of AChR dynamics on the living muscle in 
vitro and in vivo (Akaaboune et al., 1999; Bruneau et al., 2005b), study of scaffolding 
protein dynamics at the post-synaptic density has been hindered by their inaccessibility to 
extracellular ligands.  
In this study, we investigated the dynamics of rapsyn at individual clusters on 
cultured myotubes. Our interest specifically in rapsyn stems from its close association 
with AChRs and its role in receptor clustering at the post-synaptic membrane. By 
monitoring the fluorescence of rapsyn-GFP fusion proteins clustered on the surface of 
transfected C2C12 myotubes, we were able to determine that rapsyn is markedly more 
dynamic than AChRs and is not affected by pharmacological manipulation that alters 
AChR dynamics, even though both rapsyn and AChRs are similarly modulated by the 
nerve clustering factor, agrin.  
Materials and Methods 
GFP fusion construct. The rapsyn-GFP fusion construct was kindly provided by Dr. 
Jonathan Cohen (Harvard Medical School).  
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Cell culture. To generate laminin-coated dishes, 5 μg/mL of poly-ornithine (Sigma, St 
Louis, MO) was added to 35 mm culture dishes and allowed to evaporate overnight. The 
following day 10 μg/mL of EHS Laminin (Invitrogen, CA) in L-15 media supplemented 
with 0.2% sodium bicarbonate was added to the dishes, and they were placed in an 
incubator overnight until ready for plating. C2C12 myoblasts (ATCC, Manassas, VA) 
were plated and then grown in 20% fetal bovine serum with penicillin and streptomycin 
in DMEM. Cells were transfected at 70-100% confluence with 1 μg of rapsyn-GFP using 
FUGENE6 transfection reagent (Roche, Basel, Switzerland). Cells were then 
differentiated by replacing the FBS solution with 5% horse serum media with penicillin 
and streptomycin in DMEM. Media was changed every 2 days and cells were imaged 3-4 
days after differentiation.  
Immuno-fluorescence microscopy. Transfected myotubes were fixed with 2% 
paraformaldehyde and then treated for 20 minutes with 1% triton X-100 in phosphate 
buffered solution. Cells were then incubated with mouse anti-rapsyn primary (mAb 1234, 
Sigma, St. Louis, MO) and goat anti-mouse-Alexa 594 secondary antibodies (Invitrogen 
Molecular Probes, Eugene, OR). After extensive washing, cells were imaged. 
Background fluorescence was approximated by selecting a boundary region around the 
cluster and subtracting it from the original image, and the mean of the total fluorescence 
intensity (which corresponds to density) was measured. Image analysis was performed by 
using a procedure written for Matlab (The Mathworks, Natick, MA) (Martinez-Pena y 
Valenzuela et al., 2005). The acquisition and quantification of images were done with the 
experimenter blind to rapsyn-GFP expression at each cluster.  
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Electrophysiology. A rapsyn-GFP transfected myotube was located and a whole cell 
patch clamp recording was obtained under voltage-clamp. The AChR agonist carbachol 
(100 μM) was then ejected into the media with a puffer pipette placed near the patched 
cell and the resulting inward current was measured. As a control for the specificity of 
carbachol, the AChR antagonist curare (10 μM) was applied by perfusion into the cell 
media to block these inward currents. Measurements were made as above on 
untransfected myotubes for comparison. 
Receptor loss. AChR loss was determined by labeling AChRs of untransfected myotubes 
or myotubes expressing rapsyn-GFP with bungarotoxin-Alexa 594 (5 μg/ml, 1 h). Initial 
images of rapsyn-GFP and/or clustered receptors were taken, and 4 hours later the same 
clusters were found and re-imaged. The loss of fluorescence was then assayed using 
quantitative fluorescence imaging (Turney et al., 1996; Akaaboune et al., 1999). Clusters 
expressing different levels of GFP were then grouped into three categories according to 
mean GFP expression: low (0-25th percentile of mean fluorescence), medium (26th-49th 
percentile) and high (50-100th percentile). 
Fluorescent recovery after photobleaching. To determine the insertion of rapsyn into 
receptor clusters over time, the green fluorescence at individual rapsyn-GFP expressing 
clusters was removed by illuminating the cluster with an Argon laser passed through a 
neutral density filter that blocked 50% of the light. Laser illumination of myotube clusters 
has been shown previously not to affect receptor dynamics or muscle cell integrity 
(Akaaboune et al., 2002; Bruneau et al., 2005b). The recovery of fluorescence was 
assayed and the amount of fluorescence recovered at each cluster was measured. 
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 To determine the insertion of AChRs into clusters over time, receptors on 
untransfected myotubes were saturated with bungarotoxin-Alexa 488 (BTX-488) 
(5μg/ml, 1 h) (Molecular Probes, Eugene, OR) and the green fluorescence was 
completely removed with an Argon laser. Since newly synthesized receptors inserted into 
the cluster over time were unlabeled, BTX-488 was then added before each time point to 
label these receptors, excess BTX-488 was washed away, and the clusters were again 
imaged (as described by Bruneau et al, 2005). In this way the total insertion of receptors 
(both previously labeled receptors that had laterally migrated into the cluster, and the 
newly labeled receptors that had been inserted into the cluster) could be determined and 
compared to the insertion + lateral migration of rapsyn-GFP. For the purposes of this 
paper, “insertion” will refer to the accumulation of proteins at clusters both through direct 
incorporation from intracellular locations and from the lateral migration of surface-
associated proteins. 
Agrin Treatment. To determine the effect of agrin on rapsyn-GFP expression at clusters, 
myotubes grown on laminin-coated dishes transfected with rapsyn-GFP were incubated 
with BTX-594 to label all AChRs. After initial images were taken, 100 ng/ml of C-
terminal agrin (R & D Systems, Minneapolis, MN) was added to the culture dish. At 4 
and 8 hours, images were taken to determine the location of rapsyn-GFP and AChRs. 
Kinase Inhibition. To determine the effect of various kinase inhibitors on rapsyn-GFP 
insertion over time, the GFP signal from clusters on myotubes transfected with rapsyn-
GFP was carefully removed with an Argon laser and one of the following drugs was 
added to the media: 100 nM H-89 (to block PKA), 20 μM H-89 (to inhibit both PKA and 
PKC), 10 nM Calphostin C (to inhibit PKC) or 20 nM staurosporine (to block a broad 
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spectrum of kinases, including PKA and PKC) (drug specificity obtained from the 
manufacturer: Sigma, St. Louis, MO). Images were taken immediately before and after 
photobleaching, and 4 hours later the same clusters were re-imaged, and the fluorescent 
intensity at bleached and non-bleached clusters was determined. Rapsyn-GFP recovery 
was determined by comparing the GFP signal at bleached clusters after 4 hours to their 
fluorescence immediately prior to bleaching. Since the expression of rapsyn-GFP was 
variable over time and between different myotubes in these experiments, rapsyn-GFP 
insertion at each cluster was normalized to the changes in expression (if any) at control, 
unbleached clusters on the same myotube. Overall changes in expression in each culture 
dish were comparable across all treatment groups. 
 We also performed a series of experiments to determine the loss and insertion of 
receptors at individual clusters in the presence of the same pharmacological agents. To 
measure the insertion rate of receptors, untransfected myotubes were saturated with BTX-
488 (5 μg/ml, 1 h) and the fluorescence was carefully removed from individual clusters 
with an Argon laser. Initial images were taken, and one of the above kinase inhibitors 
was added to the cultures. Four hours later, after incubating with new BTX-488 to label 
new receptors inserted since initial imaging, the same clusters were found and imaged. 
The insertion of AChRs was determined by comparing cluster fluorescence at 4 hours to 
the original fluorescence prior to bleaching.  
 To measure the loss rate of receptors, untransfected myotubes were saturated with 
BTX-488 (5 μg/ml, 1 h) and individual clusters were immediately imaged and incubated 
with one of the above mentioned inhibitors. The same clusters were then re-imaged 4 
hours later and their fluorescence intensity was measured. 
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Results 
Rapsyn-GFP does not affect acetylcholine receptor clustering, function or removal 
rate. 
First, in order to verify that rapsyn-GFP was able to localize to laminin-associated 
AChR clusters on our cultured myotubes, we transiently transfected C2C12 myoblasts 
with a rapsyn-GFP fusion protein (Ramarao and Cohen, 1998). Three to four days after 
differentiation into myotubes, cultured cells were bathed with bungarotoxin conjugated to 
Alexa 594 (BTX-594) to label AChRs and receptor clusters were imaged. Rapsyn-GFP 
clusters were found to always perfectly co-localize with AChRs (Figure 6.1A). 
We also wanted to determine if the insertion and accumulation of rapsyn-GFP at 
laminin-induced receptor clusters affected AChR function. To examine this question, we 
compared inward current across the muscle membrane in response to the application of 
the AChR agonist, carbachol, on myotubes expressing rapsyn-GFP and non-transfected 
myotubes. Under direct visual control we obtained a whole cell patch on a myotube, 
clamped voltage and stimulated with carbachol. We found that the inward currents were 
similar in both transfected and untransfected cells, and were both completely blocked by 
addition of the AChR antagonist curare (Figure 6.1B). These results indicate that the 
surface expression of rapsyn-GFP does not disrupt receptor function. 
Next, we asked whether the overall density of rapsyn molecules at clusters 
(endogenous rapsyn + exogenous rapsyn-GFP) was increased by rapsyn-GFP expression 
in transfected myotubes. To examine this, myotube cultures that were transfected with 
rapsyn-GFP were fixed and permeabilized, and then immuno-stained with an anti-rapsyn 
antibody. We used an anti-rapsyn antibody that has been shown previously to recognize 
both rapsyn and rapsyn-GFP fusion proteins (Gervasio and Phillips, 2005). Since 
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transfection efficiency of myotubes in each culture dish was variable, we were able to use 
the same culture dish to determine the relative number of rapsyn molecules at non-
transfected clusters and at rapsyn-GFP expressing clusters over a wide range of 
expression levels (Figure 6.1C). Quantitative analysis of the mean fluorescence intensity 
of anti-rapsyn immunostaining revealed that the average density of total rapsyn at rapsyn-
GFP expressing clusters was 12.5 ±3.2 SD. (arbitrary units), n=198. This is nearly 
identical to the density at clusters containing only endogenous rapsyn (11.8 ±3.2 SD, 
n=123) (Figure 6.1C-E). Even over a nearly 10 fold range of rapsyn-GFP expression at 
clusters, the difference in total rapsyn density was negligible (Figure 6.1E). It is possible 
that the number of rapsyn-GFP molecules at transfected clusters is negligible compared 
to the total number of endogenous rapsyn molecules. In this case the presence of 
exogenous rapsyn-GFP would not detectibly alter overall rapsyn density. Alternatively, it 
is possible that exogenous rapsyn-GFP replaces the endogenous rapsyn allowing overall 
rapsyn density at clusters to remain constant (see discussion). 
Finally, we wanted to determine whether rapsyn-GFP expression levels at clusters 
had any effect on AChR stability. To do this, transfected myotubes were saturated with 
BTX-594 and receptor loss was monitored at clusters expressing low, medium and high 
levels of rapsyn-GFP on two separate myotube cultures. After 4 hours, we found that 
65% ±15 SD, (n = 29) of fluorescently labeled AChRs remained at clusters expressing 
low rapsyn-GFP fluorescence, 60% ±13 SD, (n = 42) remained at clusters expressing 
medium rapsyn-GFP and 62% ±15 SD (n = 44) remained at clusters expressing high 
rapsyn-GFP. These results are similar to fluorescence remaining after 4 hours at AChR 
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clusters expressing no rapsyn-GFP (63% ±17 SD, n = 77) (Figure 6.2A-C). This indicates 
that rapsyn-GFP expression has no effect on AChR stability in our culture system. 
 
Figure 6.1. Rapsyn-GFP cluster expression does not alter AChR clustering, stability or activity.  
(A) Example of a myotube transfected with rapsyn-GFP and labeled with bungarotoxin-Alexa 594. 
Shown are representative clusters in which rapsyn-GFP perfectly co-localizes with acetylcholine 
receptors. Scale bar = 20 μm. (B) Untransfected myotubes and myotubes expressing rapsyn-GFP 
responded similarly to the application of the AChR agonist, carbachol, and this response was blocked 
after the addition of the AChR antagonist, curare, indicating that AChR function is not disrupted by 
rapsyn-GFP. (C) Example of myotubes expressing different levels of rapsyn-GFP at clusters that were 
labeled with anti-rapsyn antibodies and DAPI to stain nuclei. Images illustrate that overall rapsyn 
density is the same in rapsyn-GFP expressing clusters and in clusters that do not express rapsyn-GFP. 
Scale bar = 20 μm. (D) Histogram showing the mean fluorescence intensity of anti-rapsyn staining from 
many clusters of non-transfected myotubes and myotubes transfected with rapsyn-GFP. Note that the 
mean fluorescence is comparable in both transfected and untransfected myotube clusters. Histograms 
represent mean fluorescent intensity ±SD. (E) Quantification of rapsyn immuno-fluorescence and 
rapsyn-GFP for many clusters on transfected myotubes. As shown by the scatter plot, rapsyn-GFP 




Figure 6.2. The cluster expression of rapsyn-GFP has no effect on AChR removal. Non-transfected 
myotubes and myotubes transfected with rapsyn-GFP were labeled with BTX-Alexa 594 and the loss of 
AChR-BTX-594 was monitored over 4 hours. (A) Example of clustered AChRs on rapsyn-GFP 
transfected myotubes that were labeled with BTX-594, imaged, and imaged again 4 hours later to 
determine the receptor loss rate. (B) Clustered AChRs on untransfected myotubes were labeled as above 
and also followed over 4 hours. (C) Histogram summarizes data obtained from many clusters on 
transfected and untransfected myotubes. Note that the change in fluorescently labeled AChR levels 
monitored over 4 hours on untransfected myotubes and at myotube clusters expressing a wide range of 
rapsyn-GFP were not significantly different (p > 0.3). All values represent mean ±SD. 
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Recovery rate of rapsyn-GFP at individual myotube clusters. 
Having found that rapsyn-GFP has no effect on the clustering, function or 
turnover of AChRs, we wanted to determine the lifetime of rapsyn at individual clusters. 
To do this, transfected myotubes expressing rapsyn-GFP were imaged and then the GFP 
at individual clusters was removed with an Argon laser. Confirmation of the removal of 
fluorescence was done by acquiring a second image (Figure 3A). We then monitored the 
recovery of fluorescence at bleached clusters over time from a number of cultures (data 
from 3-5 culture dishes at each time point). We found that rapsyn clusters recovered 
fluorescence very rapidly, gaining 61% (±11 SD, n = 40) of original fluorescence after 
only 2 hours, 71% (±19 SD, n = 56) after 4 hours, and 75% (±18 SD, n = 58) after 6 
hours (Figure 6.3A,B). The recovery at each data point was nearly identical for rapsyn-
GFP clusters from myotubes not grown on laminin (2h: 63% ±12 SD, n = 35; 4h: 73% 
±17 SD, n = 15; 6h: 78% ±21 SD, n = 33) (Figure 3A, B). This recovery was not due to 
reversible bleaching of GFP, because no fluorescence was observed after bleaching 
rapsyn-GFP clusters on fixed myotubes. In addition we found that the recovery of rapsyn-
GFP over 4 hours was not affected by rapsyn-GFP expression levels (Figure 6.3C).  
Given this rapid rate of rapsyn insertion, and past reports suggesting that rapsyn is 
co-transported with AChRs to the cell surface (Marchand et al., 2000; Marchand et al., 
2002), we wanted to determine the rate of AChR insertion into individual clusters using 
the same FRAP method. To do this, myotubes were bathed with a single saturating dose 
of BTX-488 and then all fluorescence was carefully removed from individual clusters 
with an Argon laser. After 2, 4 or 6 hours a second dose of BTX-488 was added to label 
all AChRs that had been inserted into clusters over this time. We found that 15% (±4 SD, 
n = 30) of original fluorescence was returned to the clusters after 2 hours, 25% (±7 SD, n 
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= 54) after 4 hours, and 28% (±9 SD, n = 39) after 6 hours (data obtained from 3-5 
cultures per data point) (Figure 6.3A,B). The number of AChR molecules inserted over 
time was therefore significantly lower than the number of rapsyn-GFP molecules inserted 
over the same time period (see discussion). 
Given the large amount of rapsyn-GFP recovery during the first 2 hours, we 
wanted to monitor more closely the insertion of rapsyn-GFP immediately after 
photobleaching. To do this, rapsyn-GFP clusters on transfected myotubes were bleached, 
and time-lapse imaging was used to monitor the fluorescent recovery every 15 minutes at 
room temperature. We found that rapsyn-GFP recovery was 11% ±4 SD, 17 % ±5 SD, 
23% ±9 SD and 27 % ±11 SD at 15, 30, 45, 60 min (n=15 clusters/3 culture dishes) 
(Figure 6.3D,E). The rapid recovery of fluorescence observed in clusters is not due to 
reversible bleaching of the fluorophore, as rapsyn-GFP clusters on fixed myotubes that 
are bleached show no spontaneous fluorescence recovery, even over days (data not 
shown). We also found that the labeling of AChRs with BTX-647 also had no effect on 
rapsyn insertion dynamics, as rapsyn insertion measured by FRAP was identical at 
rapsyn-GFP expressing clusters that were not labeled with any BTX, and at rapsyn-GFP 













Figure 6.3. Rapsyn is inserted rapidly into individual clusters. (A) The insertion of rapsyn-GFP into 
individual clusters on myotubes grown either on laminin-coated dishes or uncoated dishes was 
measured by determining the fluorescent recovery after photobleaching using quantitative fluorescent 
imaging. The insertion of rapsyn-GFP into bleached laminin-associated clusters (top panels) and non-
laminin clusters (middle panels) is rapid and nearly identical over two hours in both cases. In contrast, 
acetylcholine receptor clusters that were labeled with bungarotoxin-Alexa 488, bleached, and then 
incubated in new bungarotoxin-488 (bottom panels) show far fewer inserted AChRs over the same time 
period. (B) Graph summarizes the data from the recovery of rapsyn and AChRs at 2, 4 and 6 hour time 
points. (C) The rate of rapsyn-GFP insertion is independent of the level of rapsyn-GFP expression. (D) 
Sample images from a time-lapse experiment in which the fluorescent recovery at a number of clusters 
was determined every 15 minutes for 60 minutes. (E) Results from 3 experiments performed as in (D) 
(n=15 clusters). Note that the recovery of fluorescence is > 25% after 1 hour even though cells were 
maintained at room temperature for the duration of the experiment. All graph points for (B) and (E) 
represent mean ± SEM, and all data were fit well by single exponential curves. Scale bars = 20 μm. 
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The clustering of AChRs and rapsyn are altered similarly by agrin treatment 
In order to determine if rapsyn and AChRs are regulated similarly despite the 
difference in dynamics, we attempted to manipulate AChR stability and insertion using 
the neuronal clustering factor, agrin. Our previous results showed that when agrin was 
added to myotubes grown on a laminin substrate, most new receptors were not directed 
into pre-existing laminin-induced clusters but instead formed numerous small aggregates 
on the entire muscle surface (Bruneau et al., 2005b). Since rapsyn is required for the 
clustering of AChRs, and its interaction with the receptor is highly regulated and 
increased by agrin (Moransard et al., 2003), we wanted to know whether newly inserted 
rapsyn molecules are also directed away from pre-existing laminin-associated clusters 
and into new, agrin-induced clusters when agrin is added to the cultures. To investigate 
this issue, transfected myotubes expressing rapsyn-GFP were labeled with BTX-594, 
imaged, treated with agrin and then imaged again 4 and 8 hours later. Over the time-
course of our study we found that rapsyn clustering was altered similarly to AChRs, 
being directed away from the same regions on laminin-associated clusters and inserted 




Effect of kinase inhibition on Rapsyn-GFP and AChR dynamics. 
Having found that AChRs and rapsyn respond similarly to agrin treatment, we 
wanted to extend our analysis to determine if alterations in kinase activity could affect 
rapsyn and AChRs in a similar manner. Previous studies have shown that agrin-induced 
clustering of AChRs can be inhibited by the broad spectrum kinase inhibitor, 
staurosporine (Wallace, 1994; Ferns et al., 1996; Marangi et al., 2002). To further 
investigate the role of kinase activity on receptor and rapsyn dynamics at single clusters, 
we performed a series of experiments using various kinase inhibitors. As a first step we 
Figure 6.4. Agrin redirects both AChRs and rapsyn away from pre-existing laminin clusters and 
into new agrin-induced clusters. Myotubes expressing rapsyn-GFP were incubated with BTX-594 to 
label all AChRs. Agrin was then added to the culture media and rapsyn and receptors were imaged 4 
and 8 hours later. Note that both AChRs and rapsyn were directed away from some locations on the pre-
existing laminin-associated clusters (arrowheads) and were also aggregated together into new, agrin-
induced clusters (arrows). Scale bar = 20 μm. 
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used the broad spectrum kinase inhibitor, staurosporine. To study the effect of 
staurosporine on receptor insertion, cultured myotubes were labeled with BTX-488, and 
clusters were imaged and photobleached. Cells were then incubated with 20 nM 
staurosporine and 4 hours later the cells were bathed with new BTX-488 to label all new 
receptors. We found that the number of AChRs accumulated at bleached clusters was 
significantly decreased to 18 % (±5 SD, n=15, p<0.0001) of the original receptor density, 
compared to 28% (±6 SD, n=20) for control clusters (Figure 6.5A,B). 
Since staurosporine inhibits PKC, PKA and other kinases, we wanted to more 
specifically determine the effect of PKA and PKC on receptor insertion. To do this, 
myotubes were labeled with BTX-488 as above and the recovery of fluorescence in 
bleached clusters was monitored in the presence of 100nM H-89 (to specifically block 
PKA), 20 nM H-89 (to block PKA and PKC) or 10 nM Calphostin C (to specifically 
block PKC). We found that 100 nM H-89 had no effect on receptor insertion (27% ±8 
SD, n=20) compared to controls. However, in the presence of 20 μM H-89, the 
accumulation of new receptors at bleached clusters decreased to 23% (±4 SD, n=21, 
p<0.005). Similar results were obtained when PKC was more specifically inhibited by 10 
nM Calphostin C (21% ±6 SD, n=20, p<0.005). At higher concentration of Calphostin C 
(> 50 nM), most cells were dead after 4 hours. These experiments suggest that PKC 
activity is somehow involved in the insertion of receptors (Figure 6.5B).  
Next we asked whether AChR loss was also affected by kinase inhibition. To 
answer this question, cells were labeled with BTX-488 and individual receptor clusters 
were imaged and then incubated with one of the same drugs used in the above 
experiments before being imaged again at 4 hours. At clusters on untreated control 
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myotubes, 72% of original fluorescence remained after 4 hours (±8 SD, n=15). When 
cells were treated with 100 nM H-89, 20 μM H-89 or 10 nM Calphostin C, there was no 
difference in receptor loss compared to control (68% ± 9 SD, n=23; 71% ± 10, n=10; 
73% ± 12, n=20) (Figure 5D). However, incubation in 20 nM staurosporine resulted in an 
increase in receptor removal from clusters, with only 52% of original fluorescence 
remaining at clusters after 4 hours (±10 SD, n=21, p<0.0001) (Figures 6.5C,D). These 
results suggest that staurosporine, in addition to inhibiting AChR insertion, increases 
receptor removal from clusters in a non PKC/PKA-dependent manner.  
Finally, we investigated whether rapsyn-GFP insertion is similarly affected by 
kinase inhibition. To do this, myotubes expressing rapsyn-GFP at clusters were imaged 
and the fluorescence was removed from individual clusters using an Argon laser. 
Bleached clusters were then imaged and staurosporine (20 nM), H-89 (100 nM or 20 μM) 
or Calphostin C (10 nM) were added to the cultures, and the rate of rapsyn-GFP insertion 
into the bleached clusters was determined at 4 hours. We found that bleached clusters 
regained 67% (±15 SD, n = 37), 64% (±15 SD, n = 10), 67% (±15 SD, n = 16) and 76% 
(±11 SD, n = 19) of their original fluorescence, respectively (Figure 6.5E,F). The 
insertion at bleached clusters was normalized to the changes in expression (if any) at 
control, unbleached clusters on the same myotube. It should be noted that higher 
concentrations (200 nM) of staurosporine did result in a significant decrease in rapsyn-
GFP insertion over 2 hours (clusters were too dim to be imaged after 4 hours) that was 
similar to the decrease in AChR insertion measured over the same time period. However, 
it seems likely that this was due to decreased cell viability, as has been observed 




Figure 6.5. Kinase inhibitors alter AChR dynamics, but not the dynamics of rapsyn-GFP. 
Laminin-associated clusters on rapsyn-GFP transfected myotubes were bleached, and on non-
transfected myotubes AChRs were labeled with BTX-488 before bleaching individual clusters. Cells 
were then incubated in either 100 nM H-89, 20 μM H-89, 10 nM Calphostin C or 20 nM staurosporine. 
Myotubes were imaged and the fluorescence at each cluster was compared to its original fluorescence. 
(A) Example of clusters that were bleached on either control or 20 nM staurosporine treated myotubes. 
(B) Graph summarizes data obtained from many clusters in untreated control cultures and in cultures 
incubated with one of the above drugs. Note that PKA inhibition alone had no effect on AChR 
insertion, while the blockade of PKC (with higher concentrations of H-89 and with Calphostin C) 
resulted in a significant decrease in AChR insertion. Inhibition of a broader spectrum of kinases along 
with PKC by staurosporine caused a slightly greater inhibition of AChR insertion. (C) Representative 
clusters showing loss of receptors from control myotubes or myotubes treated with 20 nM 
staurosporine. (D) AChR loss from individual clusters in the presence of the same kinase inhibitors 
shows that only incubation with staurosporine caused a decrease in overall receptor density remaining 
at clusters after 4 hours, indicating that the blockade of kinases other than PKA and PKC with 
staurosporine treatment resulted in the accelerated removal of AChRs from clusters. (E) Representative 
images of control and staurosporine-treated myotubes that are expressing rapsyn-GFP. (F) Clusters 
expressing rapsyn-GFP were bleached, and the insertion of rapsyn was measured by determining the 
recovery in fluorescence over time in the presence of the same drugs as used above. Note that the 
insertion of rapsyn-GFP was not altered by any of the drug treatments. Insertion into clusters was 
normalized to the changes in fluorescence at neighboring, unbleached clusters on the same myotube. 
All bar graphs represent mean ±SD. * indicates p-values < 0.005, ** indicates p-values < 0.0001 on a 
Student’s T-test. Scale bars = 10 μm.
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Discussion 
In this study, we investigated the dynamics of rapsyn in cultured myotubes and 
found that rapsyn is remarkably dynamic compared to AChRs. Further, although the 
localization of both rapsyn and receptor were similarly affected by agrin treatment, their 
dynamics were differentially regulated by kinase inhibition.  
One unexpected finding from this work is the rapid recovery of rapsyn-GFP 
fluorescence at individual clusters after photobleaching. For a number of reasons, we 
believe that the fused GFP is not interfering with rapsyn function, and that the recovery in 
fluorescence observed in our studies therefore reflects the turnover rate of rapsyn. First, it 
has been shown previously that the rapsyn-GFP construct used in the present studies is 
indistinguishable from wild-type rapsyn in its ability to associate with and cluster AChRs 
in heterologous cells (Ramarao and Cohen, 1998). Second, the present work demonstrates 
that rapsyn-GFP expression at clusters does not alter receptor function, clustering or 
turnover in muscle cells. Third, the rapid recovery of fluorescence after photobleaching 
was independent of rapsyn-GFP expression at myotube clusters (Figure 3). Finally, the 
accumulation of rapsyn-GFP at clusters was regulated by agrin in a similar manner as 
AChRs. Consistent with these observations, it has been shown that fluorescent rapsyn 
also recovers rapidly after photobleaching in QT-6 cells (Gervasio and Phillips, 2005). 
The remarkable dynamism of rapsyn at surface clusters is further supported by 
biochemical studies which show that the metabolic turnover of rapsyn is short compared 
to AChRs, with a metabolic half-life of ~ 3 hours (Frail et al., 1989). Since our studies 
were done on aneural receptor clusters, it is possible that the turnover of rapsyn might be 
decreased under the influence of the nerve. Further studies investigating the dynamics of 
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rapsyn at the NMJ will be necessary to determine if rapsyn is indeed stabilized by 
innervation. Although we cannot definitively exclude the possibility that GFP may 
diminish the affinity of rapsyn for the AChR or other scaffold proteins, these results 
argue strongly that rapsyn-GFP behaves as endogenous rapsyn, and that rapsyn therefore 
turns over very rapidly in muscle cells.  
While our studies indicate that the acetylcholine receptor-associated protein turns 
over more rapidly than AChRs, recent studies on the turnover of receptor-associated 
proteins at glutamatergic synapses have yielded analogous results. For example, PSD-95, 
a dynamic protein affiliated with the AMPA and NMDA receptors (Rutter and 
Stephenson, 2000; Chetkovich et al., 2002; Choi et al., 2002; El-Husseini Ael et al., 
2002; Schnell et al., 2002; Cai et al., 2006), when tagged with GFP and measured with 
FRAP was shown to turn over very rapidly relative to the glutamate receptors with which 
it associates (Rasse et al., 2005; Sharma et al., 2006a). This result opens the possibility 
that the rapid turnover of rapsyn observed in muscle cells in the present study may be 
similar to the behavior of receptor-associated proteins in the central nervous system.  
Previously it has been shown that AChRs and rapsyn are transported together in 
the same intracellular vesicles from the Golgi complex to the membrane surface both in 
COS cells co-transfected with AChRs and rapsyn, and at the mature torpedo electric 
organ (a structure analogous to the mammalian NMJ) (Marchand et al., 2000; Marchand 
et al., 2002). While the ratio of rapsyn to receptor during intracellular trafficking remains 
undetermined, estimates from our results suggest that multiple rapsyn molecules may 
accompany each AChR to the membrane surface in aneural myotubes. 
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In addition to highlighting the difference in turnover between receptors and 
rapsyn, the present study also shows that the expression of exogenous rapsyn at clusters 
does not increase receptor stability. The effect of exogenous rapsyn on AChR dynamics 
has previously been studied in heterologous cells. In these studies, the effect of rapsyn on 
AChR stability was determined by comparing the degradation of radioactive-
bungarotoxin in heterologous cells devoid of endogenous rapsyn to cells transfected with 
rapsyn cDNA (15,29,30). They found that the metabolic half-life of receptors was 
increased upon co-expression with rapsyn. A recent study also indicates that the over-
expression rapsyn through electroporation of rapsyn-GFP into muscle cells in vivo can 
stabilize receptors (Gervasio and Phillips, 2005). This in vivo result is further supported 
by findings that mutant rapsyn results in a decrease in receptor stability in some forms of 
myasthenia gravis (Ohno et al., 2002). By contrast, our results indicate that rapsyn-GFP 
expression at clusters did not alter AChR stability. This result can be explained by two 
possibilities. First it is conceivable that that exogenous rapsyn-GFP is able to replace 
endogenous rapsyn at clusters without increasing rapsyn density, as demonstrated by 
quantitative immuno-fluorescence (Figure 1C-E). It is also possible that despite the 
strong GFP fluorescence signal, the number of exogenous rapsyn-GFP molecules inserted 
at clusters was negligible compared to the density of endogenous rapsyn. It is important 
to mention that the anti-rapsyn antibody used for assaying the total rapsyn content has 
been shown to recognize both endogenous rapsyn and exogenous rapsyn-GFP (Gervasio 
and Phillips, 2005).  
Despite the difference in turnover between rapsyn and AChRs, our work indicates 
that both rapsyn and AChRs are subject to similar modulation following treatment with 
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neural agrin. Previously, work from our lab has shown that when AChRs at laminin-
associated clusters are treated with agrin, most new receptors are not directed into pre-
existing laminin-induced clusters but instead form numerous small aggregates on the 
entire muscle surface (Bruneau et al., 2005b). The present work extends this observation 
and demonstrates that when agrin is added to myotubes, rapsyn-GFP is directed into the 
new aggregates to co-localize with AChRs, suggesting that rapsyn and AChRs are 
responding to agrin similarly and simultaneously. It is possible that the redirection of 
AChRs into small aggregates is driven by the rapsyn, since rapsyn is the bridge between 
biological activity following agrin treatment and receptor clustering. This idea is 
supported by experiments showing that AChRs fail to associate with cytoskeletal proteins 
in agrin treated myotubes devoid of rapsyn (Fuhrer et al., 1999; Mittaud et al., 2001). In 
fact, AChRs fail to cluster at all in vitro or in vivo when rapsyn is not present (Apel et al., 
1995; Gautam et al., 1995; Ramarao and Cohen, 1998). On the other hand, there is also 
reason to believe that rapsyn could instead follow AChRs to clusters. For example, in the 
absence of receptors, rapsyn fails to cluster (Marangi et al., 2001; Ono et al., 2001) 
(Bruneau et al., unpublished results).  
Although rapsyn and AChR are intimately associated and similarly directed by 
agrin, the mechanisms regulating their delivery and removal from individual clusters are 
at least partially distinct. While PKA inhibition with 100 nM H-89 had no effect on the 
insertion of rapsyn or AChRs, or on the loss of AChRs from individual clusters, 
inhibition of PKC with higher concentrations of H-89 (20 μM) or 10 nM Calphostin C 
significantly decreased AChR insertion without affecting AChR loss or rapsyn insertion. 
The broad-spectrum kinase inhibitor staurosporine was able to further decrease AChR 
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insertion, and resulted also in the increase in AChR removal without altering rapsyn 
insertion. Previous work has shown that the in vivo inhibition of PKC by Calphostin C 
injection retards the development of neuromuscular synapses (Lanuza et al., 2002). 
Although our cells are aneural, they were plated on laminin, which has been shown to 
mimic, at least in some respects, the development of the neuromuscular junction 
(Kummer et al., 2004). Therefore, it is possible that the mechanism by which PKC 
inhibition decreases AChR insertion in our system could account for the alterations in 
post-synaptic growth observed when PKC is blocked in vivo by the same 
pharmacological agent. The fact that staurosporine increases the removal of AChRs in 
addition to decreasing their insertion implies that staurosporine may act to increase AChR 
dispersal through a non-PKA/PKC-dependent mechanism. In support of this conclusion, 
it has been shown previously that non-PKC-dependent tyrosine phosphorylation 
contributes to receptor clustering. For example, Src class kinases promote the 
phosphorylation of the beta subunit and increase the association of AChRs with the 
intracellular cytoskeleton (Fuhrer and Hall, 1996; Mohamed and Swope, 1999; Mohamed 
et al., 2001; Sadasivam et al., 2005), and agrin-induced receptor clusters are removed 
rapidly in the absence of Src class kinases (Mohamed et al., 2001).  
Our results show that rapsyn-GFP insertion was not affected by any of the kinase 
inhibitors used. This may indicate that the synthesis and delivery of rapsyn to individual 
clusters is independent of the phosphorylation either of rapsyn or of proteins that are 
necessary for rapsyn exocytosis. Previous reports have shown that receptors and rapsyn 
are co-transported in the same vesicle and inserted into the plasma membrane. It is 
possible that the difference in the amount of receptor and rapsyn insertion when cultured 
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cells were treated with PKC inhibitor could therefore be due to impaired transcription of 
receptors compared rapsyn.     
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In this thesis I have described a body of work that has investigated the dynamics 
and regulation of acetylcholine receptors and scaffolding proteins, as well as the 
interactions between these post-synaptic protein populations, both in vitro in cultured 
myotubes, and in vivo in the living mouse neuromuscular junction. While AChR 
dynamics have been studied for over 3 decades at the mouse neuromuscular junction with 
radio-labeled bungarotoxin, the availability of fluorescently conjugated bungarotoxin and 
recent advances in fluorescence microscopy have enabled a mini-renaissance in our 
understanding of AChR dynamics and the regulated development of the neuromuscular 
synapse. It is in this context that I began my work in Mohammed Akaaboune’s lab. The 
highlights of my work include the following: the identification of an interaction between 
agrin and substrate laminin that causes a shift in clustering that is reminiscent of the shift 
from pre-patterned AChR clusters to agrin-induced neuromuscular junctions; the 
identification of a previously unknown recycled receptor pool in vivo, which we found to 
be highly dynamic and regulated by post-synaptic activity, but that is absent in vitro; 
characterization of a novel method by which to induce the dissipation of Alexa 594 
labeled AChRs with low-intensity laser light, which enabled us to determine that AChRs 
are critical organizing components of the post-synaptic scaffold; analysis of rapsyn 
 179
dynamics in vitro, which showed that rapsyn is more dynamic than the receptors to which 
it binds, and indicated that the turnover of rapsyn and AChRs are differently regulated by 
phosphorylation. The background of the field and my specific contributions to our current 
understanding are summarized in the following sections.  
Synaptic development 
Although neural agrin has been identified as the nerve clustering factor essential 
for the development of the mature neuromuscular junction (McMahan, 1990; Reist et al., 
1992), the spontaneous clustering of AChRs and scaffolding components occurs even in 
aneural cultured myotubes. Agrin-independent clustering of post-synaptic components 
requires rapsyn and the receptors themselves and has been shown to be induced by the 
extracellular matrix protein, laminin (Montanaro et al., 1998; Marangi et al., 2002). 
During development AChR clusters also form prior to innervation near the site of 
eventual innervation, raising the possibility that pre-patterned junctions may be replaced 
by agrin-induced AChR clusters upon innervation. Although recent work suggests that 
nerves can be induced to grow to pre-patterned clusters of MuSK (Kim and Burden, 
2008), high resolution time-lapse imaging is not possible in utero, so the question of 
whether incoming nerve terminals grow to the pre-patterned junctions or whether they 
replace these junctions with new AChR clusters is still not clearly understood. In my 
work I used an in vitro system to examine this question (Bruneau et al., 2005b). To do 
this I first cultured C2C12 myotubes on a laminin substrate to stimulate the formation of 
large, topologically complex AChR clusters and then identified receptor clusters by 
incubating the cells with fluorescent bungarotoxin. By adding soluble agrin to the media 
and then adding new fluorescent bungarotoxin to the cell cultures at later time points, I 
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was then able to track the formation of new clusters and the fate of originally imaged 
laminin-induced clusters. From these studies I found that new, agrin induced clusters 
grew quickly over the course of hours, while laminin-induced clusters rapidly dissipated. 
The addition of agrin therefore resulted in the re-distribution of receptors to new, agrin-
induced clusters and re-directed the insertion of new receptors to these clusters. While the 
mechanism by which agrin negates laminin clustering is not known, this data supports a 
model of agrin-induced NMJ formation in which pre-patterned AChR clusters are 
replaced by new, agrin-induced clusters after innervation during synaptic development in 
vivo.  
Receptor dynamics 
Once the synapse is formed and the cluster has gained a more mature, pretzel-
shaped topology, receptor density and cluster architecture is maintained over months. 
Beginning nearly 40 years ago AChR turnover studies relied mostly on radio-labeling, 
which required the removal of the muscle to assay receptor density (Fertuck and Salpeter, 
1974, 1976). A common finding from these studies was that two populations of AChRs 
existed at the NMJ: one that turns over rapidly and one that turns over more slowly. More 
recently the availability of fluorescent bungarotoxin conjugates and the development of 
quantitative fluorescent imaging allowed the investigation of receptor density over time 
at the same junction in the living muscle. These studies demonstrated that the synaptic 
dwell-time of AChRs is dependent upon synaptic activity: when the synapse is active, 
synaptic turnover is slow, and when synaptic activity is blocked, turnover increases 
(Akaaboune et al., 1999). This indicates that rather than two different populations of 
receptors with distinct turnover rates, AChR turnover is activity-dependent, with turnover 
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decreasing over time when synaptic activity slowly recovers as new, unlabeled (and thus 
unblocked) AChRs are progressively inserted into the synapse. In addition to synaptic 
activity, recent evidence also indicates that scaffolding proteins are involved in AChR 
turnover. For example, the rate of AChR removal is significantly increased in mice 
deficient in dystrobrevin, and AChRs are stabilized in the membrane after co-transfection 
with rapsyn in heterologous cells (Wang et al., 1999b; Akaaboune et al., 2002).  
While it has been recognized for many years that the insertion, lateral mobility 
and removal of receptors provides a dynamic equilibrium that enables the AChR density 
to remain relatively constant, underlying this was an assumption that unlike receptors in 
central synapses, AChRs make a one way trip to be degraded following removal from the 
membrane. This question had not been directly investigated, though, since there was no 
method with which to study receptor recycling in vivo. This limitation was overcome in 
our lab by using a two-step labeling method (Bruneau et al., 2005a; Bruneau and 
Akaaboune, 2006a). In this technique, AChRs in vivo were labeled first with btx-biotin 
and then strept-Alexa. The binding at later time points of new strept-Alexa indicated that 
these labeled AChRs had lost their original strept-Alexa tag while retaining their btx-
biotin label. Since a number of controls determined that this biotin-streptavidin 
dissociation does not happen at the muscle surface, this result indicated that a significant 
number of AChRs were internalized, stripped of their strep-Alexa tag and then returned 
to the muscle surface. We found that this AChR recycling mechanism was rapid and 
robust, inserting recycled AChRs into the synapse within 2 hours and inserting a large 
number of receptors into the synapse over time. Following post-synaptic activity 
blockade receptor recycling was inhibited, and even more suppressed than the insertion 
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of newly synthesized receptors. Surprisingly, we found also that recycled AChRs turn 
over more rapidly than non-recycled AChRs despite being intermingled in the same post-
synaptic membrane, arguing that the recycled receptor pool is specifically regulated. In 
agreement with this idea, we found that recycled AChRs are selectively mistargeted to 
perisynaptic sites by phosphatase inhibition. Finally, receptor recycling was found to be 
absent in vitro, indicating that the activation of recycling may be activated by 
innervation. Together these studies identified and characterized a previously unknown 
receptor recycling mechanism that provides a significant portion of the AChRs at the 
mature NMJ and enables post-synaptic receptor density to remain constant over time.  
Receptor-scaffold interactions 
Anchoring the AChR in place at the NMJ is a complex of proteins that 
collectively make up the post-synaptic scaffold. Naturally occurring mutations, genetic 
knockouts and protein truncations have revealed the essential role that a number of these 
proteins play in the initiation of AChR clustering. For example, MuSK, Dok-7 and rapsyn 
knockouts do not form mature neuromuscular junctions at motor nerve terminals, and 
muscle cells from these mice do not form spontaneous clusters when cultured in vitro 
(Gautam et al., 1995; DeChiara et al., 1996; Okada et al., 2006). Other post-synaptic 
density (PSD) proteins affect AChR density more subtly. Deletions in utrophin, for 
example, disrupt AChR organization by decreasing post-synaptic folding, but have little 
effect on AChR density or turnover (Deconinck et al., 1997; Grady et al., 1997). Alpha-
dystrobrevin knockouts, on the other hand, show a dramatic decrease in post synaptic 
AChR density and an increase in AChR turnover (Akaaboune et al., 2002). Even while 
these knockout mice indicate that a complex network of post-synaptic proteins enable 
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proper AChR clustering, it was not clear whether AChRs are required for the 
establishment and maintenance of the scaffolding complex. 
It was in this context that I stumbled upon an interesting interaction between low-
power laser emission and bungarotoxin Alexa 594 conjugates that resulted in the 
dissipation of AChRs from illuminated spots (Bruneau et al., 2008). This serendipitous 
discovery enabled me to directly investigate a number of AChR-scaffolding protein 
interactions. From these studies I found first that the laser-induced dissipation of AChRs 
from individual clusters on C2C12 myotubes resulted in the complete dissipation of 
rapsyn, dystroglycan, utrophin and scaffold-specific actin from the illuminated clusters 
without affecting the muscle membrane or intracellular cytoskeleton. This indicates that 
AChRs are not only necessary for the formation of post-synaptic scaffolds in skeletal 
muscle cells, but that a high density of AChRs is required to maintain the post-synaptic 
scaffold and enable new scaffolding proteins to accumulate at that spot. Further, since 
dissipation of AChRs and associated scaffolding proteins occurred only from illuminated 
regions, even from small regions within individual clusters, it seems likely that the 
AChRs and scaffolding proteins are organized not as a complex network of cross-linked 
proteins, but rather as modular units of AChRs and their associated scaffolding 
components that can be untethered from surrounding scaffold and locally removed. 
Finally, not all receptors in a given region needed to be labeled with btx-594 and 
illuminated in order for the entire AChR density and intracellular scaffold to dissipate. 
This indicates that a critical density of AChRs may be required in order for the local 
intracellular scaffolding proteins to accumulate and be maintained. Since these studies 
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were performed on muscle cell cultures, it remains to be seen whether this effect will be 
applicable in vivo. 
Receptor-associated protein dynamics 
Over the past decades, AChR dynamics have been extensively studied, while the 
movement and regulation of scaffolding proteins have received little attention. Since 
many lines of evidence indicate that dynamic changes in the post-synaptic apparatus 
(receptors and associated scaffolding proteins) may underlie synaptic plasticity during 
development, learning and memory, recent work has turned towards investigating the 
dynamics of the intracellular receptor scaffold. 
What remains unclear about the scaffold is the stability and potential regulation of 
the scaffolding proteins with which the receptors associate. The lack of information about 
scaffolding protein dynamics is largely due to the inaccessibility of intracellular proteins 
to fluorescent ligands such as bungarotoxin, which has enabled detailed investigation of 
AChR dynamics both in vitro and in vivo. We sought to circumvent this limitation by 
introducing rapsyn-GFP fusion proteins into cells so that we could use the same 
quantitative fluorescent microscopy techniques that we have used previously to 
characterize AChR dynamics. By transfecting C2C12 myotubes with rapsyn-GFP and 
using FRAP, we were able to investigate rapsyn dynamics in vitro (Bruneau and 
Akaabourne, 2007). The principle, and surprising, finding from these studies was that 
rapsyn turns over at laminin-induced clusters approximately 4 times more rapidly than 
the receptors to which it binds. The second main finding from this work was that receptor 
insertion and removal are affected by kinase inhibitors, while rapsyn dynamics are not. 
Together these findings challenge the view that the intracellular receptor scaffold is a 
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static and stable structure, and provides evidence that receptor and rapsyn dynamics are 
regulated by distinct mechanisms. Analogously, recent studies on receptor-associated 
proteins at glutamatergic synapses have also been shown to turn over more rapidly than 
the receptors to which they associate, and that scaffolding protein turnover can be 
regulated by distinct mechanisms.  
Future directions: Rapsyn in vivo 
Expanding on the results above and utilizing all the molecular biology, cellular 
biology and live animal quantitative fluorescence microscopy that I have acquired in my 
graduate studies is a final, ongoing project to determine the turnover and regulation of 
rapsyn in vivo. Some significant progress has been made in this project, and clear future 
directions for the continuation of this research have emerged.  
To determine the turnover of rapsyn in vivo, I had to first insert rapsyn-GFP into 
living mouse muscles. Using electroporation I have now successfully inserted plasmids 
containing a rapsyn-GFP fusion protein construct into the mouse sternomastoid muscle 
without damaging the muscle fibers. Expression of the rapsyn-GFP at synapses appears 
to be stable, even over months, with an average loss of fluorescence of <3% per day at 
any given synapse when measured at 3, 6, 21 or 42 days (Figure 7.1). Similar to the 
FRAP studies of rapsyn-GFP turnover in vitro, I have also been able to successfully 
measure the recovery of GFP fluorescence over time at individual synapses expressing 
rapsyn-GFP. As with protein turnover in vitro, we have found that rapsyn turns over ~4 
times more rapidly than AChRs at the same synapse. These experiments were performed 
both in fully active muscles that were incubated with a sub-saturating dose of btx-594, 
and in muscles that were incubated with a saturating dose of btx-594 which transiently 
 186
blocks post-synaptic muscle activity (Figure 7.2). As has been shown previously, 
complete inhibition of post-synaptic activity is able to increase AChR turnover at 
synapses, while an incomplete block of less than ~20% of the AChRs at the synapse 
allows normal muscle activity and slower AChR turnover. Although the effect of muscle 
activity blockade on AChR turnover was clearly evident, the insertion of rapsyn at 
functional and transiently blocked synapses was similar. This suggested that changes in 
activity which dramatically alter AChR turnover at synaptic sites may not have an effect 
on rapsyn dynamics. 
 
Figure 7.1. Rapsyn-GFP expression is stable over weeks at individual synapses in vivo following 
electroporation. Mouse sternomastoid muscle was electroporated with rapsyn-GFP and 4 weeks later 
the muscle was exposed and imaged (d0). At various time points over the following 6 weeks the muscle 
was re-exposed and the same synapses were imaged. (A) A representative synapse imaged at multiple 
time points over 6 weeks. Images were all taken using the same imaging parameters. (B) Quantitative 
fluorescence data from a number of synapses imaged as in (A). All data represented as mean ±S.D. 
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Figure 7.2. Synaptic Turnover of Rapsyn-GFP is Significantly more Rapid than the Turnover of 
AChRs at the Same Synapse. Sternomastoid muscles of living mice were electroporated with rapsyn-
GFP. At least 4 weeks later the muscles were re-exposed, synapses expressing rapsyn-GFP were 
imaged and then fluorescence from discrete sections of individual junctions was removed with a laser. 
Muscles were then incubated immediately in either (A) saturating or (B) non-saturating doses of Btx-
biotin followed by a saturating dose of strept-594. After labeling, synapses were imaged and initial 
fluorescence from AChRs and recovered fluorescence from rapsyn-GFP was measured. After 1 and/or 3 
days the muscle was re-exposed and the same synapses were again imaged. (C) Data from many 
synapses measured as in (A) and (B). Since overall AChR density remains constant over these time 
periods (Bruneau et al., 2005a), receptor loss was converted to receptor insertion for ease of comparison 
with rapsyn-GFP insertion. Note that AChR removal/insertion is dramatically altered at saturated (post-
synaptic activity blocked) vs. unsaturated (post-synaptic activity not blocked) synapses, while rapsyn 
insertion is unaffected by activity blockade at these same synapses. All data represent mean ±S.D.  
 
To directly test if rapsyn turnover is subject to modulation by post-synaptic 
activity blockade, we performed the following experiments: first, we examined rapsyn 
insertion using the same methods as above in muscle that had been denervated 8 days 
previously that were then labeled with btx-594. As shown previously, muscle denervation 
resulted in a dramatic increase in AChR removal 1 and/or 3 days later (Figure 7.3A). 
Consistent with the role of post-synaptic activity on AChR turnover from synapses, 
 188
AChR removal from denervated synapses was best described by a linear function (since 
post-synaptic activity was chronically absent), while removal from innervated control 
synapses was best fit by 2 functions (as complete post-synaptic blockade was only 
transient in these synapses). The first question we asked was whether AChR removal was 
altered by the presence of rapsyn-GFP at these denervated synapses. It has been shown 
previously that the overexpression of rapsyn is able to decrease AChR loss in 
experimental myasthenia gravis (Losen et al., 2005; Martinez-Martinez et al., 2007). If 
the presence of rapsyn-GFP results in an overall increase in rapsyn density at 
electroporated synapses, then we suspected that AChR removal might be slowed. We 
found, however, that AChR removal was unaffected at synapses expressing rapsyn-GFP 
(Figure 7.3B). This indicates either that increased rapsyn does not prevent AChR loss 
following denervation, or that rapsyn-GFP may replace endogenous rapsyn at synapses in 
our system to keep rapsyn density constant at the synapse, consistent with our results in 
vitro (Bruneau and Akaabourne, 2007). We also investigated the overall change in 
rapsyn-GFP density at synapses on denervated muscles. Although overall AChR and 
rapsyn transcription increase following denervation, the expression of each protein at 
synaptic sites decreases. Since the rapsyn-GFP construct is driven by a CMV promoter 
rather than a rapsyn promoter, we were interested to see what effect denervation had on 
the synaptic expression rapsyn. We found that overall rapsyn-GFP density decreased 
dramatically over 3 days in denervated synapses (Figure 7.3A, B). Consistent with our 
previous work (Bruneau et al., 2008), this suggests that AChRs may be critical for 
maintaining rapsyn density in vivo. Finally, we also examined rapsyn dynamics at 
denervated synapses with FRAP. When fluorescent recovery at bleached regions was 
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normalized to the fluorescence at unbleached control regions of the same synapse, 
recovery was similar to the normalized recovery of fluorescence at synapses on the non-
denervated control muscle in the same animal (Figure 7.3A, C). When we examined 
rapsyn-GFP insertion prior to normalization, the insertion of rapsyn (46 ± 20% (s.d.) of 
original fluorescence, n = 9) was nearly half the insertion at innervated synapses (83 ± 
14% (s.d.) of original fluorescence, n = 14) over the same time period. Interestingly, 
when btx-594 was added at the end of the experiment, the resulting increase in 
fluorescence from btx-594 binding to newly inserted receptors was similar for both 
denervated (32 ± 11% (s.d.) of original fluorescence, n = 14) and innervated (33 ± 6% 
(s.d.) of original fluorescence, n = 7) muscles. These data indicate that rapsyn insertion 
may be altered by denervation while receptor insertion is not. In light of the fact that 
nerve trophic factors may be necessary to induce and maintain AChR recycling, these 
preliminary results suggest that rapsyn turnover may also be regulated by trophic factors. 
At the least, these results are interesting and warrant further investigation. 
As a second test for the effect of activity on rapsyn insertion, we examined AChR 
and/or rapsyn turnover at rapsyn-GFP expressing synapses that were either unblocked or 
chronically blocked with a saturating dose of btx-594 followed by constant incubation 
with curare. For synapses that were incubated with btx-594, both GFP and Alexa 594 
fluorescence were removed from synapses and the muscles were re-incubated with new 
btx-594 at the end of the experiment to label the new, unblocked AChRs that were 
inserted over the experimental period. Animals were maintained on a ventilator for the 
duration of the experiment to prevent asphyxiation. Similar to previous studies, we found 
that chronic inhibition of post-synaptic activity almost completely prevented AChR 
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insertion during the 8 hours of blockade. Interestingly, for both conditions the insertion of 
rapsyn-GFP was similar (Figure 7.4). Although preliminary, these studies indicate that 
the turnover of rapsyn from synaptic sites is significantly more rapid than the turnover of 




Figure 7.3. Normalized Rapsyn-GFP Synaptic Turnover is Unaffected by Denervation. Four days 
after rapsyn-GFP electroporation of both sternomastoid muscles, the left muscle of a number of mice 
was denervated by surgically by removing a 5 mm section of the sternomastoid nerve. Eight days later 
the fluorescence was removed from discrete regions of individual synapses expressing rapsyn-GFP by 
carefully tracing the region with a laser. The muscles were then incubated in a saturating dose of Btx-
594 and images of synapses expressing rapsyn-GFP and synapses devoid of rapsyn-GFP were taken on 
both denervated and control muscles.  (A) Sample image of a synapse expressing rapsyn-GFP on a 
denervated muscle. FRAP calculated at bleached synaptic regions is relative to original fluorescence at 
0h and normalized (in parenthesis) to unbleached regions of the same synapse at each time point. Note 
that the presence of rapsyn-GFP does not prevent the accelerated receptor loss at denervated synapses. 
(B) Quantification of receptor loss from denervated synapses either devoid of or expressing rapsyn-GFP 
shows that rapsyn-GFP expression does not slow AChR loss. (C) Data obtained from many experiments 
performed as described above show that rapsyn-GFP insertion (normalized to unbleached regions of the 
same synapse at each time point) after 5 hours and 3 days is similar at innervated and denervated 




Figure 7.4. Rapsyn-GFP synaptic turnover is not altered by post-synaptic activity blockade. 
Sternomastoid muscles of living mice were electroporated with rapsyn-GFP, and at least 4 weeks later 
the muscles were surgically exposed. (A) Muscles were incubated with a saturating dose of btx-594 and 
initial images were taken. The GFP fluorescence from rapsyn-GFP and the Alexa 594 fluorescence 
from AChR-btx-594 were removed from discrete sections of individual synapses with a laser and the 
muscle was immediately incubated in the AChR antagonist, curare, for the duration of the experiment. 
After 8 hours fresh btx-594 was applied to label any newly inserted receptors (and also any receptors 
that had lost their btx-594 tag after photo-unbinding), and images were again obtained. Note that rapsyn 
insertion is far greater than AChR insertion/re-binding at the same synapse. (B)  A sample image of a 
synapse that was imaged and bleached of rapsyn-GFP fluorescence in the absence of any post-synaptic 
activity blockade. (C) Data obtained from 7 and 13 synapses from experiments done as in (A) and (B), 









In preparation for the final stage of this work, we have begun to develop an 
shRNA construct that will allow us to replace rapsyn with rapsyn-GFP at individual 
synapses. The reasons for pursuing this line of investigation are many-fold: for example, 
it will provide a powerful control that will enable us to determine if rapsyn-GFP serves as 
an effective mimic of endogenous rapsyn, and it will enable us to ask a number of novel 
questions about the role of rapsyn density on AChR synaptic dynamics. As a first step I 
have created a rapsyn-GFP construct that contains 5 silent point mutations at the wobble 
positions within the rapsyn gene that is targeted by the shRNA oligomer (rapsyn5*-GFP), 
rendering the mRNA transcript of this rapsyn5*-GFP invisible to the shRNA. A control 
GFP-dystrobrevin construct has also been created to test the effectiveness of the shRNA 
rapsyn in vivo. The control will be performed by inserting the GFP-DB gene sequence 
into the shRNA plasmid at a second cloning site that allows the fusion protein to be 
driven by a CMV promoter. Since the GFP-DB construct codes for both DB-1, which is 
expressed selectively at synaptic sites, and DB-2, which is expressed extrasynaptically, 
this will allow effective identification of electroporated fibers containing the rapsyn 
shRNA. Electroporated muscles will be immediately incubated in btx-594 (to label all 
AChRs) and fasciculin2-647 (to label all AChEs), and the quantitative fluorescence at 
individual synapses will be assayed. The DB-2 labeling will allow us to identify 
electroporated muscle fibers, and the fasciculin2-647 labeling will enable us to locate 
synaptic sites even if rapsyn knock-down results in the complete dissipation of synaptic 
AChRs, since the extracellular AChE molecules labeled with fasciculin2 have been 
shown to remain even after nerve retraction has induced the post-synaptic cluster to 
disperse. Subsequent labeling days or weeks later with new btx-594 will enable us to 
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Figure 7.5. Triple-labeling of dystrobrevin, acetylcholine receptors and acetylcholinesterase at the 
neuromuscular junction. Sternomastoid muscles of living mice were electroporated with GFP-
dystrobrevin (GFP-DB) and then incubated with btx-594 (to label all AChRs) and Fasciculin2-647 (to 
label all AChEs). Note that the dystrobrevin isoforms label both the junction and the muscle surface, as 
indicated by green staining at the synapse and along the length of the muscle fiber.  
assess the rate of receptor dissipation, which should provide an estimate of rapsyn knock-
down since rapsyn is required for AChR clustering. However, since rapsyn dissipation 
from synapses may precede AChR dispersion, we will also use quantitative 
immunohisochemistry of muscles fixed at various times after electroporation to 
determine the rapsyn density at muscles expressing GFP-DB (and rapsyn shRNA) and at 
neighboring fibers on the same muscle that are not electroporated with rapsyn 
shRNA/GFP-DB. Our initial experiments have shown that individual synapses expressing 
GFP-DB can be identified within 24 hours of electroporation and can be labeled with btx-
594 and fasciculin2-647 and imaged at later time points, verifying the feasibility of this 
approach (Figure 7.5).  
 
 
After determining the time of maximum rapsyn knock-down with these control 
experiments, we will electroporate muscles with the rapsyn shRNA/rapsyn5*-GFP 
construct, and then incubate the sternomastoid muscle with a saturating dose of btx-
biotin/strept-594 at a time point after maximum knock-down to label all superficial 
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AChRs. Subsequent imaging of Alexa 594 fluorescence 1 and/or 3 days later will enable 
us to determine the rate of receptor loss at synapses expressing exogenous rapsyn5*-GFP 
and at synapses on neighboring, non-electroporated fibers containing only endogenous 
synaptic rapsyn. Imaging after sequential labeling with new strept-594 and then new Btx-
biotin/strept-594 will enable us to determine AChR recycling and AChR insertion, 
respectively, at synapses containing only rapsyn5*-GFP and at synapses containing only 
endogenous rapsyn. This will enable us to compare AChR removal, insertion and 
recycling at synapses exclusively expressing exogenous rapsyn5*-GFP and at synapses 
exclusively expressing endogenous rapsyn on different fibers on the same sternomastoid 
muscle. Finally, in a separate set of experiments, synapses containing rapsyn5*-GFP and 
synapses containing only endogenous rapsyn will be labeled with btx-594 and the Alexa 
594 fluorescence from individual synapses will be removed with a laser. Recovery of 
fluorescence over time will then be assessed to determine the rate of receptor migration 
from extrasynaptic to synaptic regions. Together, these experiments will allow us to 
definitively determine if exogenous rapsyn-GFP mimics the AChR clustering function of 
endogenous rapsyn. Further, if AChR dynamics correlate with the density of exogenous 
rapsyn-GFP expression at synapses (determined by average synaptic GFP fluorescence), 
this would indicate that rapsyn density is able to regulate AChR density at synapses, 
potentially serving as a mechanism by which synaptic plasticity may be governed.  
A second set of experiments will determine rapsyn-GFP turnover using FRAP 
analysis of rapsyn-GFP after 1 and/or 3 days. If these results are similar to the results 
obtained at clusters on muscles electroporated with only rapsyn-GFP, which presumably 
contain mixed populations of endogenous rapsyn and exogenous rapsyn-GFP, the RNAi 
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data will be pooled with data already obtained. If the data obtained from the rapsyn 
shRNA/rapsyn5*-GFP FRAP experiments are different, then this data will replace the 
data obtained in rapsyn-GFP electroporation experiments.  
If the shRNA approach is successful, it opens the door to a number of exciting 
future options. For example, the replacement of endogenous rapsyn with various rapsyn 
constructs containing common mutations which cause myasthenic syndrome could allow 
us to examine the effect of these mutant rapsyn proteins on receptor and rapsyn dynamics 
and the maintenance of the post-synaptic apparatus, while the insertion of various GFP-
dystrobrevin constructs into adbn-/- mice could allow analogous studies on the dynamics 
of dystrobrevin and the effect of dystrobrevin on the maintenance of the intracellular 
scaffold. This represents an exciting potential future and an interesting extension of the 
work that I have completed in my PhD studies, which may expand our understanding of 
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